| 1 |
Kasahara K, Tanaka-mizuno S, Tsuji S, Ohashi M, Kasahara M, Kawasaki T, Murakami T. Epidemiology of premenopausal osteoporosis in Japan: a retrospective cohort study based on real-world data.. [DOI: 10.21203/rs.3.rs-2649675/v1] [Reference Citation Analysis]
|
| 2 |
Brent MB. Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies. Pharmacol Ther 2023;244:108383. [PMID: 36933702 DOI: 10.1016/j.pharmthera.2023.108383] [Reference Citation Analysis]
|
| 3 |
Cianferotti L, Cipriani C, Corbetta S, Corona G, Defeudis G, Lania AG, Messina C, Napoli N, Mazziotti G. Bone quality in endocrine diseases: determinants and clinical relevance. J Endocrinol Invest 2023. [PMID: 36918505 DOI: 10.1007/s40618-023-02056-w] [Reference Citation Analysis]
|
| 4 |
Bayir A. Generalized tonic-clonic seizures cause lumbar spine fracture. Genel Tıp Dergisi 2023. [DOI: 10.54005/geneltip.1192647] [Reference Citation Analysis]
|
| 5 |
Ferraù F, Giovinazzo S, Alessi Y, Catalano A, Tessitore A, Mormina E, Bellone F, Giuffrida G, Paola G, Cotta OR, Ragonese M, Granata F, Lania AG, Mazziotti G, Cannavò S. Trabecular bone score, bone marrow fat and vertebral fractures in cushing syndrome. Endocrine 2023. [PMID: 36790522 DOI: 10.1007/s12020-023-03318-6] [Reference Citation Analysis]
|
| 6 |
Pignolo RJ. Aging and Bone Metabolism. Compr Physiol 2023;13:4355-86. [PMID: 36715278 DOI: 10.1002/cphy.c220012] [Reference Citation Analysis]
|
| 7 |
Mountain RV, Langlais AL, Hu D, Baron R, Lary CW, Motyl KJ. Social Isolation Causes Cortical and Trabecular Bone Loss in Adult Male, but not Female, C57BL/6J Mice. bioRxiv 2023:2023. [PMID: 36747686 DOI: 10.1101/2023.01.27.525939] [Reference Citation Analysis]
|
| 8 |
Rife E, Abdalla JE, de la Rocha JL, Emejuaiwe N. Glucocorticoid-Induced Osteoporosis: Are We Practicing Prevention? SN Compr Clin Med 2023;5:57. [DOI: 10.1007/s42399-023-01392-5] [Reference Citation Analysis]
|
| 9 |
Zebaze R, Shore-Lorenti C, Nguyen HH, Chiang C, Milat F, Ebeling PR. A Quantification Method for Disorganized Bone Components: Application to the Femoral Shaft. JBMR Plus 2023;7:e10713. [PMID: 36751414 DOI: 10.1002/jbm4.10713] [Reference Citation Analysis]
|
| 10 |
Zhang T, Zhao Z, Wang T. Pulsed electromagnetic fields as a promising therapy for glucocorticoid-induced osteoporosis. Front Bioeng Biotechnol 2023;11:1103515. [PMID: 36937753 DOI: 10.3389/fbioe.2023.1103515] [Reference Citation Analysis]
|
| 11 |
Fernandes S, Varlamov EV, Fleseriu M. ACTH-dependent Cushing's syndrome. Endocrine Hypertension 2023. [DOI: 10.1016/b978-0-323-96120-2.00011-x] [Reference Citation Analysis]
|
| 12 |
Lekhwani S, Vaswani ND, Kumar S, Kamboj P. Four hundred IU vs One thousand IU of vitamin D supplementation in first episode of nephrotic syndrome. IJCBR 2022;9:315-321. [DOI: 10.18231/j.ijcbr.2022.062] [Reference Citation Analysis]
|
| 13 |
Ben Halima H, Zine N, Bausells J, Jaffrezic-Renault N, Errachid A. A Novel Cortisol Immunosensor Based on a Hafnium Oxide/Silicon Structure for Heart Failure Diagnosis. Micromachines (Basel) 2022;13. [PMID: 36557534 DOI: 10.3390/mi13122235] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Zhang J, Lin S, Luo L, Zhang Q, Jiao Y, Liu W. Psychological stress: neuroimmune roles in periodontal disease. Odontology 2022. [DOI: 10.1007/s10266-022-00768-8] [Reference Citation Analysis]
|
| 15 |
Li G, Li Z, Li L, Liu S, Wu P, Zhou M, Li C, Li X, Luo G, Zhang J. Stem Cell‐Niche Engineering via Multifunctional Hydrogel Potentiates Stem Cell Therapies for Inflammatory Bone Loss. Adv Funct Materials 2022. [DOI: 10.1002/adfm.202209466] [Reference Citation Analysis]
|
| 16 |
Wang A, Wang Y, Liu H, Hu X, Li J, Xu H, Nie Z, Zhang L, Lyu Z. Bone and mineral metabolism in patients with primary aldosteronism: A systematic review and meta-analysis. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1027841] [Reference Citation Analysis]
|
| 17 |
Stürznickel J, Behler-Janbeck F, Baranowsky A, Schmidt T, Schwinge D, John C, Lohse AW, Schramm C, Heeren J, Schinke T, Amling M. Increased concentrations of conjugated bile acids are associated with osteoporosis in PSC patients. Sci Rep 2022;12:16491. [PMID: 36192408 DOI: 10.1038/s41598-022-20351-z] [Reference Citation Analysis]
|
| 18 |
Chu H, Jang BH, Kim G, Bae S, Lee H, Nam S, Ahn J. Comparative effectiveness of bisphosphonate treatments for the prevention of re-fracture in glucocorticoid-induced osteoporosis: protocol for a systematic review and meta-analysis. BMJ Open 2022;12:e062537. [PMID: 36167395 DOI: 10.1136/bmjopen-2022-062537] [Reference Citation Analysis]
|
| 19 |
Yamasaki S, Kamezaki K, Ito Y, Horiuchi T. Bisphosphonate Use for Glucocorticoid-Induced Osteoporosis in Elderly Patients with Immune Thrombocytopenia Receiving Prolonged Steroid Therapy: A Single Institute Retrospective Study. Hematol Rep 2022;14:276-85. [PMID: 36135323 DOI: 10.3390/hematolrep14030039] [Reference Citation Analysis]
|
| 20 |
Buyukdemirci S, Oguz EG, Cimen SG, Sahin H, Cimen S, Ayli MD. Vitamin D deficiency may predispose patients to increased risk of kidney transplant rejection. World J Transplant 2022; 12(9): 299-309 [DOI: 10.5500/wjt.v12.i9.299] [Reference Citation Analysis]
|
| 21 |
Huo J, Ding Y, Wei X, Chen Q, Zhao B. Antiosteoporosis and bone protective effect of nimbolide in steroid-induced osteoporosis rats. J Biochem Mol Toxicol 2022;:e23209. [PMID: 36086868 DOI: 10.1002/jbt.23209] [Reference Citation Analysis]
|
| 22 |
Rai D, Tripathi AK, Sardar A, Pandey AR, Sinha S, Chutani K, Dhaniya G, Kothari P, Sashidhara KV, Trivedi R. A novel BMP2 secretagogue ameliorates glucocorticoid induced oxidative stress in osteoblasts by activating NRF2 dependent survival while promoting Wnt/β-catenin mediated osteogenesis. Free Radic Biol Med 2022;190:124-47. [PMID: 35963563 DOI: 10.1016/j.freeradbiomed.2022.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 23 |
Wysham KD, Baker JF, Narla R. Osteoporosis and fractures in rheumatoid arthritis - risk factors. Best Pract Res Clin Rheumatol 2022;36:101757. [PMID: 35739049 DOI: 10.1016/j.berh.2022.101757] [Reference Citation Analysis]
|
| 24 |
Rai R, Singh KB, Khanka S, Maurya R, Singh D. Cladrin alleviates dexamethasone-induced apoptosis of osteoblasts and promotes bone formation through autophagy induction via AMPK/mTOR signaling. Free Radic Biol Med 2022;190:339-50. [PMID: 35998794 DOI: 10.1016/j.freeradbiomed.2022.08.028] [Reference Citation Analysis]
|
| 25 |
Urquiaga M, Saag KG. Risk for osteoporosis and fracture with glucocorticoids. Best Pract Res Clin Rheumatol 2022;36:101793. [PMID: 36347775 DOI: 10.1016/j.berh.2022.101793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
Rymuza J, Gutowska K, Kurpios-Piec D, Struga M, Miśkiewicz P. Decrease in Bone Formation and Bone Resorption during Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy. J Clin Med 2022;11. [PMID: 36078937 DOI: 10.3390/jcm11175005] [Reference Citation Analysis]
|
| 27 |
de Vasconcelos RF, Costa V, Araujo B, Maia TAC, Dias R, Vasconcelos L, Silveira H, Carneiro B, Thiers D, Costa FWG, Kurita L, Ayala A, Leitão R, Pereira KMA, Gondim DV, Goes P. Milk kefir therapy improves the skeletal response to resistance exercise in rats submitted to glucocorticoid-induced osteoporosis. Exp Gerontol 2022;167:111921. [PMID: 35964897 DOI: 10.1016/j.exger.2022.111921] [Reference Citation Analysis]
|
| 28 |
Wu P, Gao M, Zhang C, Li C, Li G, Yan X, Lai X, Zhang Y, Zhang J. Engineering of Biodegradable and Excretable Inflammation‐Resolving Materials. Adv Funct Materials. [DOI: 10.1002/adfm.202205528] [Reference Citation Analysis]
|
| 29 |
di Filippo L, Compagnone N, Frara S, Allora A, Doga M, Rovere Querini P, Cremona G, Giustina A. Vertebral fractures at hospitalization predict impaired respiratory function during follow-up of COVID-19 survivors. Endocrine 2022;77:392-400. [PMID: 35676466 DOI: 10.1007/s12020-022-03096-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 30 |
Frara S, di Filippo L, Doga M, Loli P, Casanueva FF, Giustina A. Novel approaches to bone comorbidity in Cushing's disease: an update. Pituitary 2022. [PMID: 35849272 DOI: 10.1007/s11102-022-01252-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 31 |
Rymuza J, Pelewicz K, Przedlacki J, Miśkiewicz P. Therapy With Intravenous Methylprednisolone Pulses Is Associated With Loss of Bone Microarchitecture in Trabecular Bone Score -Assessment Among Patients With Moderate-to-Severe Graves’ Orbitopathy: A Pilot Study. Front Endocrinol 2022;13:893600. [DOI: 10.3389/fendo.2022.893600] [Reference Citation Analysis]
|
| 32 |
Ma T, Zhu P, Ke Z, Chen J, Hu Y, Xie J. Focusing on OB-OC-MΦ Axis and miR-23a to Explore the Pathogenesis and Treatment Strategy of Osteoporosis. Front Endocrinol 2022;13:891313. [DOI: 10.3389/fendo.2022.891313] [Reference Citation Analysis]
|
| 33 |
Oki Y, Doi K, Kobatake R, Makihara Y, Morita K, Kubo T, Tsuga K. Histological and histomorphometric aspects of continual intermittent parathyroid hormone administration on osseointegration in osteoporosis rabbit model. PLoS ONE 2022;17:e0269040. [DOI: 10.1371/journal.pone.0269040] [Reference Citation Analysis]
|
| 34 |
de Oliveira JAGT, Neves MD, Sampaio GFS, Constantino CJL, Nakagaki WR. Analysis of the effects of turmeric and symbiotic consumption on bones of rats submitted to the use of dexamethasone. Life Sciences 2022. [DOI: 10.1016/j.lfs.2022.120690] [Reference Citation Analysis]
|
| 35 |
Abdul-fattah Baraka N, Fathallah Ahmed N, Ismail Hussein S. The effect of Rutin hydrate on Glucocorticoids induced osteoporosis in mandibular alveolar bone in Albino rats (Radiological, histological and histochemical study). The Saudi Dental Journal 2022. [DOI: 10.1016/j.sdentj.2022.06.009] [Reference Citation Analysis]
|
| 36 |
Azadvari M, Mirmosayyeb O, Hosseini M, Vaheb S, Razavi SZE. The prevalence of osteoporosis/osteopenia in patients with multiple sclerosis (MS): a systematic review and meta-analysis. Neurol Sci 2022;43:3879-92. [PMID: 35038045 DOI: 10.1007/s10072-022-05871-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 37 |
Di Marcello F, Di Donato G, d'Angelo DM, Breda L, Chiarelli F. Bone Health in Children with Rheumatic Disorders: Focus on Molecular Mechanisms, Diagnosis, and Management. Int J Mol Sci 2022;23:5725. [PMID: 35628529 DOI: 10.3390/ijms23105725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 38 |
Anderson G, O'sullivan J. Increased fracture risk in prostate cancer: causes and consequences. Trends Urol & Men's Health 2022;13:6-10. [DOI: 10.1002/tre.853] [Reference Citation Analysis]
|
| 39 |
Ghoraba HH, Matsumiya W, Khojasteh H, Akhavanrezayat A, Karaca I, Or C, Yavari N, Lajevardi S, Hwang J, Yasar C, Do D, Nguyen QD. Safety of Intravenous Methylprednisolone in Refractory and Severe Pediatric Uveitis. OPTH 2022;Volume 16:1697-706. [DOI: 10.2147/opth.s366370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 40 |
Kerkadi A, Lathief S, Khial Y, Teleb T, Attieh G, Rahman MM, Shi Z, Agouni A. The Relationship Between Bone Mineral Density and Body Composition Among Qatari Women With High Rate of Obesity: Qatar Biobank Data. Front Nutr 2022;9:834007. [PMID: 35479749 DOI: 10.3389/fnut.2022.834007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 41 |
Moessmer P, Suren T, Majdic U, Dahiya V, Rutz D, Buchner J, Rief M. Active unfolding of the glucocorticoid receptor by the Hsp70/Hsp40 chaperone system in single-molecule mechanical experiments. Proc Natl Acad Sci U S A 2022;119:e2119076119. [PMID: 35377810 DOI: 10.1073/pnas.2119076119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 42 |
Ersu N, Akyol R, Etöz M. Fractal properties and radiomorphometric indices of the trabecular structure of the mandible in patients using systemic glucocorticoids. Oral Radiol 2022;38:252-60. [PMID: 34213705 DOI: 10.1007/s11282-021-00552-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 43 |
Gado M, Baschant U, Hofbauer LC, Henneicke H. Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes. Front Endocrinol 2022;13:835720. [DOI: 10.3389/fendo.2022.835720] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 44 |
Queiroz Júnior JRAD, Cartaxo MFDS, Paz ST, Tenório FDCÂM, Lemos AJJMD, Maia CS. Histomorfometria da microarquitetura óssea em ratas tratadas com vitamina D e bisfosfonato no manejo da osteoporose. Rev Bras Ortop (Sao Paulo). [DOI: 10.1055/s-0041-1741023] [Reference Citation Analysis]
|
| 45 |
Ebeling PR, Nguyen HH, Aleksova J, Vincent AJ, Wong P, Milat F. Secondary Osteoporosis. Endocr Rev 2022;43:240-313. [PMID: 34476488 DOI: 10.1210/endrev/bnab028] [Cited by in Crossref: 30] [Cited by in F6Publishing: 8] [Article Influence: 30.0] [Reference Citation Analysis]
|
| 46 |
Hsiue PP, Tran Z, Chen CJ, Chiou D, Benharash P, Stavrakis AI. Hip Arthroplasty Outcomes for Femoral Neck Fractures in Transplant Patients. J Arthroplasty 2022;37:530-537.e1. [PMID: 34838925 DOI: 10.1016/j.arth.2021.11.029] [Reference Citation Analysis]
|
| 47 |
Hobson AD, McPherson MJ, Waegell W, Goess CA, Stoffel RH, Li X, Zhou J, Wang Z, Yu Y, Hernandez A Jr, Bryant SH, Mathieu SL, Bischoff AK, Fitzgibbons J, Pawlikowska M, Puthenveetil S, Santora LC, Wang L, Wang L, Marvin CC, Hayes ME, Shrestha A, Sarris KA, Li B. Design and Development of Glucocorticoid Receptor Modulators as Immunology Antibody-Drug Conjugate Payloads. J Med Chem 2022. [PMID: 35133822 DOI: 10.1021/acs.jmedchem.1c02099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 48 |
Krüger BT, Steppe L, Vettorazzi S, Haffner-luntzer M, Lee S, Dorn A, Ignatius A, Tuckermann J, Ahmad M. Inhibition of Cdk5 Ameliorates Skeletal Bone Loss in Glucocorticoid-Treated Mice. Biomedicines 2022;10:404. [DOI: 10.3390/biomedicines10020404] [Reference Citation Analysis]
|
| 49 |
Han J, Li L, Zhang C, Huang Q, Wang S, Li W, Zong J, Li L, Zhao Z, Zhang Z, Liu Z, Wang Q, Shi Y. Eucommia, Cuscuta, and Drynaria Extracts Ameliorate Glucocorticoid-Induced Osteoporosis by Inhibiting Osteoclastogenesis Through PI3K/Akt Pathway. Front Pharmacol 2022;12:772944. [DOI: 10.3389/fphar.2021.772944] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 50 |
Löfdahl E, Tran-Lundmark K, Haggård C, Nilsson J, Odermarsky M, Rådegran G. Bone mineral density in pediatric heart transplanted patients: A retrospective single-center study at Skåne University Hospital in Lund 1988-2016. Pediatr Transplant 2022;26:e14127. [PMID: 34467613 DOI: 10.1111/petr.14127] [Reference Citation Analysis]
|
| 51 |
Betella N, Cellini M. Terapia di prima linea dell’osteoporosi indotta da glucocorticoidi. L'Endocrinologo 2022;23:95-97. [DOI: 10.1007/s40619-022-01034-3] [Reference Citation Analysis]
|
| 52 |
Peng Y, Zhao W, Hu Y, Guo XE, Wang J, Hao K, He Z, Toro C, Bauman WA, Qin W. Administration of High-Dose Methylprednisolone Worsens Bone Loss after Acute Spinal Cord Injury in Rats. Neurotrauma Rep 2021;2:592-602. [PMID: 35018361 DOI: 10.1089/neur.2021.0035] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 53 |
Favero V, Cremaschi A, Parazzoli C, Falchetti A, Gaudio A, Gennari L, Scillitani A, Vescini F, Morelli V, Aresta C, Chiodini I. Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside. Int J Mol Sci 2022;23:673. [PMID: 35054858 DOI: 10.3390/ijms23020673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 54 |
El Miedany Y. Bone Health in Men. New Horizons in Osteoporosis Management 2022. [DOI: 10.1007/978-3-030-87950-1_5] [Reference Citation Analysis]
|
| 55 |
Henning P, Conaway HH, Lerner UH. Stimulation of osteoclast formation and bone resorption by glucocorticoids: Synergistic interactions with the calcium regulating hormones parathyroid hormone and 1,25(OH)2-vitamin D3. Vitamins and Hormones 2022. [DOI: 10.1016/bs.vh.2022.04.005] [Reference Citation Analysis]
|
| 56 |
El Miedany Y. Glucocorticoids and Musculoskeletal Health. New Horizons in Osteoporosis Management 2022. [DOI: 10.1007/978-3-030-87950-1_31] [Reference Citation Analysis]
|
| 57 |
Ciancia S, van Rijn RR, Högler W, Appelman-Dijkstra NM, Boot AM, Sas TCJ, Renes JS. Osteoporosis in children and adolescents: when to suspect and how to diagnose it. Eur J Pediatr 2022;181:2549-61. [PMID: 35384509 DOI: 10.1007/s00431-022-04455-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 58 |
Lewiecki EM. Glucocorticoid-Induced Osteoporosis. Endocrinology and Diabetes 2022. [DOI: 10.1007/978-3-030-90684-9_26] [Reference Citation Analysis]
|
| 59 |
Curley N, Yang Y, Dean J, Salorio C, Sadowsky C. Description of Bone Health Changes in a Cohort of Children With Acute Flaccid Myelitis (AFM). Top Spinal Cord Inj Rehabil 2022;28:42-52. [PMID: 35145334 DOI: 10.46292/sci21-00035] [Reference Citation Analysis]
|
| 60 |
Atzeni F, Siragusano C, Gómez-puerta JA. Interstitial lung disease and rheumatoid arthritis. Handbook of Systemic Autoimmune Diseases 2022. [DOI: 10.1016/b978-0-323-91083-5.00010-4] [Reference Citation Analysis]
|
| 61 |
Zhang B, Lu C, Xu Z, Guo H, Zhang G, Hao Y. The effect of Moringa oleifera polysaccharides on the regulation of glucocorticoid-induced femoral head necrosis: In vitro and in vivo. Arabian Journal of Chemistry 2022;15:103410. [DOI: 10.1016/j.arabjc.2021.103410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 62 |
El Miedany Y. Pediatric Osteoporosis and Optimizing Bone Health in Children. New Horizons in Osteoporosis Management 2022. [DOI: 10.1007/978-3-030-87950-1_26] [Reference Citation Analysis]
|
| 63 |
El Miedany Y. Osteoporosis Management: Gaps in Patients’ Care and Treatment. New Horizons in Osteoporosis Management 2022. [DOI: 10.1007/978-3-030-87950-1_21] [Reference Citation Analysis]
|
| 64 |
Xavier A, Toumi H, Lespessailles E. Animal Model for Glucocorticoid Induced Osteoporosis: A Systematic Review from 2011 to 2021. Int J Mol Sci 2021;23:377. [PMID: 35008803 DOI: 10.3390/ijms23010377] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 65 |
Baban YN, Edicheria CM, Joseph J, Kaur P, Mostafa JA. Osteoporosis Complications in Crohn's Disease Patients: Factors, Pathogenesis, and Treatment Outlines. Cureus 2021. [DOI: 10.7759/cureus.20564] [Reference Citation Analysis]
|
| 66 |
Ebid A, El-Boshy M, El-Shamy S, Thabet A, Abedalla M, Ali T. Long-term effect of full-body pulsed electromagnetic field and exercise protocol in the treatment of men with osteopenia or osteoporosis: A randomized placebo-controlled trial. F1000Res 2021;10:649. [PMID: 34900231 DOI: 10.12688/f1000research.54519.3] [Reference Citation Analysis]
|
| 67 |
Hayes KN, Baschant U, Hauser B, Burden AM, Winter EM. When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis. Front Endocrinol 2021;12:782118. [DOI: 10.3389/fendo.2021.782118] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 68 |
Alrowaili MG, Hussein AM, Eid EA, Serria MS, Abdellatif H, Sakr HF. Effect of Intermittent Fasting on Glucose Homeostasis and Bone Remodeling in Glucocorticoid-Induced Osteoporosis Rat Model. J Bone Metab 2021;28:307-16. [PMID: 34905677 DOI: 10.11005/jbm.2021.28.4.307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 69 |
Lu L, Cai Y, Luo X, Wang Z, Fung SH, Jia H, Yu CL, Chan WY, Miu KK, Xiao W. A Core Omnigenic Non-coding Trait Governing Dex-Induced Osteoporotic Effects Identified Without DEXA. Front Pharmacol 2021;12:750959. [PMID: 34899306 DOI: 10.3389/fphar.2021.750959] [Reference Citation Analysis]
|
| 70 |
Brent MB, Brüel A, Thomsen JS. Sparse dose-dependent difference in skeletal effects of short-term glucocorticoid excess in outbred Swiss mice. Endocrine and Metabolic Science 2021;5:100114. [DOI: 10.1016/j.endmts.2021.100114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 71 |
Kannan A, Minardi S, Ellenbogen DJ, Hallman MJ, Greene AC, Yamaguchi JT, Plantz MA, Jeong S, Sana KC, Shah V, Yun C, Hsu EL, Hsu WK. The effect of local steroid application on bony fusion in a rat posterolateral spinal arthrodesis model. JOR Spine 2021;4. [DOI: 10.1002/jsp2.1177] [Reference Citation Analysis]
|
| 72 |
Bilezikian JP, Formenti AM, Adler RA, Binkley N, Bouillon R, Lazaretti-Castro M, Marcocci C, Napoli N, Rizzoli R, Giustina A. Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all? Rev Endocr Metab Disord 2021;22:1201-18. [PMID: 34940947 DOI: 10.1007/s11154-021-09693-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 73 |
Ahmad A, Deeb H, Alasmar D. Hajdu Cheney syndrome; A novel NOTCH2 mutation in a Syrian child, and treatment with zolidronic acid: A case report and a literature review of treatments. Ann Med Surg (Lond) 2021;71:103023. [PMID: 34840770 DOI: 10.1016/j.amsu.2021.103023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 74 |
Amin LE, Salama N. Osteoprotective Effect of Enamel Matrix Derivatives on the Regeneration of Mandibular Defects in Experimentally Glucocorticoid-Induced Osteoporosis. Int J Dent 2021;2021:8659010. [PMID: 34804167 DOI: 10.1155/2021/8659010] [Reference Citation Analysis]
|
| 75 |
van der Burgh AC, de Keyser CE, Zillikens MC, Stricker BH. The Effects of Osteoporotic and Non-osteoporotic Medications on Fracture Risk and Bone Mineral Density. Drugs 2021;81:1831-58. [PMID: 34724173 DOI: 10.1007/s40265-021-01625-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 76 |
Buehring B, Thomasius F, Schultz K, Maus U. Osteoporosis and Rheumatoid Arthritis-Diagnosis, Diagnostics and Therapy. Osteologie 2021;30:326-334. [DOI: 10.1055/a-1648-4414] [Reference Citation Analysis]
|
| 77 |
Leipe J, Holle JU, Weseloh C, Pfeil A, Krüger K. German Society of Rheumatology recommendations for management of glucocorticoid-induced osteoporosis. Z Rheumatol 2021. [PMID: 34705070 DOI: 10.1007/s00393-021-01025-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 78 |
Nam B, Sung YK, Choi CB, Kim TH, Jun JB, Bae SC, Yoo DH, Cho SK. Fracture Risk and Its Prevention Patterns in Korean Patients with Polymyalgia Rheumatica: a Retrospective Cohort Study. J Korean Med Sci 2021;36:e263. [PMID: 34697929 DOI: 10.3346/jkms.2021.36.e263] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 79 |
Kaddu-Mulindwa D, Lesan V, Berdel C, Stilgenbauer S, Bewarder M, Thurner L, Witzens-Harig M, Viardot A, Soekler M, Keller U, Truemper L, Christofyllakis K, Fleser O, Bittenbring JT, Poeschel V, Held G, Jagoda P. Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial. Leuk Lymphoma 2021;:1-9. [PMID: 34668817 DOI: 10.1080/10428194.2021.1975193] [Reference Citation Analysis]
|
| 80 |
Ledford CK, VanWagner MJ, Spaulding AC, Spencer-Gardner LS, Wilke BK, Porter SB. Outcomes of Femoral Neck Fracture Treated With Hip Arthroplasty in Solid Organ Transplant Patients. Arthroplast Today 2021;11:212-6. [PMID: 34660866 DOI: 10.1016/j.artd.2021.09.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 81 |
Velentza L, Zaman F, Sävendahl L. Bone health in glucocorticoid-treated childhood acute lymphoblastic leukemia. Crit Rev Oncol Hematol 2021;168:103492. [PMID: 34655742 DOI: 10.1016/j.critrevonc.2021.103492] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 82 |
Golovach I. Дискусійні питання визначення порога втручання при глюкокортикоїдіндукованому остеопорозі: кого лікувати? PJS 2021;9:237-250. [DOI: 10.22141/2224-1507.9.4.2019.191923] [Reference Citation Analysis]
|
| 83 |
Martin-Aragon S, Bermejo-Bescós P, Benedí J, Raposo C, Marques F, Kydonaki EK, Gkiata P, Koutedakis Y, Ntina G, Carrillo AE, Amorim T. A Neuroprotective Bovine Colostrum Attenuates Apoptosis in Dexamethasone-Treated MC3T3-E1 Osteoblastic Cells. Int J Mol Sci 2021;22:10195. [PMID: 34638536 DOI: 10.3390/ijms221910195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 84 |
Salamanna F, Maglio M, Sartori M, Landini MP, Fini M. Vitamin D and Platelets: A Menacing Duo in COVID-19 and Potential Relation to Bone Remodeling. Int J Mol Sci 2021;22:10010. [PMID: 34576172 DOI: 10.3390/ijms221810010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 85 |
Catalano A, Vita GL, Bellone F, Sframeli M, Distefano MG, La Rosa M, Gaudio A, Vita G, Morabito N, Messina S. Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates. J Endocrinol Invest 2021. [PMID: 34524678 DOI: 10.1007/s40618-021-01676-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 86 |
Ebid A, El-boshy M, El-shamy S, Thabet A, Abedalla M, Ali T. Long-term effect of full-body pulsed electromagnetic field and exercise protocol in the treatment of men with osteopenia or osteoporosis: A randomized placebo-controlled trial. F1000Res 2021;10:649. [DOI: 10.12688/f1000research.54519.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 87 |
Cardet JC, Bulkhi AA, Lockey RF. Nonrespiratory Comorbidities in Asthma. J Allergy Clin Immunol Pract 2021;9:3887-97. [PMID: 34492402 DOI: 10.1016/j.jaip.2021.08.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 88 |
Steplewski A, Fertala J, Tomlinson RE, Wang ML, Donahue A, Arnold WV, Rivlin M, Beredjiklian PK, Abboud JA, Namdari S, Fertala A. Mechanisms of reducing joint stiffness by blocking collagen fibrillogenesis in a rabbit model of posttraumatic arthrofibrosis. PLoS One 2021;16:e0257147. [PMID: 34492074 DOI: 10.1371/journal.pone.0257147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 89 |
Martin CS, Cooper MS, Hardy RS. Endogenous Glucocorticoid Metabolism in Bone: Friend or Foe. Front Endocrinol (Lausanne) 2021;12:733611. [PMID: 34512556 DOI: 10.3389/fendo.2021.733611] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 90 |
Steell L, Gray SR, Russell RK, MacDonald J, Seenan JP, Wong SC, Gaya DR. Pathogenesis of Musculoskeletal Deficits in Children and Adults with Inflammatory Bowel Disease. Nutrients 2021;13:2899. [PMID: 34445056 DOI: 10.3390/nu13082899] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 91 |
Leipe J, Holle JU, Weseloh C, Pfeil A, Krüger K; die Kommission Pharmakotherapie der Deutschen Gesellschaft für Rheumatologie e. V. (DGRh). [German Society of Rheumatology Recommendations for the management of glucocorticoid-induced Osteoporosis. German version]. Z Rheumatol 2021;80:670-87. [PMID: 34357436 DOI: 10.1007/s00393-021-01028-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 92 |
Robin F, Lescoat A, Jego P, Guggenbuhl P. [Is it (really) necessary to treat all postmenopausal women receiving corticosteroid therapy with bone preventive therapy?]. Rev Med Interne 2021;42:597-9. [PMID: 34353612 DOI: 10.1016/j.revmed.2021.07.005] [Reference Citation Analysis]
|
| 93 |
Ebid A, El-boshy M, El-shamy S, Thabet A, Abedalla M, Ali T. Long-term effect of full-body pulsed electromagnetic field and exercise protocol in the treatment of men with osteopenia or osteoporosis: A randomized placebo-controlled trial. F1000Res 2021;10:649. [DOI: 10.12688/f1000research.54519.1] [Reference Citation Analysis]
|
| 94 |
Tantisattamo E, Ho BT, Workeneh BT. Editorial: Metabolic Changes After Kidney Transplantation. Front Med (Lausanne) 2021;8:709644. [PMID: 34307432 DOI: 10.3389/fmed.2021.709644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 95 |
Corrado A, Rotondo C, Mele A, Cici D, Maruotti N, Sanpaolo E, Colia R, Cantatore FP. Influence of glucocorticoid treatment on trabecular bone score and bone remodeling regulators in early rheumatoid arthritis. Arthritis Res Ther 2021;23:180. [PMID: 34229744 DOI: 10.1186/s13075-021-02562-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 96 |
An L, Shi L, Ye Y, Wu D, Ren G, Han X, Xu G, Yuan G, Du P. Protective effect of Sika Deer bone polypeptide extract on dexamethasone-induced osteoporosis in rats. Electronic Journal of Biotechnology 2021;52:52-8. [DOI: 10.1016/j.ejbt.2021.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 97 |
Cates NK, Wagler EC, Bunka TJ, Elmarsafi T, Tefera E, Kim PJ, Liu GT, Evans KK, Steinberg JS, Attinger CE. Charcot Reconstruction: Outcomes in Patients With and Without Diabetes. J Foot Ankle Surg 2020;59:1229-33. [PMID: 32921562 DOI: 10.1053/j.jfas.2020.05.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 98 |
Mishra R, Das N, Varshney R, Juneja K, Sircar D, Roy P. Betel leaf extract and its major component hydroxychavicol promote osteogenesis and alleviate glucocorticoid-induced osteoporosis in rats. Food Funct 2021;12:6603-25. [PMID: 34105538 DOI: 10.1039/d0fo02619k] [Reference Citation Analysis]
|
| 99 |
Hassan AB, Ghalib KW, Jahrami HA, El-Agroudy AE. Prevalence of Musculoskeletal Manifestations in Adult Kidney Transplant's Recipients: A Systematic Review. Medicina (Kaunas) 2021;57:525. [PMID: 34071098 DOI: 10.3390/medicina57060525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 100 |
Testini V, Eusebi L, Tupputi U, Carpagnano FA, Bartelli F, Guglielmi G. Metabolic Bone Diseases in the Pediatric Population. Semin Musculoskelet Radiol 2021;25:94-104. [PMID: 34020471 DOI: 10.1055/s-0040-1722566] [Reference Citation Analysis]
|
| 101 |
Ferreira AC, Mendes M, Silva C, Cotovio P, Aires I, Navarro D, Caeiro F, Salvador R, Correia B, Cabral G, Nolasco F, Ferreira A. Bone densitometry versus bone histomorphometry in renal transplanted patients: a cross-sectional study. Transpl Int 2021;34:1065-73. [PMID: 33909300 DOI: 10.1111/tri.13888] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 102 |
Duncan CN. Posttransplantation bone disease: prevalence, surveillance, prevention, and management. Blood and Marrow Transplantation Long Term Management 2021. [DOI: 10.1002/9781119612780.ch30] [Reference Citation Analysis]
|
| 103 |
Renan Vieira da Costa Júnior J, Luchini Batista S. Glucocorticoid-Induced Osteoporosis. Osteoporosis - Recent Advances, New Perspectives and Applications [Working Title] 2021. [DOI: 10.5772/intechopen.97416] [Reference Citation Analysis]
|
| 104 |
Barnsley J, Buckland G, Chan PE, Ong A, Ramos AS, Baxter M, Laskou F, Dennison EM, Cooper C, Patel HP. Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people. Aging Clin Exp Res 2021;33:759-73. [PMID: 33742387 DOI: 10.1007/s40520-021-01817-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 105 |
Messina OD, Vidal LF, Wilman MV, Bultink IEM, Raterman HG, Lems W. Management of glucocorticoid-induced osteoporosis. Aging Clin Exp Res 2021;33:793-804. [PMID: 33751462 DOI: 10.1007/s40520-021-01823-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 106 |
Liao F, Zhu Z, Xiao C, Yuan J, Geng B, Hu J. Hydrogen sulfide inhibits calcium and phosphorus loss after fracture by negatively regulating glucocorticoid/glucocorticoid receptor α. Life Sci 2021;274:119363. [PMID: 33737083 DOI: 10.1016/j.lfs.2021.119363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 107 |
Formenti AM, Dalla Volta A, di Filippo L, Berruti A, Giustina A. Effects of Medical Treatment of Prostate Cancer on Bone Health. Trends Endocrinol Metab 2021;32:135-58. [PMID: 33509658 DOI: 10.1016/j.tem.2020.12.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 108 |
Frara S, Allora A, di Filippo L, Formenti AM, Loli P, Polizzi E, Tradati D, Ulivieri FM, Giustina A. Osteopathy in mild adrenal Cushing's syndrome and Cushing disease. Best Pract Res Clin Endocrinol Metab 2021;35:101515. [PMID: 33795196 DOI: 10.1016/j.beem.2021.101515] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 109 |
Miyama A, Ebina K, Hirao M, Okamura G, Etani Y, Takami K, Goshima A, Miura T, Oyama S, Kanamoto T, Yoshikawa H, Nakata K. Effects of iguratimod on glucocorticoid-induced disorder of bone metabolism in vitro. J Bone Miner Metab 2021;39:639-48. [PMID: 33564917 DOI: 10.1007/s00774-021-01206-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 110 |
Dardari D, Dardari R. Why the Risk of Developing Neuroarthropathy Is Higher After Simultaneous Kidney and Pancreatic Transplantation Compared to Kidney Transplantation Only: The Role of Euglycemia. Ann Transplant 2021;26:e928449. [PMID: 33526764 DOI: 10.12659/AOT.928449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 111 |
Maus U, Schultz K, Bühring B. Diagnose, Differenzialdiagnose und Diagnostik bei Osteoporose. Arthritis und Rheuma 2021;41:24-29. [DOI: 10.1055/a-1365-0964] [Reference Citation Analysis]
|
| 112 |
Fiscaletti M, Samoilenko M, Dubois J, Miron MC, Lefebvre G, Krajinovic M, Laverdière C, Sinnett D, Alos N. Predictors of Vertebral Deformity in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia: The PETALE Study. J Clin Endocrinol Metab 2021;106:512-25. [PMID: 33150433 DOI: 10.1210/clinem/dgaa806] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 113 |
di Filippo L, Formenti AM, Doga M, Pedone E, Rovere-Querini P, Giustina A. Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes. J Clin Endocrinol Metab 2021;106:e602-14. [PMID: 33159451 DOI: 10.1210/clinem/dgaa738] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 24.5] [Reference Citation Analysis]
|
| 114 |
Lovšin N, Marc J. Glucocorticoid Receptor Regulates TNFSF11 Transcription by Binding to Glucocorticoid Responsive Element in TNFSF11 Proximal Promoter Region. Int J Mol Sci 2021;22:1054. [PMID: 33494362 DOI: 10.3390/ijms22031054] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 115 |
Weare-Regales N, Hudey SN, Lockey RF. Practical Guidance for Prevention and Management of Glucocorticoid-Induced Osteoporosis for the Allergist/Immunologist. J Allergy Clin Immunol Pract 2021;9:1841-50. [PMID: 33444813 DOI: 10.1016/j.jaip.2020.12.050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 116 |
Wang T, Liu X, He C. Glucocorticoid-induced autophagy and apoptosis in bone. Apoptosis 2020;25:157-68. [PMID: 32157482 DOI: 10.1007/s10495-020-01599-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 117 |
Agarwal A, Adachi JD. Therapies for Preventing Bone Loss with Glucocorticoid Treatment. Curr Osteoporos Rep 2021;19:34-9. [PMID: 33409989 DOI: 10.1007/s11914-020-00653-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 118 |
Epsley S, Tadros S, Farid A, Kargilis D, Mehta S, Rajapakse CS. The Effect of Inflammation on Bone. Front Physiol 2020;11:511799. [PMID: 33584321 DOI: 10.3389/fphys.2020.511799] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 17.0] [Reference Citation Analysis]
|
| 119 |
Chanplakorn P, Lertudomphonwanit T, Daraphongsataporn N, Sritara C, Jaovisidha S, Sa-Ngasoongsong P. Development of prediction model for osteoporotic vertebral compression fracture screening without using clinical risk factors, compared with FRAX and other previous models. Arch Osteoporos 2021;16:84. [PMID: 34085107 DOI: 10.1007/s11657-021-00957-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 120 |
Caraccio DM, Jones MS. Principles of Diagnosis and Treatment of Osteoporosis. Clinical Foundations of Musculoskeletal Medicine 2021. [DOI: 10.1007/978-3-030-42894-5_7] [Reference Citation Analysis]
|
| 121 |
Abdulkhaliq A. Bones and Rheumatology. Skills in Rheumatology 2021. [DOI: 10.1007/978-981-15-8323-0_10] [Reference Citation Analysis]
|
| 122 |
Claessen KM, Appelman-dijkstra NM, Biermasz NR. Osteoporosis and arthropathy in functioning pituitary tumors. Pituitary Tumors 2021. [DOI: 10.1016/b978-0-12-819949-7.00019-6] [Reference Citation Analysis]
|
| 123 |
Monteverdi S, Pedersini R, Gallo F, Maffezzoni F, Dalla Volta A, Di Mauro P, Turla A, Vassalli L, Ardine M, Formenti AM, Simoncini EL, Giustina A, Maroldi R, Amoroso V, Berruti A. The Interaction of Lean Body Mass With Fat Body Mass Is Associated With Vertebral Fracture Prevalence in Women With Early Breast Cancer Undergoing Aromatase Inhibitor Therapy. JBMR Plus 2021;5:e10440. [PMID: 33615109 DOI: 10.1002/jbm4.10440] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 124 |
Dubrovsky AM, Nyman JS, Uppuganti S, Chmiel KJ, Kimmel DB, Lane NE. Bone Strength/Bone Mass Discrepancy in Glucocorticoid-Treated Adult Mice. JBMR Plus 2021;5:e10443. [PMID: 33778319 DOI: 10.1002/jbm4.10443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 125 |
Ward LM. Glucocorticoid-Induced Osteoporosis: Why Kids Are Different. Front Endocrinol (Lausanne) 2020;11:576. [PMID: 33391179 DOI: 10.3389/fendo.2020.00576] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 126 |
Lee TH, Song YJ, Kim H, Sung YK, Cho SK. Intervention Thresholds for Treatment in Patients with Glucocorticoid-Induced Osteoporosis: Systematic Review of Guidelines. J Bone Metab 2020;27:247-59. [PMID: 33317228 DOI: 10.11005/jbm.2020.27.4.247] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 127 |
Putman MS, Anabtawi A, Le T, Tangpricha V, Sermet-Gaudelus I. Cystic fibrosis bone disease treatment: Current knowledge and future directions. J Cyst Fibros 2019;18 Suppl 2:S56-65. [PMID: 31679730 DOI: 10.1016/j.jcf.2019.08.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 128 |
Batteux B, Gras-Champel V, Lando M, Brazier F, Mentaverri R, Desailly-Henry I, Rey A, Bennis Y, Masmoudi K, Choukroun G, Liabeuf S. Early steroid withdrawal has a positive effect on bone in kidney transplant recipients: a propensity score study with inverse probability-of-treatment weighting. Ther Adv Musculoskelet Dis. 2020;12:1759720x20953357. [PMID: 33193832 DOI: 10.1177/1759720x20953357] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 129 |
Wang Y, Chen J, Chen J, Dong C, Yan X, Zhu Z, Lu P, Song Z, Liu H, Chen S. Daphnetin ameliorates glucocorticoid-induced osteoporosis via activation of Wnt/GSK-3β/β-catenin signaling. Toxicol Appl Pharmacol 2020;409:115333. [PMID: 33171191 DOI: 10.1016/j.taap.2020.115333] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 130 |
Kupka T, Svoboda P, Bojková M, Blaho M, Vašura A, Hrabovský V, Dítě P. Bone metabolism in inflammatory bowel diseases 1. Vnitr Lek 2020;66:e3-e7. [DOI: 10.36290/vnl.2020.131] [Reference Citation Analysis]
|
| 131 |
Zea M, Bellagambi FG, Ben Halima H, Zine N, Jaffrezic-renault N, Villa R, Gabriel G, Errachid A. Electrochemical sensors for cortisol detections: Almost there. TrAC Trends in Analytical Chemistry 2020;132:116058. [DOI: 10.1016/j.trac.2020.116058] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 132 |
Yildiz S, Glanzman AM, Estilow T, Flickinger J, Brandsema JF, Tennekoon G, Banwell BL, Yum S. Retrospective Analysis of Fractures and Factors Causing Ambulation Loss After Lower Limb Fractures in Duchenne Muscular Dystrophy. Am J Phys Med Rehabil 2020;99:789-94. [PMID: 32195737 DOI: 10.1097/PHM.0000000000001423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 133 |
Sharma AK, Shi X, Isales CM, McGee-Lawrence ME. Endogenous Glucocorticoid Signaling in the Regulation of Bone and Marrow Adiposity: Lessons from Metabolism and Cross Talk in Other Tissues. Curr Osteoporos Rep 2019;17:438-45. [PMID: 31749087 DOI: 10.1007/s11914-019-00554-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 134 |
Dineen R, Behan LA, Kelleher G, Hannon MJ, Brady JJ, Rogers B, Keevil BG, Tormey W, Smith D, Thompson CJ, McKenna MJ, Arlt W, Stewart PM, Agha A, Sherlock M. The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy. BMC Endocr Disord 2020;20:154. [PMID: 33036588 DOI: 10.1186/s12902-020-00633-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 135 |
Ramírez-Villaescusa J, Ruiz-Picazo D, Oliveira CL, Morillas-Ariño C. Secondary thoracolumbar deformity and sagittal imbalance due to osteoporosis in a young man with Cushing's disease: A case report. Int J Surg Case Rep 2020;76:134-8. [PMID: 33032043 DOI: 10.1016/j.ijscr.2020.09.182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 136 |
Liu X, Fan JB, Hu J, Li F, Yi R, Tan F, Zhao X. Lactobacillus Fermentum ZS40 prevents secondary osteoporosis in Wistar Rat. Food Sci Nutr 2020;8:5182-91. [PMID: 32994978 DOI: 10.1002/fsn3.1824] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 137 |
Manousaki D, Forgetta V, Keller-Baruch J, Zhao K, Greenwood CM, Mooser V, Bassett JD, Leslie WD, Richards JB. A Polygenic Risk Score as a Risk Factor for Medication-Associated Fractures. J Bone Miner Res 2020;35:1935-41. [PMID: 32511779 DOI: 10.1002/jbmr.4104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 138 |
Caetano CM, Sliwinska A, Madhavan P, Grady J, Malchoff CD. Empiric Determination of the Daily Glucocorticoid Replacement Dose in Adrenal Insufficiency. J Endocr Soc 2020;4:bvaa145. [PMID: 33123657 DOI: 10.1210/jendso/bvaa145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 139 |
Dorrington AM, Selinger CP, Parkes GC, Smith M, Pollok RC, Raine T. The Historical Role and Contemporary Use of Corticosteroids in Inflammatory Bowel Disease. J Crohns Colitis 2020;14:1316-29. [PMID: 32170314 DOI: 10.1093/ecco-jcc/jjaa053] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 140 |
Edouard T, Guillaume-Czitrom S, Bacchetta J, Sermet-Gaudelus I, Dugelay E, Martinez-Vinson C, Salles JP, Linglart A. Guidelines for the management of children at risk of secondary bone fragility: Expert opinion of a French working group. Arch Pediatr 2020;27:393-8. [PMID: 32921532 DOI: 10.1016/j.arcped.2020.07.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 141 |
Florez H, Hernández-Rodríguez J, Carrasco JL, Prieto-González S, Muxi A, Filella X, Ruiz-Gaspà S, Gómez-Puerta JA, Cid M, Espinosa G, Monegal A, Guañabens N, Peris P. Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses. RMD Open 2020;6:e001355. [PMID: 32917834 DOI: 10.1136/rmdopen-2020-001355] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 142 |
Quyum F, Hasan M, Atiqur Rahman M. Bone mineral density and fracture risk in leprosy affected people with leprosy reaction. LEPROSY 2020;91:274-281. [DOI: 10.47276/lr.91.3.274] [Reference Citation Analysis]
|
| 143 |
Huang S, Kronzer VL, Dellaripa PF, Deane KD, Bolster MB, Nagaraja V, Khanna D, Doyle TJ, Sparks JA. Rheumatoid arthritis-associated interstitial lung disease: Current update on prevalence, risk factors, and pharmacologic treatment. Curr Treatm Opt Rheumatol 2020;6:337-53. [PMID: 33282632 DOI: 10.1007/s40674-020-00160-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 144 |
Brance ML, Cóccaro N, Pastor M, Larroudé M. Vertebral fractures: evaluation, diagnosis and treatment. Rev Argent Reumatol 2020. [DOI: 10.47196/rar.v31i3.397] [Reference Citation Analysis]
|
| 145 |
Pinchi V, Bianchi I, Pradella F, Vitale G, Focardi M, Tonni I, Ferrante L, Bucci A. Dental age estimation in children affected by juvenile rheumatoid arthritis. Int J Legal Med 2021;135:619-29. [PMID: 32820356 DOI: 10.1007/s00414-020-02395-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 146 |
Kisling A, Jones J, Hixson C, Hostler D, Hostler J. Mepolizumab: an alternative therapy for idiopathic chronic eosinophilic pneumonia with glucocorticoid intolerance. Drugs Context 2020;9:2020-5-3. [PMID: 32884574 DOI: 10.7573/dic.2020-5-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 147 |
Jacobsson M, van Raalte DH, Heijboer AC, den Heijer M, de Jongh RT. Short-Term Glucocorticoid Treatment Reduces Circulating Sclerostin Concentrations in Healthy Young Men: A Randomized, Placebo-Controlled, Double-Blind Study. JBMR Plus 2020;4:e10341. [PMID: 32803106 DOI: 10.1002/jbm4.10341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 148 |
Chen L, Shi X, Weng SJ, Xie J, Tang JH, Yan DY, Wang BZ, Xie ZJ, Wu ZY, Yang L. Vitamin K2 Can Rescue the Dexamethasone-Induced Downregulation of Osteoblast Autophagy and Mitophagy Thereby Restoring Osteoblast Function In Vitro and In Vivo. Front Pharmacol 2020;11:1209. [PMID: 32848799 DOI: 10.3389/fphar.2020.01209] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 149 |
Wang XY, Gong LJ, Huang JM, Jiang C, Yan ZQ. Pinocembrin alleviates glucocorticoid-induced apoptosis by activating autophagy via suppressing the PI3K/Akt/mTOR pathway in osteocytes. Eur J Pharmacol 2020;880:173212. [PMID: 32470335 DOI: 10.1016/j.ejphar.2020.173212] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 150 |
Chotiyarnwong P, McCloskey EV. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment. Nat Rev Endocrinol 2020;16:437-47. [PMID: 32286516 DOI: 10.1038/s41574-020-0341-0] [Cited by in Crossref: 143] [Cited by in F6Publishing: 119] [Article Influence: 47.7] [Reference Citation Analysis]
|
| 151 |
Deng J, Silver Z, Huang E, Zheng E, Kavanagh K, Panicker J. The effect of calcium and vitamin D compounds on bone mineral density in patients undergoing glucocorticoid therapies: a network meta-analysis. Clin Rheumatol 2021;40:725-34. [PMID: 32681366 DOI: 10.1007/s10067-020-05294-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 152 |
Starup-Linde J, Rosendahl SB, Storgaard M, Langdahl B. Management of Osteoporosis in Patients Living With HIV-A Systematic Review and Meta-analysis. J Acquir Immune Defic Syndr 2020;83:1-8. [PMID: 31809356 DOI: 10.1097/QAI.0000000000002207] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 153 |
Aktuna Belgin C, Serindere G. Fractal and radiomorphometric analysis of mandibular bone changes in patients undergoing intravenous corticosteroid therapy. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2020;130:110-5. [DOI: 10.1016/j.oooo.2019.12.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 154 |
Brasil-Oliveira R, Cruz ÁA, Sarmento VA, Souza-Machado A, Lins-Kusterer L. Corticosteroid Use and Periodontal Disease: A Systematic Review. Eur J Dent 2020;14:496-501. [PMID: 32610361 DOI: 10.1055/s-0040-1713954] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 155 |
Kovvuru K, Kanduri SR, Vaitla P, Marathi R, Gosi S, Garcia Anton DF, Cabeza Rivera FH, Garla V. Risk Factors and Management of Osteoporosis Post-Transplant. Medicina (Kaunas) 2020;56:E302. [PMID: 32575603 DOI: 10.3390/medicina56060302] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 156 |
Çalapkulu M, Kızılgül M, Sencar ME, Düğer H, Uçan B, Çakal E, Özbek M. Avascular necrosis of the femoral head due to low-dose corticosteroid used in a patient with panhypopituitarism: A case report and literature review. Jt Dis Relat Surg 2020;31:390-4. [PMID: 32584743 DOI: 10.5606/ehc.2020.72773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 157 |
Zhu X, Zheng H. Factors influencing peak bone mass gain. Front Med 2021;15:53-69. [PMID: 32519297 DOI: 10.1007/s11684-020-0748-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 158 |
Zhang T, Liang Y, Zhang J. Natural and synthetic compounds as dissociated agonists of glucocorticoid receptor. Pharmacological Research 2020;156:104802. [DOI: 10.1016/j.phrs.2020.104802] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 159 |
Peng Y, Lv S, Li Y, Zhu J, Chen S, Zhen G, Cao X, Wu S, Crane JL. Glucocorticoids Disrupt Skeletal Angiogenesis Through Transrepression of NF-κB-Mediated Preosteoclast Pdgfb Transcription in Young Mice. J Bone Miner Res 2020;35:1188-202. [PMID: 32078184 DOI: 10.1002/jbmr.3987] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 160 |
Kumarathas I, Harsløf T, Andersen CU, Langdahl B, Hilberg O, Bjermer L, Løkke A. The risk of osteoporosis in patients with asthma. Eur Clin Respir J 2020;7:1763612. [PMID: 32595917 DOI: 10.1080/20018525.2020.1763612] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 161 |
Glanzman AM, Jones J, Thompson CZ, Pendergast EA, Beam M, Hughes AL, King M, Brandsema J, Horn B. Rehabilitation Following Fracture in Dystrophinopathy, A Case Series. J Neuromuscul Dis 2020;7:343-54. [PMID: 32417791 DOI: 10.3233/JND-200470] [Reference Citation Analysis]
|
| 162 |
Huang RX, Tao J. Nicotinamide mononucleotide attenuates glucocorticoid‑induced osteogenic inhibition by regulating the SIRT1/PGC‑1α signaling pathway. Mol Med Rep 2020;22:145-54. [PMID: 32377728 DOI: 10.3892/mmr.2020.11116] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 163 |
Topliss DJ. Editorial: long-term oral budesonide treatment and risk of osteoporotic fractures in patients with microscopic colitis-not a totally clean bill of health. Aliment Pharmacol Ther 2020;51:991-2. [PMID: 32338783 DOI: 10.1111/apt.15723] [Reference Citation Analysis]
|
| 164 |
Fu SQ, Wang ZY, Jiang ZM, Bi ZM, Liu EH. Integration of Zebrafish Model and Network Pharmacology to Explore Possible Action Mechanisms of Morinda officinalis for Treating Osteoporosis. Chem Biodivers 2020;17:e2000056. [PMID: 32190963 DOI: 10.1002/cbdv.202000056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 165 |
Wang T, He H, Liu S, Jia C, Fan Z, Zhong C, Yu J, Liu H, He C. Autophagy: A Promising Target for Age-related Osteoporosis. Curr Drug Targets 2019;20:354-65. [PMID: 29943700 DOI: 10.2174/1389450119666180626120852] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 166 |
Schepper JD, Collins F, Rios-Arce ND, Kang HJ, Schaefer L, Gardinier JD, Raghuvanshi R, Quinn RA, Britton R, Parameswaran N, McCabe LR. Involvement of the Gut Microbiota and Barrier Function in Glucocorticoid-Induced Osteoporosis. J Bone Miner Res 2020;35:801-20. [PMID: 31886921 DOI: 10.1002/jbmr.3947] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 23.3] [Reference Citation Analysis]
|
| 167 |
Aru M, Alev K, Pehme A, Purge P, Õnnik L, Ellam A, Kaasik P, Seene T. Changes in Body Composition of Old Rats at Different Time Points After Dexamethasone Administration. Curr Aging Sci 2019;11:255-60. [PMID: 30648531 DOI: 10.2174/1874609812666190114144238] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 168 |
Galindo-Zavala R, Bou-Torrent R, Magallares-López B, Mir-Perelló C, Palmou-Fontana N, Sevilla-Pérez B, Medrano-San Ildefonso M, González-Fernández MI, Román-Pascual A, Alcañiz-Rodríguez P, Nieto-Gonzalez JC, López-Corbeto M, Graña-Gil J. Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children. Pediatr Rheumatol Online J 2020;18:20. [PMID: 32093703 DOI: 10.1186/s12969-020-0411-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 169 |
Cai J, Shao X, Yang Q, Yang Y, Yan Z, Luo E, Feng X, Jing D. Pulsed electromagnetic fields modify the adverse effects of glucocorticoids on bone architecture, bone strength and porous implant osseointegration by rescuing bone-anabolic actions. Bone 2020;133:115266. [PMID: 32044333 DOI: 10.1016/j.bone.2020.115266] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 170 |
Yang C, Le G, Lu C, Wei R, Lan W, Tang J, Zhan X. Effects of teriparatide compared with risedronate in the treatment of osteoporosis: A meta-analysis of randomized controlled trials. Medicine (Baltimore) 2020;99:e19042. [PMID: 32049802 DOI: 10.1097/MD.0000000000019042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 171 |
Xi L, De Falco P, Barbieri E, Karunaratne A, Bentley L, Esapa C, Davis G, Terrill N, Cox R, Pugno N, Thakker R, Weinkamer R, Wu W, Fang D, Gupta H. Reduction of fibrillar strain-rate sensitivity in steroid-induced osteoporosis linked to changes in mineralized fibrillar nanostructure. Bone 2020;131:115111. [DOI: 10.1016/j.bone.2019.115111] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 172 |
Krasivina IG, Dolgova LN, Dolgov NV, Larina AA. Glucocorticoid-induced osteoporosis: pathogenesis and prevention. Medicinskij sovet 2020. [DOI: 10.21518/2079-701x-2019-21-126-134] [Reference Citation Analysis]
|
| 173 |
Rothe R, Schulze S, Neuber C, Hauser S, Rammelt S, Pietzsch J, Pietzsch J, Jung F. Adjuvant drug-assisted bone healing: Part I – Modulation of inflammation. CH 2020;73:381-408. [DOI: 10.3233/ch-199102] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 174 |
Camozzi V. Drug-Induced Male Osteoporosis. Trends in Andrology and Sexual Medicine 2020. [DOI: 10.1007/978-3-319-96376-1_11] [Reference Citation Analysis]
|
| 175 |
Zaidi M, Yuen T, Kim S, Iqbal J, Lizneva D. Bone Loss and Body Composition Across The Menopausal Transition. Encyclopedia of Bone Biology 2020. [DOI: 10.1016/b978-0-12-801238-3.11581-8] [Reference Citation Analysis]
|
| 176 |
Zhou H, Cooper MS, Seibel MJ. Basic and clinical aspects of glucocorticoid action in bone. Principles of Bone Biology 2020. [DOI: 10.1016/b978-0-12-814841-9.00039-7] [Reference Citation Analysis]
|
| 177 |
Schmidt E, Pachtman SL, Diedrich JT. Contraception in Chronic Kidney Disease and Renal Transplantation. Obstetric and Gynecologic Nephrology 2020. [DOI: 10.1007/978-3-030-25324-0_16] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 178 |
Infante M, Caprio M, Fabbri A. Introduction: Causes and Risk Factors for Male Osteoporosis. Trends in Andrology and Sexual Medicine 2020. [DOI: 10.1007/978-3-319-96376-1_5] [Reference Citation Analysis]
|
| 179 |
Ogbechi J, Clanchy FI, Huang YS, Topping LM, Stone TW, Williams RO. IDO activation, inflammation and musculoskeletal disease. Exp Gerontol 2020;131:110820. [PMID: 31884118 DOI: 10.1016/j.exger.2019.110820] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 180 |
Annexstad EJ, Bollerslev J, Westvik J, Myhre AG, Godang K, Holm I, Rasmussen M. The role of delayed bone age in the evaluation of stature and bone health in glucocorticoid treated patients with Duchenne muscular dystrophy. Int J Pediatr Endocrinol 2019;2019:4. [PMID: 31889957 DOI: 10.1186/s13633-019-0070-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 181 |
Dlamini S, Kuipa M, Enfield K, Skosana S, Woodland JG, Moliki JM, Bick AJ, van der Spuy Z, Maritz MF, Avenant C, Hapgood JP. Reciprocal Modulation of Antiretroviral Drug and Steroid Receptor Function In Vitro. Antimicrob Agents Chemother 2019;64:e01890-19. [PMID: 31658973 DOI: 10.1128/AAC.01890-19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 182 |
Valavi E, Javaherizadeh H, Hakimzadeh M, Amoori P. Improvement Of Congenital Chloride Diarrhea With Corticosteroids: An Incidental Finding. Pediatric Health Med Ther 2019;10:153-6. [PMID: 31827341 DOI: 10.2147/PHMT.S220725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 183 |
Bao M, Zhang K, Wei Y, Hua W, Gao Y, Li X, Ye L. Therapeutic potentials and modulatory mechanisms of fatty acids in bone. Cell Prolif 2020;53:e12735. [PMID: 31797479 DOI: 10.1111/cpr.12735] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 184 |
Kroon FPB, Kortekaas MC, Boonen A, Böhringer S, Reijnierse M, Rosendaal FR, Riyazi N, Starmans M, Turkstra F, van Zeben J, Allaart CF, Kloppenburg M. Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial. Lancet 2019;394:1993-2001. [PMID: 31727410 DOI: 10.1016/S0140-6736(19)32489-4] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 185 |
Conaway HH, Henning P, Lie A, Tuckermann J, Lerner UH. Glucocorticoids employ the monomeric glucocorticoid receptor to potentiate vitamin D3 and parathyroid hormone-induced osteoclastogenesis. FASEB J 2019;33:14394-409. [PMID: 31675485 DOI: 10.1096/fj.201802729RRR] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 186 |
Decker A, Askar H, Tattan M, Taichman R, Wang HL. The assessment of stress, depression, and inflammation as a collective risk factor for periodontal diseases: a systematic review. Clin Oral Investig 2020;24:1-12. [PMID: 31677052 DOI: 10.1007/s00784-019-03089-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 187 |
Iconaru L, Moreau M, Kinnard V, Baleanu F, Paesmans M, Karmali R, Body JJ, Bergmann P. Does the Prediction Accuracy of Osteoporotic Fractures by BMD and Clinical Risk Factors Vary With Fracture Site? JBMR Plus 2019;3:e10238. [PMID: 31844826 DOI: 10.1002/jbm4.10238] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 188 |
van Vugt J. Human Body Prediction of Size and Shape A Hormonal Framework. Proceedings of the 2019 3rd International Symposium on Computer Science and Intelligent Control 2019. [DOI: 10.1145/3386164.3387262] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 189 |
Adami G, Rahn EJ, Saag KG. Glucocorticoid-induced osteoporosis: from clinical trials to clinical practice. Ther Adv Musculoskelet Dis 2019;11:1759720X19876468. [PMID: 31565078 DOI: 10.1177/1759720X19876468] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 190 |
Formenti AM, Tecilazich F, Giubbini R, Giustina A. Risk of vertebral fractures in hypoparathyroidism. Rev Endocr Metab Disord 2019;20:295-302. [PMID: 31471845 DOI: 10.1007/s11154-019-09507-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 191 |
Wada H. Damage-Fitness Model: the missing piece in integrative stress models. Stress 2019;22:548-62. [PMID: 31124379 DOI: 10.1080/10253890.2019.1614556] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 192 |
Taylor AD, Saag KG. Anabolics in the management of glucocorticoid-induced osteoporosis: an evidence-based review of long-term safety, efficacy and place in therapy. Core Evid 2019;14:41-50. [PMID: 31692480 DOI: 10.2147/CE.S172820] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 193 |
Kim Y, Kim J, Lee H, Shin WR, Lee S, Lee J, Park JI, Jhun BH, Kim YH, Yi SJ, Kim K. Tetracycline Analogs Inhibit Osteoclast Differentiation by Suppressing MMP-9-Mediated Histone H3 Cleavage. Int J Mol Sci 2019;20:E4038. [PMID: 31430857 DOI: 10.3390/ijms20164038] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 194 |
Kutlu O, Üzüm İ, Durmuşcan M, Kekilli E, Parlakpınar H, Kutlu NO. Anti-osteoporotic effects of melatonin and misoprostol in glucocorticoid-induced osteoporosis: An experimental study. Journal of Surgery and Medicine 2019. [DOI: 10.28982/josam.595295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 195 |
Ferraù F, Giovinazzo S, Messina E, Tessitore A, Vinci S, Mazziotti G, Lania A, Granata F, Cannavò S. High bone marrow fat in patients with Cushing’s syndrome and vertebral fractures. Endocrine 2020;67:172-9. [DOI: 10.1007/s12020-019-02034-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 196 |
Chandler H, Brooks DJ, Hattersley G, Bouxsein ML, Lanske B. Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia. Osteoporos Int 2019;30:1607-16. [PMID: 31053927 DOI: 10.1007/s00198-019-04999-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 197 |
Komaki Y, Komaki F, Micic D, Ido A, Sakuraba A. Risk of Fractures in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. J Clin Gastroenterol 2019;53:441-8. [PMID: 29672437 DOI: 10.1097/MCG.0000000000001031] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 198 |
Maus U, Maier GS, Lazovic D, Niedhart C. Beeinflussung der Knochenheilung durch häufig verordnete Medikamente. Unfallchirurg 2019;122:500-505. [DOI: 10.1007/s00113-019-0670-4] [Reference Citation Analysis]
|
| 199 |
Colditz J, Thiele S, Baschant U, Garbe AI, Niehrs C, Hofbauer LC, Rauner M. Osteogenic Dkk1 Mediates Glucocorticoid-Induced but Not Arthritis-Induced Bone Loss. J Bone Miner Res 2019;34:1314-23. [PMID: 30779862 DOI: 10.1002/jbmr.3702] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 200 |
Pukajło-Marczyk A, Jakubowska A, Bargenda-Lange A, Kiliś-Pstrusińska K, Zwolińska D. Assessment of the Concentration of Bone Metabolism Markers: Sclerostin and FGF-23 in Children with Idiopathic Nephrotic Syndrome Treated with Glucocorticosteroids. Dis Markers 2019;2019:9698367. [PMID: 31354894 DOI: 10.1155/2019/9698367] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 201 |
Kim SW, Kim EH, Lee J, Choi YC, Kim SM, Shin HY. Risk of osteoporosis in patients with chronic inflammatory neuropathy- a population-based cohort study. Sci Rep 2019;9:9131. [PMID: 31235735 DOI: 10.1038/s41598-019-45591-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 202 |
Muruganandan S, Govindarajan R, Sinal CJ. Bone Marrow Adipose Tissue and Skeletal Health. Curr Osteoporos Rep 2018;16:434-42. [PMID: 29855795 DOI: 10.1007/s11914-018-0451-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 203 |
Raterman HG, Bultink IEM, Lems WF. Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis. Drugs 2019;79:1065-87. [DOI: 10.1007/s40265-019-01145-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 204 |
Dalla Volta A, Formenti AM, Berruti A. Higher Risk of Fragility Fractures in Prostate Cancer Patients Treated with Combined Radium-223 and Abiraterone: Prednisone May Be the Culprit. European Urology 2019;75:894-5. [DOI: 10.1016/j.eururo.2019.01.026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 205 |
Hu K, Adachi JD. Glucocorticoid induced osteoporosis. Expert Rev Endocrinol Metab 2019;14:259-66. [PMID: 31094232 DOI: 10.1080/17446651.2019.1617131] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 206 |
Walz S, Maas M, Stenzl A, Todenhöfer T. Bone Health Issues in Patients with Prostate Cancer: An Evidence-Based Review. World J Mens Health 2020;38:151-63. [PMID: 31081297 DOI: 10.5534/wjmh.190044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 207 |
Permuy M, López-Peña M, Muñoz F, González-Cantalapiedra A. Rabbit as model for osteoporosis research. J Bone Miner Metab 2019;37:573-83. [PMID: 31087186 DOI: 10.1007/s00774-019-01007-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 208 |
Adhikary S, Choudhary D, Tripathi AK, Karvande A, Ahmad N, Kothari P, Trivedi R. FGF-2 targets sclerostin in bone and myostatin in skeletal muscle to mitigate the deleterious effects of glucocorticoid on musculoskeletal degradation. Life Sci 2019;229:261-76. [PMID: 31082400 DOI: 10.1016/j.lfs.2019.05.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 209 |
Ahn SH, Kim JH, Cho YY, Suh S, Kim BJ, Hong S, Lee SH, Koh JM, Song KH. The effects of cortisol and adrenal androgen on bone mass in Asians with and without subclinical hypercortisolism. Osteoporos Int 2019;30:1059-69. [PMID: 30719548 DOI: 10.1007/s00198-019-04871-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 210 |
Takeuchi T, Tanaka Y, Soen S, Yamanaka H, Yoneda T, Tanaka S, Nitta T, Okubo N, Genant HK, van der Heijde D. Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial. Ann Rheum Dis 2019;78:899-907. [PMID: 31036625 DOI: 10.1136/annrheumdis-2018-214827] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 17.8] [Reference Citation Analysis]
|
| 211 |
Gu Q, Chen M, Zhang Y, Huang Y, Yang H, Shi Q. Haem oxygenase-1 induction prevents glucocorticoid-induced osteoblast apoptosis through activation of extracellular signal-regulated kinase1/2 signalling pathway. J Orthop Translat 2019;19:29-37. [PMID: 31844611 DOI: 10.1016/j.jot.2019.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 212 |
Kerezoudis P, Rinaldo L, Alvi MA, Hunt CL, Qu W, Maus TP, Bydon M. The Effect of Epidural Steroid Injections on Bone Mineral Density and Vertebral Fracture Risk: A Systematic Review and Critical Appraisal of Current Literature. Pain Med 2018;19:569-79. [PMID: 29304236 DOI: 10.1093/pm/pnx324] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 213 |
Skjødt M, Ostadahmadli Y, Abrahamsen B. Long term time trends in use of medications associated with risk of developing osteoporosis: Nationwide data for Denmark from 1999 to 2016. Bone 2019;120:94-100. [DOI: 10.1016/j.bone.2018.08.019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 214 |
Bami H, Lau AN, Adachi JD. Metabolic Bone Disease in Gastrointestinal Disorders. Evidence-based Gastroenterology and Hepatology 4e 2019. [DOI: 10.1002/9781119211419.ch16] [Reference Citation Analysis]
|
| 215 |
Bedatsova L, Drake MT. The skeletal impact of cancer therapies. Br J Clin Pharmacol 2019;85:1161-8. [PMID: 30723928 DOI: 10.1111/bcp.13866] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 216 |
Mann V, Noble B. Techniques for the Study of Apoptosis in Bone. Methods Mol Biol 2019;1914:451-65. [PMID: 30729482 DOI: 10.1007/978-1-4939-8997-3_26] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 217 |
Yoon SH, Grynpas M, Mitchell J. Intermittent PTH treatment improves bone and muscle in glucocorticoid treated Mdx mice: A model of Duchenne Muscular Dystrophy. Bone 2019;121:232-42. [PMID: 30716510 DOI: 10.1016/j.bone.2019.01.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 218 |
Tang Q, Su YW, Fan CM, Chung R, Hassanshahi M, Peymanfar Y, Xian CJ. Release of CXCL12 From Apoptotic Skeletal Cells Contributes to Bone Growth Defects Following Dexamethasone Therapy in Rats. J Bone Miner Res 2019;34:310-26. [PMID: 30395366 DOI: 10.1002/jbmr.3597] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 219 |
Wang T, Yang L, Jiang J, Liu Y, Fan Z, Zhong C, He C. Pulsed electromagnetic fields: promising treatment for osteoporosis. Osteoporos Int 2019;30:267-76. [PMID: 30603841 DOI: 10.1007/s00198-018-04822-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 220 |
Löfdahl E, Söderlund C, Rådegran G. Bone mineral density and osteoporosis in heart transplanted patients: A single‐center retrospective study at Skåne University Hospital in Lund 1988‐2016. Clin Transplant 2019;33:e13477. [DOI: 10.1111/ctr.13477] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 221 |
Pal S, Kumar P, Ramakrishna E, Kumar S, Porwal K, Kumar B, Arya KR, Maurya R, Chattopadhyay N. Extract and fraction of Cassia occidentalis L. (a synonym of Senna occidentalis) have osteogenic effect and prevent glucocorticoid-induced osteopenia. J Ethnopharmacol 2019;235:8-18. [PMID: 30703497 DOI: 10.1016/j.jep.2019.01.029] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 222 |
Javaheri B, Herbert E, Hopkinson M, Al-Jazzar A, Pitsillides AA. Sost Haploinsufficiency Provokes Peracute Lethal Cardiac Tamponade without Rescuing the Osteopenia in a Mouse Model of Excess Glucocorticoids. Am J Pathol 2019;189:753-61. [PMID: 30664862 DOI: 10.1016/j.ajpath.2018.12.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 223 |
Hill QA, Grainger JD, Thachil J, Provan D, Evans G, Garg M, Bradbury C, Bagot C, Kanis JA, Compston JE; the British Society of Haematology in conjunction with the UK ITP forum. The prevention of glucocorticoid‐induced osteoporosis in patients with immune thrombocytopenia receiving steroids: a British Society for Haematology Good Practice Paper. Br J Haematol 2019;185:410-7. [DOI: 10.1111/bjh.15735] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 224 |
Suh C. Korean Guideline of Glucocorticoid-induced Osteoporosis; Time to Prevent Fracture! J Rheum Dis 2019;26:87. [DOI: 10.4078/jrd.2019.26.2.87] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 225 |
Stout SD, Cole ME, Agnew AM. Histomorphology. Ortner's Identification of Pathological Conditions in Human Skeletal Remains. Elsevier; 2019. pp. 91-167. [DOI: 10.1016/b978-0-12-809738-0.00006-5] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 226 |
Lewis M. Endocrine Disturbances. Ortner's Identification of Pathological Conditions in Human Skeletal Remains 2019. [DOI: 10.1016/b978-0-12-809738-0.00016-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 227 |
Navarra SV, Torralba TP. The Musculoskeletal System and Bone Metabolism. Dubois' Lupus Erythematosus and Related Syndromes 2019. [DOI: 10.1016/b978-0-323-47927-1.00034-7] [Reference Citation Analysis]
|
| 228 |
Iolascon G, Paoletta M, Liguori S, Curci C, Moretti A. Neuromuscular Diseases and Bone. Front Endocrinol (Lausanne) 2019;10:794. [PMID: 31824418 DOI: 10.3389/fendo.2019.00794] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 229 |
Fossey SL, Hall DG, Suttie AW, Guillot M, Varela A. Pathology of Bone, Skeletal Muscle, and Tooth. Toxicologic Pathology for Non-Pathologists 2019. [DOI: 10.1007/978-1-4939-9777-0_14] [Reference Citation Analysis]
|
| 230 |
Roux C. Management of Glucocorticoid-Induced Osteoporosis. Pocket Reference to Osteoporosis 2019. [DOI: 10.1007/978-3-319-26757-9_8] [Reference Citation Analysis]
|
| 231 |
Llahana S, Mitchelhill I, Yeoh P, Quinkler M. Diagnosis and Management of Adrenal Insufficiency in Children and Adults. Advanced Practice in Endocrinology Nursing 2019. [DOI: 10.1007/978-3-319-99817-6_37] [Reference Citation Analysis]
|
| 232 |
Zaman NN, Gibbs K, Maltser S. Safety Considerations in the Rehabilitation of Persons With Cancer of the Brain and Spinal Cord. Central Nervous System Cancer Rehabilitation 2019. [DOI: 10.1016/b978-0-323-54829-8.00002-0] [Reference Citation Analysis]
|
| 233 |
Qiao J, Liu A, Liu J, Guan D, Chen T. Salvianolic acid B (Sal B) alleviates the decreased activity induced by prednisolone acetate on osteoblasts by up-regulation of bone formation and differentiation genes. Food Funct 2019;10:6184-92. [DOI: 10.1039/c9fo01246j] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 234 |
Emkey GR. Secondary Osteoporosis. Encyclopedia of Endocrine Diseases 2019. [DOI: 10.1016/b978-0-12-801238-3.65820-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 235 |
Pivonello R, Iacuaniello D, Simeoli C, De Martino MC, Colao A. Long-Term Complications of Hypercortisolism. Encyclopedia of Endocrine Diseases 2019. [DOI: 10.1016/b978-0-12-801238-3.64305-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 236 |
Lim SY, Bolster MB. Corticosteroids. Neurorheumatology 2019. [DOI: 10.1007/978-3-030-16928-2_28] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 237 |
Russow G, Jahn D, Appelt J, Märdian S, Tsitsilonis S, Keller J. Anabolic Therapies in Osteoporosis and Bone Regeneration. Int J Mol Sci 2018;20:E83. [PMID: 30587780 DOI: 10.3390/ijms20010083] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 13.6] [Reference Citation Analysis]
|
| 238 |
Wilbur RE, Griffin JS, Sorensen M, Furberg RD. Establishing Digital Biomarkers for Occupational Health Assessment in Commercial Salmon Fishermen: Protocol for a Mixed-Methods Study. JMIR Res Protoc 2018;7:e10215. [PMID: 30530453 DOI: 10.2196/10215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 239 |
Adams JT PT, DPT, NCS. Clinical decision making and application of an active rehabilitation program for a person with the neuromuscular symptoms of Allgrove syndrome: a case report. Physiother Theory Pract 2020;36:1035-42. [PMID: 30501443 DOI: 10.1080/09593985.2018.1548049] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 240 |
Censi S, Manso J, Pandolfo G, Franceschet G, Cavedon E, Zhu YH, Carducci S, Gomiero W, Plebani M, Zaninotto M, Watutantrige-Fernando S, Mian C, Camozzi V. Bone turnover markers, BMD and TBS after short-term, high-dose glucocorticoid therapy in patients with Graves' orbitopathy: a small prospective pilot study. J Endocrinol Invest 2019;42:859-65. [PMID: 30519958 DOI: 10.1007/s40618-018-0992-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 241 |
Rymuza J, Popow M, Żurecka Z, Przedlacki J, Bednarczuk T, Miśkiewicz P. Therapy of moderate-to-severe Graves' orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density. Endocrine 2019;64:308-15. [PMID: 30506426 DOI: 10.1007/s12020-018-1823-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 242 |
Tecilazich F, Formenti AM, Frara S, Giubbini R, Giustina A. Treatment of hypoparathyroidism. Best Pract Res Clin Endocrinol Metab 2018;32:955-64. [PMID: 30551988 DOI: 10.1016/j.beem.2018.12.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 129] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 243 |
Park SY, Gong HS, Kim KM, Kim D, Kim HY, Jeon CH, Ju JH, Lee SS, Park DA, Sung YK, Kim SW. Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis. J Bone Metab 2018;25:195-211. [PMID: 30574464 DOI: 10.11005/jbm.2018.25.4.195] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 244 |
Zhang L, Mager DE. Systems Modeling of Bortezomib and Dexamethasone Combinatorial Effects on Bone Homeostasis in Multiple Myeloma Patients. J Pharm Sci 2019;108:732-40. [PMID: 30472266 DOI: 10.1016/j.xphs.2018.11.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 245 |
Lemaire V, Cox DR. Dynamics of Bone Cell Interactions and Differential Responses to PTH and Antibody-Based Therapies. Bull Math Biol 2019;81:3575-622. [PMID: 30460589 DOI: 10.1007/s11538-018-0533-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 246 |
Shi L, Ning Y, Xu L, Li J, Zhang X. Technetium-99 Conjugated with Methylene Diphosphonate Ameliorates Glucocorticoid Induced Osteoporosis by Inhibiting Osteoclastogenesis. Biomed Res Int 2018;2018:7902760. [PMID: 30406140 DOI: 10.1155/2018/7902760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 247 |
Abdolmohammadi K, Pakdel FD, Aghaei H, Assadiasl S, Fatahi Y, Rouzbahani NH, Rezaiemanesh A, Soleimani M, Tayebi L, Nicknam MH. Ankylosing spondylitis and mesenchymal stromal/stem cell therapy: a new therapeutic approach. Biomed Pharmacother. 2019;109:1196-1205. [PMID: 30551369 DOI: 10.1016/j.biopha.2018.10.137] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 248 |
Langdahl BL, Silverman S, Fujiwara S, Saag K, Napoli N, Soen S, Enomoto H, Melby TE, Disch DP, Marin F, Krege JH. Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies. Bone 2018;116:58-66. [DOI: 10.1016/j.bone.2018.07.013] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 249 |
Maurice F, Dutour A, Vincentelli C, Abdesselam I, Bernard M, Dufour H, Lefur Y, Graillon T, Kober F, Cristofari P, Jouve E, Pini L, Fernandez R, Chagnaud C, Brue T, Castinetti F, Gaborit B. Active Cushing syndrome patients have increased ectopic fat deposition and bone marrow fat content compared to cured patients and healthy subjects: a pilot 1H-MRS study. European Journal of Endocrinology 2018;179:307-17. [DOI: 10.1530/eje-18-0318] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 250 |
Sterl K, Thompson B, Goss CW, Dacey RG, Rich KM, Zipfel GJ, Chicoine MR, Kim AH, Silverstein JM. Withholding Perioperative Steroids in Patients Undergoing Transsphenoidal Resection for Pituitary Disease: Randomized Prospective Clinical Trial to Assess Safety. Neurosurgery 2019;85:E226-32. [DOI: 10.1093/neuros/nyy479] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 251 |
Wu Z, Yan D, Xie Z, Weng S, Zhou Q, Li H, Bai B, Boodhun V, Shen Z, Tang J, Yang L. Combined treatment with cinnamaldehyde and PTH enhances the therapeutic effect on glucocorticoid-induced osteoporosis through inhibiting osteoclastogenesis and promoting osteoblastogenesis. Biochem Biophys Res Commun 2018;505:945-50. [PMID: 30309646 DOI: 10.1016/j.bbrc.2018.10.039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 252 |
Lin JB, Wu H, Liu YL, Shaw PC, Li PB. Transcriptome analysis reveals functional roles of nacreous protein N16 in prednisolone-induced osteoporotic zebrafish. Int J Biol Macromol 2019;122:1071-9. [PMID: 30219513 DOI: 10.1016/j.ijbiomac.2018.09.055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 253 |
Rosa-Parra JA, Tamayo-Ortiz M, Lamadrid-Figueroa H, Cantoral-Preciado A, Montoya A, Wright RJ, Baccarelli AA, Just AC, Svensson K, Wright RO, Téllez-Rojo MM. Diurnal Cortisol Concentrations and Growth Indexes of 12- to 48-Month-Old Children From Mexico City. J Clin Endocrinol Metab 2018;103:3386-93. [PMID: 30020462 DOI: 10.1210/jc.2018-00550] [Reference Citation Analysis]
|
| 254 |
Ferreira Junior DB, Pizziolo VR, Oliveira TTD, Matta SLPD, Píccolo MS, Queiroz JHD. Perfil biométrico, histomorfométrico e bioquímico no tratamento com atorvastatina cálcica de ratas com osteoporose induzida com dexametasona. Revista Brasileira de Ortopedia 2018;53:607-13. [DOI: 10.1016/j.rbo.2017.06.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 255 |
Badarau E, Robert F, Massip S, Jakob F, Lucas S, Frormann S, Ghosez L. Design and synthesis of spirocyclic ligands of glucocorticoid receptors. Tetrahedron 2018;74:5119-28. [DOI: 10.1016/j.tet.2018.02.030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 256 |
Ferreira Junior DB, Pizziolo VR, Oliveira TTD, Matta SLPD, Píccolo MS, Queiroz JHD. Biometric, histomorphometric, and biochemical profile in atorvastatin calcium treatment of female rats with dexamethasone-induced osteoporosis. Revista Brasileira de Ortopedia (English Edition) 2018;53:607-613. [DOI: 10.1016/j.rboe.2018.07.007] [Reference Citation Analysis]
|
| 257 |
Liu YZ, Akhter MP, Gao X, Wang XY, Wang XB, Zhao G, Wei X, Wu HJ, Chen H, Wang D, Cui L. Glucocorticoid-induced delayed fracture healing and impaired bone biomechanical properties in mice. Clin Interv Aging 2018;13:1465-74. [PMID: 30197508 DOI: 10.2147/CIA.S167431] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 258 |
Sato D, Takahata M, Ota M, Fukuda C, Tsuda E, Shimizu T, Okada A, Hiruma Y, Hamano H, Hiratsuka S, Fujita R, Amizuka N, Hasegawa T, Iwasaki N. Siglec-15-targeting therapy increases bone mass in rats without impairing skeletal growth. Bone 2018;116:172-80. [PMID: 30076992 DOI: 10.1016/j.bone.2018.07.026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 259 |
Mazziotti G, Frara S, Giustina A. Pituitary Diseases and Bone. Endocr Rev 2018;39:440-88. [PMID: 29684108 DOI: 10.1210/er.2018-00005] [Cited by in Crossref: 84] [Cited by in F6Publishing: 75] [Article Influence: 16.8] [Reference Citation Analysis]
|
| 260 |
Xi L, De Falco P, Barbieri E, Karunaratne A, Bentley L, Esapa CT, Terrill NJ, Brown SDM, Cox RD, Davis GR, Pugno NM, Thakker RV, Gupta HS. Bone matrix development in steroid-induced osteoporosis is associated with a consistently reduced fibrillar stiffness linked to altered bone mineral quality. Acta Biomater 2018;76:295-307. [PMID: 29902593 DOI: 10.1016/j.actbio.2018.05.053] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 261 |
Vangala C, Pan J, Cotton RT, Ramanathan V. Mineral and Bone Disorders After Kidney Transplantation. Front Med (Lausanne) 2018;5:211. [PMID: 30109232 DOI: 10.3389/fmed.2018.00211] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 262 |
Ciani A, Toumi H, Pallu S, Tsai EHR, Diaz A, Guizar-Sicairos M, Holler M, Lespessailles E, Kewish CM. Ptychographic X-ray CT characterization of the osteocyte lacuno-canalicular network in a male rat's glucocorticoid induced osteoporosis model. Bone Rep 2018;9:122-31. [PMID: 30246062 DOI: 10.1016/j.bonr.2018.07.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 263 |
González-gay MA, Pina T, Prieto-peña D, Calderon-goercke M, Blanco R, Castañeda S. Drug therapies for polymyalgia rheumatica: a pharmacotherapeutic update. Expert Opinion on Pharmacotherapy 2018;19:1235-44. [DOI: 10.1080/14656566.2018.1501360] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 264 |
Setyani DS, Qibtiyah M, Asmaningsih N, Yulistiani Y. Analysis of High Dose and Long-Term Prednisone Therapy on Trap 5B Level Change in Children with Steroid Sensitive Nephrotic Syndrome. FMI 2018;54:116. [DOI: 10.20473/fmi.v54i2.8861] [Reference Citation Analysis]
|
| 265 |
Hachemi Y, Rapp AE, Picke AK, Weidinger G, Ignatius A, Tuckermann J. Molecular mechanisms of glucocorticoids on skeleton and bone regeneration after fracture. J Mol Endocrinol 2018;61:R75-90. [PMID: 29588427 DOI: 10.1530/JME-18-0024] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 9.6] [Reference Citation Analysis]
|
| 266 |
Restrepo Valencia CA, Aguirre Arango JV, Escobar DC. Determination of vitamin D (25[OH]D) levels in kidney transplant patients and relevance thereof, in accordance with the glomerular filtration rate. Revista Colombiana de Reumatología (English Edition) 2018;25:161-168. [DOI: 10.1016/j.rcreue.2019.01.005] [Reference Citation Analysis]
|
| 267 |
Restrepo Valencia CA, Aguirre Arango JV, Cáceres Escobar D. Determinación de niveles de vitamina D (25[OH]D) en pacientes trasplantados renales y su importancia de acuerdo con la tasa de filtración glomerular. Revista Colombiana de Reumatología 2018;25:161-168. [DOI: 10.1016/j.rcreu.2018.03.006] [Reference Citation Analysis]
|
| 268 |
Ganguly P, El-Jawhari JJ, Giannoudis PV, Burska AN, Ponchel F, Jones EA. Age-related Changes in Bone Marrow Mesenchymal Stromal Cells: A Potential Impact on Osteoporosis and Osteoarthritis Development. Cell Transplant. 2017;26:1520-1529. [PMID: 29113463 DOI: 10.1177/0963689717721201] [Cited by in Crossref: 127] [Cited by in F6Publishing: 133] [Article Influence: 25.4] [Reference Citation Analysis]
|
| 269 |
González-gay MA, Pina T, Prieto-peña D, Calderon-goercke M, Blanco R, Castañeda S. Current and emerging diagnosis tools and therapeutics for giant cell arteritis. Expert Review of Clinical Immunology 2018;14:593-605. [DOI: 10.1080/1744666x.2018.1485491] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 270 |
Hildebrandt S, Baschant U, Thiele S, Tuckermann J, Hofbauer LC, Rauner M. Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo. Sci Rep 2018;8:8711. [PMID: 29880826 DOI: 10.1038/s41598-018-26300-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 271 |
Saitz R, Mesic A, Ventura AS, Winter MR, Heeren TC, Sullivan MM, Walley AY, Patts GJ, Meli SM, Holick MF, Kim TW, Bryant KJ, Samet JH. Alcohol Consumption and Bone Mineral Density in People with HIV and Substance Use Disorder: A Prospective Cohort Study. Alcohol Clin Exp Res 2018. [PMID: 29873812 DOI: 10.1111/acer.13801] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 272 |
Dalemo S, Eggertsen R, Hjerpe P, Almqvist EG, Boström KB. Bone mineral density in primary care patients related to serum calcium concentrations: a longitudinal cohort study from Sweden. Scand J Prim Health Care 2018;36:198-206. [PMID: 29623754 DOI: 10.1080/02813432.2018.1459430] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 273 |
Ohlsson C, Nilsson KH, Henning P, Wu J, Gustafsson KL, Poutanen M, Lerner UH, Movérare-Skrtic S. WNT16 overexpression partly protects against glucocorticoid-induced bone loss. Am J Physiol Endocrinol Metab 2018;314:E597-604. [PMID: 29406783 DOI: 10.1152/ajpendo.00292.2017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 274 |
Axelsen CT, Jensen AB, Jakobsen EH, Bechmann T. Bone loss during neoadjuvant/adjuvant chemotherapy for early stage breast cancer: A retrospective cohort study. Mol Clin Oncol 2018;8:767-72. [PMID: 29805791 DOI: 10.3892/mco.2018.1615] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 275 |
Schneider PS, Sandman E, Martineau PA. Osteoimmunology: Effects of Standard Orthopaedic Interventions on Inflammatory Response and Early Fracture Healing. J Am Acad Orthop Surg 2018;26:343-52. [PMID: 29659378 DOI: 10.5435/JAAOS-D-16-00646] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 276 |
Zammel N, Amri N, Chaabane R, Rebai T, Badraoui R. Proficiencies of Zingiber officinale against spine curve and vertebral damage induced by corticosteroid therapy associated with gonadal hormone deficiency in a rat model of osteoporosis. Biomed Pharmacother 2018;103:1429-35. [PMID: 29864927 DOI: 10.1016/j.biopha.2018.04.159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 277 |
Lizneva D, Yuen T, Sun L, Kim SM, Atabiekov I, Munshi LB, Epstein S, New M, Zaidi M. Emerging concepts in the epidemiology, pathophysiology, and clinical care of osteoporosis across the menopausal transition. Matrix Biol 2018;71-72:70-81. [PMID: 29738833 DOI: 10.1016/j.matbio.2018.05.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 278 |
Güler-Yüksel M, Hoes JN, Bultink IEM, Lems WF. Glucocorticoids, Inflammation and Bone. Calcif Tissue Int 2018;102:592-606. [PMID: 29313071 DOI: 10.1007/s00223-017-0335-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 279 |
Briot K. Bone and glucocorticoids. Ann Endocrinol (Paris) 2018;79:115-8. [PMID: 29685453 DOI: 10.1016/j.ando.2018.04.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 280 |
Huang HX, Lin H, Lan F, Wu YF, Yang ZG, Zhang JJ. Application of bone transgenic zebrafish in anti-osteoporosis chemical screening. Animal Model Exp Med 2018;1:53-61. [PMID: 30891547 DOI: 10.1002/ame2.12000] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 281 |
Hsu E, Nanes M. Advances in treatment of glucocorticoid-induced osteoporosis. Curr Opin Endocrinol Diabetes Obes 2017;24:411-7. [PMID: 28857847 DOI: 10.1097/MED.0000000000000368] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 282 |
Redondo L, Puigoriol E, Rodríguez J, Peris P, Kanterewicz E. Usefulness of the trabecular bone score for assessing the risk of osteoporotic fracture. Revista Clínica Española (English Edition) 2018;218:121-127. [DOI: 10.1016/j.rceng.2017.12.002] [Reference Citation Analysis]
|
| 283 |
Tay YD, Cusano NE, Rubin MR, Williams J, Omeragic B, Bilezikian JP. Trabecular Bone Score in Obese and Nonobese Subjects With Primary Hyperparathyroidism Before and After Parathyroidectomy. J Clin Endocrinol Metab 2018;103:1512-21. [PMID: 29373705 DOI: 10.1210/jc.2017-02169] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 284 |
Zanotti S, Yu J, Adhikari S, Canalis E. Glucocorticoids inhibit notch target gene expression in osteoblasts. J Cell Biochem 2018;119:6016-23. [PMID: 29575203 DOI: 10.1002/jcb.26798] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 285 |
He H, Wang C, Tang Q, Yang F, Xu Y. Possible mechanisms of prednisolone-induced osteoporosis in zebrafish larva. Biomed Pharmacother 2018;101:981-7. [PMID: 29635908 DOI: 10.1016/j.biopha.2018.02.082] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 286 |
Mohn ES, Kern HJ, Saltzman E, Mitmesser SH, McKay DL. Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update. Pharmaceutics 2018;10:E36. [PMID: 29558445 DOI: 10.3390/pharmaceutics10010036] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 287 |
Kim D, Cho SK, Park B, Jang EJ, Bae SC, Sung YK. Glucocorticoids Are Associated with an Increased Risk for Vertebral Fracture in Patients with Rheumatoid Arthritis. J Rheumatol 2018;45:612-20. [PMID: 29545455 DOI: 10.3899/jrheum.170054] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 288 |
Lima GL, Paupitz JA, Aikawa NE, Alvarenga JC, Pereira RMR. A randomized double-blind placebo-controlled trial of vitamin D supplementation in juvenile-onset systemic lupus erythematosus: positive effect on trabecular microarchitecture using HR-pQCT. Osteoporos Int 2018;29:587-94. [PMID: 29152675 DOI: 10.1007/s00198-017-4316-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 289 |
Lv F, Guan Y, Ma D, Xu X, Song Y, Li L, Jiang Y, Wang O, Xia W, Xing X, Li M. Effects of alendronate and alfacalcidol on bone in patients with myasthenia gravis initiating glucocorticoids treatment. Clin Endocrinol (Oxf) 2018;88:380-7. [PMID: 29266368 DOI: 10.1111/cen.13537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 290 |
Wilbur RE, Griffin JS, Sorensen M, Furberg RD. Establishing Digital Biomarkers for Occupational Health Assessment in Commercial Salmon Fishermen: Protocol for a Mixed-Methods Study (Preprint).. [DOI: 10.2196/preprints.10215] [Reference Citation Analysis]
|
| 291 |
Adhikary S, Choudhary D, Ahmad N, Karvande A, Kumar A, Banala VT, Mishra PR, Trivedi R. Dietary flavonoid kaempferol inhibits glucocorticoid-induced bone loss by promoting osteoblast survival. Nutrition 2018;53:64-76. [PMID: 29655780 DOI: 10.1016/j.nut.2017.12.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 292 |
Shen G, Ren H, Shang Q, Qiu T, Yu X, Zhang Z, Huang J, Zhao W, Zhang Y, Liang D, Jiang X. Autophagy as a target for glucocorticoid-induced osteoporosis therapy. Cell Mol Life Sci 2018;75:2683-93. [DOI: 10.1007/s00018-018-2776-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 293 |
Sato AY, Peacock M, Bellido T. GLUCOCORTICOID EXCESS IN BONE AND MUSCLE. Clin Rev Bone Miner Metab 2018;16:33-47. [PMID: 29962904 DOI: 10.1007/s12018-018-9242-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 294 |
Redondo L, Puigoriol E, Rodríguez JR, Peris P, Kanterewicz E. Usefulness of the Trabecular Bone Score for assessing the risk of osteoporotic fracture. Rev Clin Esp (Barc) 2018;218:121-7. [PMID: 29329765 DOI: 10.1016/j.rce.2017.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 295 |
Frara S, Chiloiro S, Porcelli T, Giampietro A, Mazziotti G, De Marinis L, Giustina A. Bone safety of dual-release hydrocortisone in patients with hypopituitarism. Endocrine 2018;60:528-31. [PMID: 29313195 DOI: 10.1007/s12020-017-1512-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 296 |
Valenzuela EN, Pietschmann P. Osteoporosis in Men. Multidisciplinary Approach to Osteoporosis 2018. [DOI: 10.1007/978-3-319-75110-8_13] [Reference Citation Analysis]
|
| 297 |
Escobar JS, Ravikumar A, Levine AC. Adrenal Cushing’s Syndrome: Updates on Overt and Mild Hypercortisolism. Contemporary Endocrinology 2018. [DOI: 10.1007/978-3-319-62470-9_10] [Reference Citation Analysis]
|
| 298 |
Chiodini I, Battista C, Cairoli E, Eller-vainicher C, Morelli V, Palmieri S, Salcuni AS, Scillitani A. Adrenal Function and Skeletal Regulation. Multidisciplinary Approach to Osteoporosis 2018. [DOI: 10.1007/978-3-319-75110-8_7] [Reference Citation Analysis]
|
| 299 |
Di Munno O, Malavolta N, Minisola G. Rheumatic Diseases and Osteoporosis. Multidisciplinary Approach to Osteoporosis 2018. [DOI: 10.1007/978-3-319-75110-8_14] [Reference Citation Analysis]
|
| 300 |
Avgeropoulos NG, Newton HB. Clinical Pharmacology of Brain Tumor Chemotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy 2018. [DOI: 10.1016/b978-0-12-812100-9.00002-4] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 301 |
Emkey GR, Epstein S. Drug and Hormone Effects on Vitamin D Metabolism. Vitamin D 2018. [DOI: 10.1016/b978-0-12-809963-6.00075-4] [Reference Citation Analysis]
|
| 302 |
Belaya ZE, Grebennikova TA, Melnichenko GA, Nikitin AG, Solodovnikov AG, Brovkina OI, Grigoriev AU, Rozhinskaya LY, Dedov II. Effects of endogenous hypercortisolism on bone mRNA and microRNA expression in humans. Osteoporos Int 2018;29:211-21. [PMID: 28980049 DOI: 10.1007/s00198-017-4241-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 303 |
Park SY, Gong HS, Kim KM, Kim D, Kim H, Jeon CH, Ju JH, Lee S, Park DA, Sung Y, Kim SW. Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis. J Rheum Dis 2018;25:263. [DOI: 10.4078/jrd.2018.25.4.263] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 304 |
Kim BJ, Lee SH, Koh JM. Bone Health in Adrenal Disorders. Endocrinol Metab (Seoul) 2018;33:1-8. [PMID: 29589383 DOI: 10.3803/EnM.2018.33.1.1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 305 |
Ward LM, Ma J. Osteoporosis: Diagnosis and Management. Pediatric Endocrinology 2018. [DOI: 10.1007/978-3-319-73782-9_24] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 306 |
Lewis M. Juvenile Arthropathies, Circulatory, and Endocrine Disorders. Paleopathology of Children 2018. [DOI: 10.1016/b978-0-12-410402-0.00010-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 307 |
Phang KF, Cho J, Lee W, Mak A. Glucocorticoid-induced osteoporosis in systemic lupus erythematosus. Rheumatology Practice and Research 2018;3:205990211880251. [DOI: 10.1177/2059902118802510] [Reference Citation Analysis]
|
| 308 |
Pignolo RJ, Mukaddam MA. Evaluation of Bone Fragility and Fracture Prevention. Fractures in the Elderly 2018. [DOI: 10.1007/978-3-319-72228-3_17] [Reference Citation Analysis]
|
| 309 |
Frara S, Maffezzoni F, Doga M, Formenti AM, Mazziotti G, Giustina A. GH/IGF-I and Bone. Multidisciplinary Approach to Osteoporosis 2018. [DOI: 10.1007/978-3-319-75110-8_6] [Reference Citation Analysis]
|
| 310 |
Santos AM, Saldarriaga EL, Giraldo-Bustos R, Ballesteros-Muñoz JG, Rueda JC, Cuervo FM, Angarita JI, Vásquez AY, Arias-Correal S, González CA, Santos-Moreno P, Londono J. Dickkopf 1 protein circulating levels as a possible biomarker of functional disability and chronic damage in patients with rheumatoid arthritis. Clin Rheumatol 2018;37:795-801. [PMID: 29282619 DOI: 10.1007/s10067-017-3957-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 311 |
Tsai CH, Liao LY, Lin CL, Chung WS. Inhaled corticosteroids and the risks of low-energy fractures in patients with chronic airway diseases: A propensity score matched study. Clin Respir J 2018;12:1830-7. [PMID: 29148205 DOI: 10.1111/crj.12744] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 312 |
Hirao M, Hashimoto J, Tsuboi H, Ebina K, Nampei A, Noguchi T, Tsuji S, Nishimoto N, Yoshikawa H. Total Ankle Arthroplasty for Rheumatoid Arthritis in Japanese Patients: A Retrospective Study of Intermediate to Long-Term Follow-up. JB JS Open Access 2017;2:e0033. [PMID: 30229229 DOI: 10.2106/JBJS.OA.17.00033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 313 |
Ghobrial EE, Abdel-aziz H, El Sayed RH, Abdel-aliem AM. Osteocalcin Level in Children with Steroid Dependent/Frequently Relapsing and Steroid Resistant Nephrotic Syndrome. Iran J Pediatr 2017;27. [DOI: 10.5812/ijp.14229] [Reference Citation Analysis]
|
| 314 |
Tang YH, Yue ZS, Xin DW, Zeng LR, Xiong ZF, Hu ZQ, Xu CD. β‑Ecdysterone promotes autophagy and inhibits apoptosis in osteoporotic rats. Mol Med Rep 2018;17:1591-8. [PMID: 29138818 DOI: 10.3892/mmr.2017.8053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 315 |
Wood CL, Soucek O, Wong SC, Zaman F, Farquharson C, Savendahl L, Ahmed SF. Animal models to explore the effects of glucocorticoids on skeletal growth and structure. J Endocrinol 2018;236:R69-91. [PMID: 29051192 DOI: 10.1530/JOE-17-0361] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 316 |
Ly KI, Wen PY. Clinical Relevance of Steroid Use in Neuro-Oncology. Curr Neurol Neurosci Rep 2017;17:5. [PMID: 28138871 DOI: 10.1007/s11910-017-0713-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 317 |
Cherian KE, Kapoor N, Paul TV. Glucocorticoid-induced Osteoporosis. Indian J Endocrinol Metab 2017;21:652-4. [PMID: 28989868 DOI: 10.4103/ijem.IJEM_187_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 318 |
Dolkart O, Chechik O, Bivas A, Brosh T, Drexler M, Weinerman Z, Maman E. Subacromial corticosteroid injections transiently decrease suture anchor pullout strength: biomechanical studies in rats. J Shoulder Elbow Surg 2017;26:1789-93. [PMID: 28689827 DOI: 10.1016/j.jse.2017.05.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 319 |
Witchel SF. Congenital Adrenal Hyperplasia. J Pediatr Adolesc Gynecol 2017;30:520-34. [PMID: 28450075 DOI: 10.1016/j.jpag.2017.04.001] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 14.2] [Reference Citation Analysis]
|
| 320 |
Bowden SA, Mahan JD. Zoledronic acid in pediatric metabolic bone disorders. Transl Pediatr 2017;6:256-68. [PMID: 29184807 DOI: 10.21037/tp.2017.09.10] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 321 |
Kawao N, Morita H, Nishida K, Obata K, Tatsumi K, Kaji H. Effects of hypergravity on gene levels in anti-gravity muscle and bone through the vestibular system in mice. J Physiol Sci 2018;68:609-16. [PMID: 28884429 DOI: 10.1007/s12576-017-0566-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 322 |
Shankar RK, Giri N, Lodish MB, Sinaii N, Reynolds JC, Savage SA, Stratakis CA, Alter BP. Bone mineral density in patients with inherited bone marrow failure syndromes. Pediatr Res 2017;82:458-64. [PMID: 28486441 DOI: 10.1038/pr.2017.117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 323 |
Löfdahl E, Rådegran G. Osteoporosis following heart transplantation and immunosuppressive therapy. Transplant Rev (Orlando) 2017;31:232-9. [PMID: 28865930 DOI: 10.1016/j.trre.2017.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 324 |
Camozzi V, Betterle C, Frigo AC, Zaccariotto V, Zaninotto M, De Caneva E, Lucato P, Gomiero W, Garelli S, Sabbadin C, Salvà M, Costa MD, Boscaro M, Luisetto G. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison’s disease on glucocorticoid and mineralocorticoid replacement therapy. Endocrine 2018;59:319-29. [DOI: 10.1007/s12020-017-1380-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 325 |
Gonçalves PA, Dos Santos Neves R, Neto LV, Madeira M, Guimarães FS, Mendonça LMC, Lopes AJ, Farias MLF. Inhaled glucocorticoids are associated with vertebral fractures in COPD patients. J Bone Miner Metab 2018;36:454-61. [PMID: 28766137 DOI: 10.1007/s00774-017-0854-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 326 |
Saag KG, Agnusdei D, Hans D, Kohlmeier LA, Krohn KD, Leib ES, MacLaughlin EJ, Alam J, Simonelli C, Taylor KA, Marcus R. Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy-Induced Osteoporosis Treated With Alendronate or Teriparatide. Arthritis Rheumatol 2016;68:2122-8. [PMID: 27111239 DOI: 10.1002/art.39726] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 327 |
Chen H, Xing J, Hu X, Chen L, Lv H, Xu C, Hong D, Wu X. Inhibition of heat shock protein 90 rescues glucocorticoid-induced bone loss through enhancing bone formation. J Steroid Biochem Mol Biol 2017;171:236-46. [PMID: 28408351 DOI: 10.1016/j.jsbmb.2017.04.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 328 |
Williams-Dautovich J, Yogendirarajah K, Dela Cruz A, Patel R, Tsai R, Morgan SA, Mitchell J, Grynpas MD, Cummins CL. The CRH-Transgenic Cushingoid Mouse Is a Model of Glucocorticoid-Induced Osteoporosis. JBMR Plus 2017;1:46-57. [PMID: 30283880 DOI: 10.1002/jbm4.10009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 329 |
Mazziotti G, Formenti AM, Frara S, Roca E, Mortini P, Berruti A, Giustina A. MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects. Eur J Endocrinol 2017;177:R231-48. [PMID: 28583942 DOI: 10.1530/EJE-17-0154] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 330 |
Zhang Y, Milojevic D. Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations. Paediatr Drugs 2017;19:193-211. [PMID: 28290112 DOI: 10.1007/s40272-017-0219-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 331 |
Kawazoe M, Kaneko K, Shikano K, Kusunoki N, Nanki T, Kawai S. Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases. Clin Rheumatol 2018;37:2169-78. [PMID: 28551822 DOI: 10.1007/s10067-017-3689-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 332 |
Beier EE, Sheu TJ, Resseguie EA, Takahata M, Awad HA, Cory-Slechta DA, Puzas JE. Sclerostin activity plays a key role in the negative effect of glucocorticoid signaling on osteoblast function in mice. Bone Res 2017;5:17013. [PMID: 28529816 DOI: 10.1038/boneres.2017.13] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 333 |
Thornton D, Gordon CM. Restrictive Eating Disorders and Skeletal Health in Adolescent Girls and Young Women. Calcif Tissue Int 2017;100:449-60. [PMID: 27339670 DOI: 10.1007/s00223-016-0164-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 334 |
Harvey NC, McCloskey EV, Mitchell PJ, Dawson-Hughes B, Pierroz DD, Reginster JY, Rizzoli R, Cooper C, Kanis JA. Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures. Osteoporos Int 2017;28:1507-29. [PMID: 28175979 DOI: 10.1007/s00198-016-3894-y] [Cited by in Crossref: 137] [Cited by in F6Publishing: 134] [Article Influence: 22.8] [Reference Citation Analysis]
|
| 335 |
Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG. Prevention and management of glucocorticoid-induced side effects: A comprehensive review: A review of glucocorticoid pharmacology and bone health. J Am Acad Dermatol 2017;76:1-9. [PMID: 27986132 DOI: 10.1016/j.jaad.2016.01.062] [Cited by in Crossref: 81] [Cited by in F6Publishing: 92] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 336 |
Jung J, Suh C. Glucocorticoid-induced Osteoporosis. Korean J Med 2017;92:142-149. [DOI: 10.3904/kjm.2017.92.2.142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 337 |
Marrani E, Giani T, Simonini G, Cimaz R. Pediatric Osteoporosis: Diagnosis and Treatment Considerations. Drugs 2017;77:679-95. [DOI: 10.1007/s40265-017-0715-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 338 |
Starup-Linde J, Frost M, Vestergaard P, Abrahamsen B. Epidemiology of Fractures in Diabetes. Calcif Tissue Int 2017;100:109-21. [PMID: 27444009 DOI: 10.1007/s00223-016-0175-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 339 |
Zelle DM, Klaassen G, van Adrichem E, Bakker SJ, Corpeleijn E, Navis G. Physical inactivity: a risk factor and target for intervention in renal care. Nat Rev Nephrol 2017;13:152-68. [DOI: 10.1038/nrneph.2016.187] [Cited by in Crossref: 112] [Cited by in F6Publishing: 116] [Article Influence: 18.7] [Reference Citation Analysis]
|
| 340 |
Kao FC, Hsu YC, Lin CJ, Lo YY, Tu YK. Corticosteroid Is Associated with Both Hip Fracture and Fracture-Unrelated Arthropathy. PLoS One 2017;12:e0169468. [PMID: 28125643 DOI: 10.1371/journal.pone.0169468] [Reference Citation Analysis]
|
| 341 |
Liu J, Lu C, Wu X, Zhang Z, Li J, Guo B, Li D, Liang C, Dang L, Pan X, Peng S, Lu A, Zhang B, Zhang G. Targeting osteoblastic casein kinase-2 interacting protein-1 to enhance Smad-dependent BMP signaling and reverse bone formation reduction in glucocorticoid-induced osteoporosis. Sci Rep 2017;7:41295. [PMID: 28128304 DOI: 10.1038/srep41295] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 342 |
Sousa LH, Moura EV, Queiroz AL, Val D, Chaves H, Lisboa M, Furlaneto F, Brito GA, Goes P. Effects of glucocorticoid-induced osteoporosis on bone tissue of rats with experimental periodontitis. Arch Oral Biol 2017;77:55-61. [PMID: 28178585 DOI: 10.1016/j.archoralbio.2017.01.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 343 |
Wang L, Zhang HY, Gao B, Shi J, Huang Q, Han YH, Hu YQ, Lu WG, Zhao ZJ, Liu BH, Jie Q, Yang L, Luo ZJ. Tetramethylpyrazine Protects Against Glucocorticoid-Induced Apoptosis by Promoting Autophagy in Mesenchymal Stem Cells and Improves Bone Mass in Glucocorticoid-Induced Osteoporosis Rats. Stem Cells Dev 2017;26:419-30. [PMID: 27917698 DOI: 10.1089/scd.2016.0233] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 344 |
Chuang MH, Chuang TL, Koo M, Wang YF. Trabecular Bone Score Reflects Trabecular Microarchitecture Deterioration and Fragility Fracture in Female Adult Patients Receiving Glucocorticoid Therapy: A Pre-Post Controlled Study. Biomed Res Int 2017;2017:4210217. [PMID: 28127556 DOI: 10.1155/2017/4210217] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 345 |
Kupfer M, Oleson CV. Osteoporosis in Patients with Peripheral Neuropathies. Osteoporosis Rehabilitation 2017. [DOI: 10.1007/978-3-319-45084-1_11] [Reference Citation Analysis]
|
| 346 |
Huntoon EA. Pain Management and Acupuncture After Vertebral Fractures. Non-Pharmacological Management of Osteoporosis 2017. [DOI: 10.1007/978-3-319-54016-0_16] [Reference Citation Analysis]
|
| 347 |
Bellan M, Sainaghi PP, Pirisi M. Role of Vitamin D in Rheumatoid Arthritis. Adv Exp Med Biol 2017;996:155-68. [PMID: 29124698 DOI: 10.1007/978-3-319-56017-5_13] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 348 |
Russell GM, Løvås K, Lightman S. Glucocorticoid Replacement in Man. Hormones, Brain and Behavior 2017. [DOI: 10.1016/b978-0-12-803592-4.00078-x] [Reference Citation Analysis]
|
| 349 |
Zhao G, Wei X, Wang D. Macromolecular Therapeutics: Development and Delivery Engineering. Neuroimmune Pharmacology 2017. [DOI: 10.1007/978-3-319-44022-4_51] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 350 |
Aderibigbe B, Aderibigbe I, Popoola P. Design and Biological Evaluation of Delivery Systems Containing Bisphosphonates. Pharmaceutics 2016;9:E2. [PMID: 28035945 DOI: 10.3390/pharmaceutics9010002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 351 |
Ishikawa K, Nagai T, Sakamoto K, Ohara K, Eguro T, Ito H, Toyoshima Y, Kokaze A, Toyone T, Inagaki K. High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis. Ther Clin Risk Manag 2016;12:1831-40. [PMID: 27980413 DOI: 10.2147/TCRM.S123172] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 352 |
Lv H, Jiang F, Guan D, Lu C, Guo B, Chan C, Peng S, Liu B, Guo W, Zhu H, Xu X, Lu A, Zhang G. Metabolomics and Its Application in the Development of Discovering Biomarkers for Osteoporosis Research. Int J Mol Sci 2016;17:E2018. [PMID: 27918446 DOI: 10.3390/ijms17122018] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 353 |
Conaway HH, Henning P, Lie A, Tuckermann J, Lerner UH. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity. Bone 2016;93:43-54. [DOI: 10.1016/j.bone.2016.08.024] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 354 |
Messazos BP, Zacharin MR. Lessons from iatrogenic Cushing syndrome in children. J Paediatr Child Health 2016;52:1106-10. [PMID: 27654665 DOI: 10.1111/jpc.13273] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 355 |
Majid H, Kanbar-agha F, Sharafkhaneh A. COPD: osteoporosis and sarcopenia. COPD Res Pract 2016;2:3. [DOI: 10.1186/s40749-016-0019-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 356 |
Kageyama G, Okano T, Yamamoto Y, Nishimura K, Sugiyama D, Saegusa J, Tsuji G, Kumagai S, Morinobu A. Very high frequency of fragility fractures associated with high-dose glucocorticoids in postmenopausal women: A retrospective study. Bone Rep 2017;6:3-8. [PMID: 28377975 DOI: 10.1016/j.bonr.2016.11.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 357 |
Sarwar G, Bisquera A, Peel R, Hancock S, Grainge C, Attia J. The effect of inhaled corticosteroids on bone mineral density measured by quantitative ultrasonography in an older population. Clin Respir J 2018;12:659-65. [PMID: 27805313 DOI: 10.1111/crj.12576] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 358 |
Mormando M, Chiloiro S, Bianchi A, Giampietro A, Angelini F, Tartaglione L, Nasto L, Milardi D, Formenti AM, Giustina A, De Marinis L. Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. Clin Endocrinol (Oxf) 2016;85:717-24. [PMID: 27437620 DOI: 10.1111/cen.13161] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 359 |
Mazziotti G, Formenti AM, Adler RA, Bilezikian JP, Grossman A, Sbardella E, Minisola S, Giustina A. Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines. Endocrine 2016;54:603-11. [PMID: 27766553 DOI: 10.1007/s12020-016-1146-8] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 360 |
Pan S, Chen A, Han Z, Wang Y, Lu X, Yang Y. 1H NMR-based metabonomic study on the effects of Epimedium on glucocorticoid-induced osteoporosis. J Chromatogr B Analyt Technol Biomed Life Sci 2016;1038:118-26. [PMID: 27810280 DOI: 10.1016/j.jchromb.2016.10.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 361 |
González-gay MA, Castañeda S. Managing of giant cell arteritis and polymyalgia rheumatica. Expert Opinion on Orphan Drugs 2016;4:1133-44. [DOI: 10.1080/21678707.2016.1244480] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 362 |
Bensiamar F, Olalde B, Cifuentes SC, Argarate N, Atorrasagasti G, González-carrasco JL, García-rey E, Vilaboa N, Saldaña L. Bioactivity of dexamethasone-releasing coatings on polymer/magnesium composites. Biomed Mater 2016;11:055011. [DOI: 10.1088/1748-6041/11/5/055011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 363 |
Allen CS, Yeung JH, Vandermeer B, Homik J. Bisphosphonates for steroid-induced osteoporosis. Cochrane Database Syst Rev 2016;10:CD001347. [PMID: 27706804 DOI: 10.1002/14651858.CD001347.pub2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 364 |
Marco E, Coll-artés R, Marín M, Coll-fernández R, Pascual M, Resa J, Múñoz L, Romero M, Burnham P, Círia M. Recomendaciones sobre programas de rehabilitación pulmonar en pacientes con enfermedad pulmonar obstructiva crónica de la Sociedad de Rehabilitación Cardiorrespiratoria. Rehabilitación 2016;50:233-62. [DOI: 10.1016/j.rh.2016.04.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 365 |
Alshaikh N, Brunklaus A, Davis T, Robb SA, Quinlivan R, Munot P, Sarkozy A, Muntoni F, Manzur AY; Dubowitz Neuromuscular Team. Vitamin D in corticosteroid-naïve and corticosteroid-treated Duchenne muscular dystrophy: what dose achieves optimal 25(OH) vitamin D levels? Arch Dis Child 2016;101:957-61. [PMID: 27246070 DOI: 10.1136/archdischild-2015-308825] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 366 |
Zhang Z, Ren H, Shen G, Qiu T, Liang, Yang Z, Yao Z, Tang J, Jiang X, Wei Q. Animal models for glucocorticoid-induced postmenopausal osteoporosis: An updated review. Biomed Pharmacother 2016;84:438-46. [PMID: 27685786 DOI: 10.1016/j.biopha.2016.09.045] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 367 |
Lems WF, Baak MM, van Tuyl LH, Lodder MC, Dijkmans BA, Boers M. One-year effects of glucocorticoids on bone density: a meta-analysis in cohorts on high and low-dose therapy. RMD Open 2016;2:e000313. [PMID: 27651928 DOI: 10.1136/rmdopen-2016-000313] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 368 |
Ueda Y, Yasoda A, Yamashita Y, Kanai Y, Hirota K, Yamauchi I, Kondo E, Sakane Y, Yamanaka S, Nakao K, Fujii T, Inagaki N. C-type natriuretic peptide restores impaired skeletal growth in a murine model of glucocorticoid-induced growth retardation. Bone 2016;92:157-67. [PMID: 27594049 DOI: 10.1016/j.bone.2016.08.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 369 |
Briot K, Abitbol V, Roux C. Os et intestin. Prise en charge des ostéopathies associées aux pathologies intestinales. Revue du Rhumatisme Monographies 2016;83:261-5. [DOI: 10.1016/j.monrhu.2016.05.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 370 |
Smith SS, Dole NS, Franceschetti T, Hrdlicka HC, Delany AM. MicroRNA-433 Dampens Glucocorticoid Receptor Signaling, Impacting Circadian Rhythm and Osteoblastic Gene Expression. J Biol Chem 2016;291:21717-28. [PMID: 27551048 DOI: 10.1074/jbc.M116.737890] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 371 |
Jacobs FA, Sadie-Van Gijsen H, van de Vyver M, Ferris WF. Vanadate Impedes Adipogenesis in Mesenchymal Stem Cells Derived from Different Depots within Bone. Front Endocrinol (Lausanne) 2016;7:108. [PMID: 27536268 DOI: 10.3389/fendo.2016.00108] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 372 |
Zhang X, Chen K, Wei B, Liu X, Lei Z, Bai X. Ginsenosides Rg3 attenuates glucocorticoid-induced osteoporosis through regulating BMP-2/BMPR1A/Runx2 signaling pathway. Chemico-Biological Interactions 2016;256:188-97. [DOI: 10.1016/j.cbi.2016.07.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 373 |
Shih MT, Tang SH, Cha TL, Wu ST, Chiang JH, Chen WC. The Risk of Nephrolithiasis Among Patients With Ankylosing Spondylitis: a Population-Based Cohort Study. Arch Rheumatol 2016;31:346-52. [PMID: 30375555 DOI: 10.5606/ArchRheumatol.2016.5938] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 374 |
Chiodini I, Vainicher CE, Morelli V, Palmieri S, Cairoli E, Salcuni AS, Copetti M, Scillitani A. MECHANISMS IN ENDOCRINOLOGY: Endogenous subclinical hypercortisolism and bone: a clinical review. Eur J Endocrinol 2016;175:R265-82. [PMID: 27412441 DOI: 10.1530/EJE-16-0289] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 375 |
Shen G, Ren H, Qiu T, Liang, Wei Q, Tang J, Zhang Z, Yao Z, Zhao W, Jiang X. Effect of glucocorticoid withdrawal on glucocorticoid inducing bone impairment. Biochem Biophys Res Commun 2016;477:1059-64. [PMID: 27402272 DOI: 10.1016/j.bbrc.2016.07.036] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 376 |
Shen C, Kim MR, Noh JM, Kim SJ, Ka SO, Kim JH, Park BH, Park JH. Glucocorticoid Suppresses Connexin 43 Expression by Inhibiting the Akt/mTOR Signaling Pathway in Osteoblasts. Calcif Tissue Int 2016;99:88-97. [PMID: 26914606 DOI: 10.1007/s00223-016-0121-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 377 |
Schwartz AV, Pavo I, Alam J, Disch DP, Schuster D, Harris JM, Krege JH. Teriparatide in patients with osteoporosis and type 2 diabetes. Bone. 2016;91:152-158. [PMID: 27374026 DOI: 10.1016/j.bone.2016.06.017] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 378 |
Ward LM, Konji VN, Ma J. The management of osteoporosis in children. Osteoporos Int 2016;27:2147-79. [PMID: 27125514 DOI: 10.1007/s00198-016-3515-9] [Cited by in Crossref: 88] [Cited by in F6Publishing: 88] [Article Influence: 12.6] [Reference Citation Analysis]
|
| 379 |
Xu L, Zhang T, Cui B, He Z, Xiang J, Long C, Peng Z, Li P, Huang G, Ji G, Zhang F. Clinical efficacy maintains patients' positive attitudes toward fecal microbiota transplantation. Medicine (Baltimore) 2016;95:e4055. [PMID: 27472679 DOI: 10.1097/MD.0000000000004055] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 380 |
Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A. Complications of Cushing's syndrome: state of the art. Lancet Diabetes Endocrinol 2016;4:611-29. [PMID: 27177728 DOI: 10.1016/S2213-8587(16)00086-3] [Cited by in Crossref: 276] [Cited by in F6Publishing: 254] [Article Influence: 39.4] [Reference Citation Analysis]
|
| 381 |
Yoon SH, Chen J, Grynpas MD, Mitchell J. Prophylactic pamidronate partially protects from glucocorticoid-induced bone loss in the mdx mouse model of Duchenne muscular dystrophy. Bone 2016;90:168-80. [PMID: 27373502 DOI: 10.1016/j.bone.2016.06.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 382 |
Casagrande SS, Cowie CC, Malozowski S. Glucocorticoid use and its association with skeletal health among U.S. adults with diabetes. J Diabetes Complications 2017;31:353-7. [PMID: 27431890 DOI: 10.1016/j.jdiacomp.2016.06.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 383 |
Hartmann K, Koenen M, Schauer S, Wittig-Blaich S, Ahmad M, Baschant U, Tuckermann JP. Molecular Actions of Glucocorticoids in Cartilage and Bone During Health, Disease, and Steroid Therapy. Physiol Rev 2016;96:409-47. [PMID: 26842265 DOI: 10.1152/physrev.00011.2015] [Cited by in Crossref: 123] [Cited by in F6Publishing: 130] [Article Influence: 17.6] [Reference Citation Analysis]
|
| 384 |
Adachi JD, Lau A. Systemic lupus erythematosus, osteoporosis, and fractures. J Rheumatol 2014;41:1913-5. [PMID: 25275093 DOI: 10.3899/jrheum.140919] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 385 |
Gahlot N, Saini UC. Bisphosphonates in Orthopedics: Evidence-based Review of Indications and Adverse Effects. Journal of Postgraduate Medicine, Education and Research 2016;50:75-85. [DOI: 10.5005/jp-journals-10028-1197] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 386 |
Gao B, Han YH, Wang L, Lin YJ, Sun Z, Lu WG, Hu YQ, Li JQ, Lin XS, Liu BH, Jie Q, Yang L, Luo ZJ. Eicosapentaenoic acid attenuates dexamethasome-induced apoptosis by inducing adaptive autophagy via GPR120 in murine bone marrow-derived mesenchymal stem cells. Cell Death Dis 2016;7:e2235. [PMID: 27228350 DOI: 10.1038/cddis.2016.144] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 387 |
Wegler C, Wikvall K, Norlin M. Effects of Osteoporosis-Inducing Drugs on Vitamin D-Related Gene Transcription and Mineralization in MG-63 and Saos-2 Cells. Basic Clin Pharmacol Toxicol 2016;119:436-42. [PMID: 27098343 DOI: 10.1111/bcpt.12612] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 388 |
Lima GL, Paupitz J, Aikawa NE, Takayama L, Bonfa E, Pereira RM. Vitamin D Supplementation in Adolescents and Young Adults With Juvenile Systemic Lupus Erythematosus for Improvement in Disease Activity and Fatigue Scores: A Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Care Res (Hoboken) 2016;68:91-8. [PMID: 25988278 DOI: 10.1002/acr.22621] [Cited by in Crossref: 92] [Cited by in F6Publishing: 97] [Article Influence: 13.1] [Reference Citation Analysis]
|
| 389 |
Yao S, Zhang Y, Wang X, Zhao F, Sun M, Zheng X, Dong H, Guo K. Pigment Epithelium-Derived Factor (PEDF) Protects Osteoblastic Cell Line from Glucocorticoid-Induced Apoptosis via PEDF-R. Int J Mol Sci 2016;17:E730. [PMID: 27187377 DOI: 10.3390/ijms17050730] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 390 |
Amiche MA, Albaum JM, Tadrous M, Pechlivanoglou P, Lévesque LE, Adachi JD, Cadarette SM. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials. Osteoporos Int 2016;27:1709-18. [PMID: 26694595 DOI: 10.1007/s00198-015-3455-9] [Cited by in Crossref: 87] [Cited by in F6Publishing: 68] [Article Influence: 12.4] [Reference Citation Analysis]
|
| 391 |
Pirsl F, Curtis LM, Steinberg SM, Tella SH, Katić M, Dobbin M, Hsu J, Hakim FT, Mays JW, Im AP, Pulanić D, Mitchell SA, Baruffaldi J, Masuch L, Halverson DC, Gress RE, Barsony J, Pavletic SZ. Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 2016;22:1517-24. [PMID: 27118572 DOI: 10.1016/j.bbmt.2016.04.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 392 |
Naylor KL, Jamal SA, Zou G, McArthur E, Lam NN, Leslie WD, Hodsman AB, Kim SJ, Knoll GA, Fraser LA. Fracture Incidence in Adult Kidney Transplant Recipients. Transplantation. 2016;100:167-175. [PMID: 26154389 DOI: 10.1097/tp.0000000000000808] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 393 |
Klouwer FCC, Abdulrahman H, Poll-The BT. Reply: Low bone mineral density is a common feature of Zellweger spectrum disorders. Mol Genet Metab Rep 2017;11:94. [PMID: 28649513 DOI: 10.1016/j.ymgmr.2016.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 394 |
Cazzaniga A, Maier JAM, Castiglioni S. Prednisolone inhibits SaOS2 osteosarcoma cell proliferation by activating inducible nitric oxide synthase. World J Transl Med 2016; 5(1): 53-58 [DOI: 10.5528/wjtm.v5.i1.53] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 395 |
Tatara M, Krupski W, Majer-dziedzic B, Szabelska A. 7. Novel and current approaches to dietary and non-dietary bone metabolism regulation. Handbook of nutrition and diet in therapy of bone diseases 2016. [DOI: 10.3920/978-90-8686-823-0_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 396 |
Bamgbola O. Metabolic consequences of modern immunosuppressive agents in solid organ transplantation. Ther Adv Endocrinol Metab 2016;7:110-27. [PMID: 27293540 DOI: 10.1177/2042018816641580] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 397 |
Yang Y, Su Y, Wang D, Chen Y, Liu Y, Luo S, Wu T, Cui L. Tanshinol Rescues the Impaired Bone Formation Elicited by Glucocorticoid Involved in KLF15 Pathway. Oxid Med Cell Longev 2016;2016:1092746. [PMID: 27051474 DOI: 10.1155/2016/1092746] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 398 |
Murphy O, Zandi MS, Lindenberg N, Murphy E, Chataway J. Bone health in patients with multiple sclerosis relapses. Multiple Sclerosis and Related Disorders 2016;6:75-80. [DOI: 10.1016/j.msard.2016.02.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 399 |
Hoke LJ, Dilich AS. The deprescribing of calcium supplements in a state operated developmental center: a 10-year longitudinal pilot study. International Journal of Developmental Disabilities 2016;62:3-10. [DOI: 10.1179/2047387714y.0000000056] [Reference Citation Analysis]
|
| 400 |
Ganesh R, Suresh N, Janakiraman L, Ravikumar K. Correlation of Bone Mineral Parameters with Anthropometric Measurements and the Effect of Glucocorticoids on Bone Mineral Parameters in Congenital Adrenal Hyperplasia. Indian J Pediatr 2016;83:126-30. [PMID: 26223873 DOI: 10.1007/s12098-015-1835-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 401 |
Whittier X, Saag KG. Glucocorticoid-induced Osteoporosis. Rheumatic Disease Clinics of North America 2016;42:177-89. [DOI: 10.1016/j.rdc.2015.08.005] [Cited by in Crossref: 81] [Cited by in F6Publishing: 66] [Article Influence: 11.6] [Reference Citation Analysis]
|
| 402 |
Leib ES, Winzenrieth R. Bone status in glucocorticoid-treated men and women. Osteoporos Int 2016;27:39-48. [PMID: 26252975 DOI: 10.1007/s00198-015-3211-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 403 |
Maes C, Kronenberg HM. Bone Development and Remodeling. Endocrinology: Adult and Pediatric. Elsevier; 2016. pp. 1038-1062.e8. [DOI: 10.1016/b978-0-323-18907-1.00060-3] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 404 |
Simões Pereira J, Silva Vieira M, Pereira P, Pereira MC. Sequelas endócrinas do tratamento oncológico – qual o papel da deficiência da hormona do crescimento no desenvolvimento de osteoporose? Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo 2016;11:48-56. [DOI: 10.1016/j.rpedm.2015.05.008] [Reference Citation Analysis]
|
| 405 |
De Paula FJ, Black DM, Rosen CJ. Osteoporosis and Bone Biology. Williams Textbook of Endocrinology 2016. [DOI: 10.1016/b978-0-323-29738-7.00029-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 406 |
Ward LM, Ma J. Bone Mineral Density as a Predictor of Vertebral Fractures in Children and Adolescents. Bone Health Assessment in Pediatrics 2016. [DOI: 10.1007/978-3-319-30412-0_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 407 |
Cimaz R, Ward L. The Impact of Rheumatic Diseases and Their Treatment on Bone Strength Development in Childhood. Textbook of Pediatric Rheumatology. Elsevier; 2016. pp. 693-705.e5. [DOI: 10.1016/b978-0-323-24145-8.00053-3] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 408 |
Stewart H, Waite E. Solid Organ Transplantation. Care of Adults with Chronic Childhood Conditions 2016. [DOI: 10.1007/978-3-319-43827-6_17] [Reference Citation Analysis]
|
| 409 |
Lee PH, Kok VC, Chou PL, Ku MC, Chen YC, Horng JT. Risk and clinical predictors of osteoporotic fracture in East Asian patients with chronic obstructive pulmonary disease: a population-based cohort study. PeerJ 2016;4:e2634. [PMID: 27812429 DOI: 10.7717/peerj.2634] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 410 |
Axelrod L. Glucocorticoid Therapy. Endocrinology: Adult and Pediatric 2016. [DOI: 10.1016/b978-0-323-18907-1.00100-1] [Reference Citation Analysis]
|
| 411 |
Maman E, Yehuda C, Pritsch T, Morag G, Brosh T, Sharfman Z, Dolkart O. Detrimental Effect of Repeated and Single Subacromial Corticosteroid Injections on the Intact and Injured Rotator Cuff: A Biomechanical and Imaging Study in Rats. Am J Sports Med 2016;44:177-82. [PMID: 26216105 DOI: 10.1177/0363546515591266] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 412 |
Lumbanraja SN. Effects of Steroid Use and Bone Mass Density in South Securai Village, Langkat, Indonesia. International J of Osteoporosis and Metabolic Disorders 2015;9:13-18. [DOI: 10.3923/ijom.2016.13.18] [Reference Citation Analysis]
|
| 413 |
Naito M, Vongsa S, Tsukune N, Ohashi A, Takahashi T. Promyelocytic leukemia zinc finger mediates glucocorticoid-induced cell cycle arrest in the chondroprogenitor cell line ATDC5. Mol Cell Endocrinol 2015;417:114-23. [PMID: 26419928 DOI: 10.1016/j.mce.2015.09.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 414 |
Karunaratne A, Xi L, Bentley L, Sykes D, Boyde A, Esapa CT, Terrill NJ, Brown SDM, Cox RD, Thakker RV, Gupta HS. Multiscale alterations in bone matrix quality increased fragility in steroid induced osteoporosis. Bone 2016;84:15-24. [PMID: 26657825 DOI: 10.1016/j.bone.2015.11.019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 415 |
Achiou Z, Toumi H, Touvier J, Boudenot A, Uzbekov R, Ominsky MS, Pallu S, Lespessailles E. Sclerostin antibody and interval treadmill training effects in a rodent model of glucocorticoid-induced osteopenia. Bone 2015;81:691-701. [DOI: 10.1016/j.bone.2015.09.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 416 |
Lima CA, Lyra AC, Rocha R, Santana GO. Risk factors for osteoporosis in inflammatory bowel disease patients. World J Gastrointest Pathophysiol 2015; 6(4): 210-218 [PMID: 26600979 DOI: 10.4291/wjgp.v6.i4.210] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 48] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 417 |
Lan GB, Xie XB, Peng LK, Liu L, Song L, Dai HL. Current Status of Research on Osteoporosis after Solid Organ Transplantation: Pathogenesis and Management. Biomed Res Int 2015;2015:413169. [PMID: 26649301 DOI: 10.1155/2015/413169] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 418 |
Frenkel B, White W, Tuckermann J. Glucocorticoid-Induced Osteoporosis. Adv Exp Med Biol 2015;872:179-215. [PMID: 26215995 DOI: 10.1007/978-1-4939-2895-8_8] [Cited by in Crossref: 86] [Cited by in F6Publishing: 92] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 419 |
Farshatova ER, Ganeev TI, Men’shikova IA, Sarmeneeva LV, Nurgaleev NV, Kamilov FK. Influence of copper-zinc sulfide ores elements on bone tissue remodeling and regulative factors. Kazan Med J 2015;96:783-787. [DOI: 10.17750/kmj2015-783] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 420 |
Cohen A, Shen W, Dempster DW, Zhou H, Recker RR, Lappe JM, Kepley A, Kamanda-Kosseh M, Bucovsky M, Stein EM, Nickolas TL, Shane E. Marrow adiposity assessed on transiliac crest biopsy samples correlates with noninvasive measurement of marrow adiposity by proton magnetic resonance spectroscopy ((1)H-MRS) at the spine but not the femur. Osteoporos Int 2015;26:2471-8. [PMID: 25986383 DOI: 10.1007/s00198-015-3161-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 421 |
Trickey J. Foot and Ankle Insufficiency Fractures in Rheumatoid Arthritis. MOJOR 2015;3. [DOI: 10.15406/mojor.2015.03.00091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 422 |
Krajewski C, Sucato G. Reproductive health care after transplantation. Best Pract Res Clin Obstet Gynaecol 2014;28:1222-34. [PMID: 25450188 DOI: 10.1016/j.bpobgyn.2014.09.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 423 |
LeBlanc CM, Ma J, Taljaard M, Roth J, Scuccimarri R, Miettunen P, Lang B, Huber AM, Houghton K, Jaremko JL, Ho J, Shenouda N, Matzinger MA, Lentle B, Stein R, Sbrocchi AM, Oen K, Rodd C, Jurencak R, Cummings EA, Couch R, Cabral DA, Atkinson S, Alos N, Rauch F, Siminoski K, Ward LM; Canadian STeroid-Associated Osteoporosis in Pediatric Population (STOPP) Consortium. Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders. J Bone Miner Res 2015;30:1667-75. [PMID: 25801315 DOI: 10.1002/jbmr.2511] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 10.4] [Reference Citation Analysis]
|
| 424 |
Cummings EA, Ma J, Fernandez CV, Halton J, Alos N, Miettunen PM, Jaremko JL, Ho J, Shenouda N, Matzinger MA, Lentle B, Stephure D, Stein R, Sbrocchi AM, Rodd C, Lang B, Israels S, Grant RM, Couch R, Barr R, Hay J, Rauch F, Siminoski K, Ward LM; Canadian STOPP Consortium (National Pediatric Bone Health Working Group). Incident Vertebral Fractures in Children With Leukemia During the Four Years Following Diagnosis. J Clin Endocrinol Metab 2015;100:3408-17. [PMID: 26171800 DOI: 10.1210/JC.2015-2176] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 425 |
Mellibovsky L, Prieto-Alhambra D, Mellibovsky F, Güerri-Fernández R, Nogués X, Randall C, Hansma PK, Díez-Perez A. Bone Tissue Properties Measurement by Reference Point Indentation in Glucocorticoid-Induced Osteoporosis. J Bone Miner Res 2015;30:1651-6. [PMID: 25736591 DOI: 10.1002/jbmr.2497] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 426 |
McCormick JA, Ellison DH. Distal convoluted tubule. Compr Physiol 2015;5:45-98. [PMID: 25589264 DOI: 10.1002/cphy.c140002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 43] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 427 |
Wen L, Kang J, Yim Y, Lee J, Lee K, Park D, Kim T, Park Y, Lee S. Risk factors for treatment failure in osteoporotic patients with rheumatoid arthritis. Modern Rheumatology 2016;26:194-9. [DOI: 10.3109/14397595.2015.1069444] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 428 |
Fairchild A, Tirumani SH, Rosenthal MH, Howard SA, Krajewski KM, Nishino M, Shinagare AB, Jagannathan JP, Ramaiya NH. Hormonal therapy in oncology: a primer for the radiologist. AJR Am J Roentgenol 2015;204:W620-30. [PMID: 26001251 DOI: 10.2214/AJR.14.13604] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 429 |
Song L, Xie XB, Peng LK, Yu SJ, Peng YT. Mechanism and Treatment Strategy of Osteoporosis after Transplantation. Int J Endocrinol 2015;2015:280164. [PMID: 26273295 DOI: 10.1155/2015/280164] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 430 |
Naylor KL, Garg AX, Hodsman AB, Rush DN, Leslie WD. Long-term changes in bone mineral density in kidney transplant recipients. Transplantation 2014;98:1279-85. [PMID: 25050472 DOI: 10.1097/TP.0000000000000284] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 431 |
Briot K, Cortet B, Roux C, Fardet L, Abitbol V, Bacchetta J, Buchon D, Debiais F, Guggenbuhl P, Laroche M, Legrand E, Lespessailles E, Marcelli C, Weryha G, Thomas T; Bone Section of the French Society for Rheumatology (SFR) and Osteoporosis Research and Information Group (GRIO). 2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis. Joint Bone Spine 2014;81:493-501. [PMID: 25455041 DOI: 10.1016/j.jbspin.2014.10.001] [Cited by in Crossref: 72] [Cited by in F6Publishing: 80] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 432 |
García Barrado F, Kuypers DR, Matricali GA. Charcot neuroarthropathy after simultaneous pancreas-kidney transplantation: risk factors, prevalence, and outcome. Clin Transplant 2015;29:712-9. [PMID: 26033225 DOI: 10.1111/ctr.12572] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 433 |
Kabir ER, Morshed N. Different approaches in the treatment of obstructive pulmonary diseases. Eur J Pharmacol 2015;764:306-17. [PMID: 26172082 DOI: 10.1016/j.ejphar.2015.07.030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 434 |
Bambury RM, Rathkopf DE. Novel and next-generation androgen receptor-directed therapies for prostate cancer: Beyond abiraterone and enzalutamide. Urol Oncol 2016;34:348-55. [PMID: 26162486 DOI: 10.1016/j.urolonc.2015.05.025] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 435 |
Ribeiro D, Zawadynski S, Pittet LF, Chevalley T, Girardin E, Parvex P. Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome. Eur J Pediatr 2015;174:911-7. [PMID: 25573461 DOI: 10.1007/s00431-014-2479-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 436 |
Migita K, Iwanaga N, Imadachi S, Jiuchi Y, Izumi Y, Tsuji Y, Kawahara C, Kawakami A, Furukawa H, Tohma S. Incidence of Symptomatic Vertebral Fractures Among Newly Diagnosed Autoimmune Diseases Initiating Glucocorticoid Therapy. Medicine (Baltimore) 2015;94:e875. [PMID: 26166127 DOI: 10.1097/MD.0000000000000875] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 437 |
Naito M, Ohashi A, Takahashi T. Dexamethasone inhibits chondrocyte differentiation by suppression of Wnt/β-catenin signaling in the chondrogenic cell line ATDC5. Histochem Cell Biol 2015;144:261-72. [DOI: 10.1007/s00418-015-1334-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 438 |
Falhammar H, Nordenström A. Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome. Endocrine 2015;50:32-50. [PMID: 26082286 DOI: 10.1007/s12020-015-0656-0] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 439 |
Zhang YP, Gong Y, Zeng QY, Hou ZD, Xiao ZY. A long-term, observational cohort study on the safety of low-dose glucocorticoids in ankylosing spondylitis: adverse events and effects on bone mineral density, blood lipid and glucose levels and body mass index. BMJ Open 2015;5:e006957. [PMID: 26041488 DOI: 10.1136/bmjopen-2014-006957] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 440 |
Lodjak J, Mägi M, Rooni U, Tilgar V. Context-dependent effects of feather corticosterone on growth rate and fledging success of wild passerine nestlings in heterogeneous habitat. Oecologia 2015;179:937-46. [DOI: 10.1007/s00442-015-3357-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 441 |
Vojinovic J, Cimaz R. Vitamin D—update for the pediatric rheumatologists. Pediatr Rheumatol Online J 2015;13:18. [PMID: 26022196 DOI: 10.1186/s12969-015-0017-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 442 |
Mirza F, Canalis E. Management of endocrine disease: Secondary osteoporosis: pathophysiology and management. Eur J Endocrinol 2015;173:R131-51. [PMID: 25971649 DOI: 10.1530/EJE-15-0118] [Cited by in Crossref: 144] [Cited by in F6Publishing: 154] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 443 |
Kenanidis E, Potoupnis ME, Kakoulidis P, Leonidou A, Sakellariou GT, Sayegh FE, Tsiridis E. Management of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk. Expert Opin Drug Saf 2015;14:1035-53. [PMID: 25952267 DOI: 10.1517/14740338.2015.1040387] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 444 |
Bellan M, Pirisi M, Sainaghi PP. Osteoporosis in rheumatoid arthritis: role of the vitamin D/parathyroid hormone system. Revista Brasileira de Reumatologia (English Edition) 2015;55:256-263. [DOI: 10.1016/j.rbre.2014.10.007] [Reference Citation Analysis]
|
| 445 |
Bellan M, Pirisi M, Sainaghi PP. Osteoporose na artrite reumatoide: papel do sistema vitamina D/hormônio paratireóideo. Revista Brasileira de Reumatologia 2015;55:256-63. [DOI: 10.1016/j.rbr.2014.10.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 446 |
Briot K, Roux C. Glucocorticoid-induced osteoporosis. RMD Open 2015;1:e000014. [PMID: 26509049 DOI: 10.1136/rmdopen-2014-000014] [Cited by in Crossref: 146] [Cited by in F6Publishing: 158] [Article Influence: 18.3] [Reference Citation Analysis]
|
| 447 |
Komori T. Animal models for osteoporosis. Eur J Pharmacol 2015;759:287-94. [PMID: 25814262 DOI: 10.1016/j.ejphar.2015.03.028] [Cited by in Crossref: 148] [Cited by in F6Publishing: 159] [Article Influence: 18.5] [Reference Citation Analysis]
|
| 448 |
Kim SY, Davydov O, Hans D, Bockman R. Insights on accelerated skeletal repair in Cushing's disease. Bone Rep 2015;2:32-5. [PMID: 28377951 DOI: 10.1016/j.bonr.2015.03.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 449 |
Rossini M, Orsolini G, Viapiana O, Adami S, Gatti D. Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros. Endocrine 2015;49:620-7. [PMID: 25649760 DOI: 10.1007/s12020-014-0506-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 450 |
Chiavistelli S, Giustina A, Mazziotti G. Parathyroid hormone pulsatility: physiological and clinical aspects. Bone Res 2015;3:14049. [PMID: 26273533 DOI: 10.1038/boneres.2014.49] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 451 |
Otovic P, Smith S, Hutchinson E. The use of glucocorticoids in marmoset wasting syndrome. J Med Primatol 2015;44:53-9. [PMID: 25614344 DOI: 10.1111/jmp.12159] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 452 |
Chen SJ, Liao WC, Huang KH, Lin CL, Tsai WC, Kung PT, Chang KH, Kao CH. Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures: a population-based cohort study. QJM 2015;108:633-40. [PMID: 25614611 DOI: 10.1093/qjmed/hcv012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 453 |
Adler RA, Giustina A. Parathyroid Hormone and Glucocorticoid-induced Osteoporosis. The Parathyroids 2015. [DOI: 10.1016/b978-0-12-397166-1.00059-x] [Reference Citation Analysis]
|
| 454 |
Micheletti RG, Murrell DF, Werth VP. Treatment and Prevention of Glucocorticoid-Induced Osteoporosis. Blistering Diseases 2015. [DOI: 10.1007/978-3-662-45698-9_63] [Reference Citation Analysis]
|
| 455 |
Lau AN, Sambrook PN, Adachi JD. Glucocorticoid-induced osteoporosis. Rheumatology 2015. [DOI: 10.1016/b978-0-323-09138-1.00202-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 456 |
Reusch CE. Glucocorticoid Therapy. Canine and Feline Endocrinology 2015. [DOI: 10.1016/b978-1-4557-4456-5.00014-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 457 |
Micheline Sanderson, Hanél Sadie-Van Gijsen, Stephen Hough, William F. Ferris. The Role of MKP-1 in the Anti-Proliferative Effects of Glucocorticoids in Primary Rat Pre-Osteoblasts. PLoS One 2015;10:e0135358. [PMID: 26263165 DOI: 10.1371/journal.pone.0135358] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 458 |
Jin Z, Li X, Wan Y. Minireview: nuclear receptor regulation of osteoclast and bone remodeling. Mol Endocrinol 2015;29:172-86. [PMID: 25549044 DOI: 10.1210/me.2014-1316] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 459 |
Eghbali-Fatourechi G. Bisphosphonate therapy in pediatric patients. J Diabetes Metab Disord 2014;13:109. [PMID: 25551100 DOI: 10.1186/s40200-014-0109-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 460 |
Canalis E, Zanotti S. Hajdu-Cheney syndrome: a review. Orphanet J Rare Dis 2014;9:200. [PMID: 25491639 DOI: 10.1186/s13023-014-0200-y] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 461 |
Emkey GR, Epstein S. Secondary osteoporosis: pathophysiology & diagnosis. Best Pract Res Clin Endocrinol Metab 2014;28:911-35. [PMID: 25432361 DOI: 10.1016/j.beem.2014.07.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 462 |
Hansen S, Gudex C, Åhrberg F, Brixen K, Voss A. Bone geometry, volumetric bone mineral density, microarchitecture and estimated bone strength in Caucasian females with systemic lupus erythematosus. A cross-sectional study using HR-pQCT. Calcif Tissue Int 2014;95:530-9. [PMID: 25326144 DOI: 10.1007/s00223-014-9918-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 463 |
Rizzoli R, Biver E. Glucocorticoid-induced osteoporosis: who to treat with what agent? Nat Rev Rheumatol. 2015;11:98-109. [PMID: 25385412 DOI: 10.1038/nrrheum.2014.188] [Cited by in Crossref: 106] [Cited by in F6Publishing: 112] [Article Influence: 11.8] [Reference Citation Analysis]
|
| 464 |
Dounousi E, Leivaditis K, Eleftheriadis T, Liakopoulos V. Osteoporosis after renal transplantation. Int Urol Nephrol 2015;47:503-11. [PMID: 25384432 DOI: 10.1007/s11255-014-0862-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 465 |
Mazziotti G, Chiavistelli S, Giustina A. Pituitary diseases and bone. Endocrinol Metab Clin North Am 2015;44:171-80. [PMID: 25732653 DOI: 10.1016/j.ecl.2014.10.014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 466 |
Aceto G, D'Addato O, Messina G, Carbone V, Cavallo L, Brunetti G, Faienza MF. Bone health in children and adolescents with steroid-sensitive nephrotic syndrome assessed by DXA and QUS. Pediatr Nephrol 2014;29:2147-55. [PMID: 24902941 DOI: 10.1007/s00467-014-2834-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 467 |
Sutter S, Nishiyama KK, Kepley A, Zhou B, Wang J, McMahon DJ, Guo XE, Stein EM. Abnormalities in cortical bone, trabecular plates, and stiffness in postmenopausal women treated with glucocorticoids. J Clin Endocrinol Metab 2014;99:4231-40. [PMID: 25127089 DOI: 10.1210/jc.2014-2177] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 468 |
Panday K, Gona A, Humphrey MB. Medication-induced osteoporosis: screening and treatment strategies. Ther Adv Musculoskelet Dis 2014;6:185-202. [PMID: 25342997 DOI: 10.1177/1759720X14546350] [Cited by in Crossref: 86] [Cited by in F6Publishing: 92] [Article Influence: 9.6] [Reference Citation Analysis]
|
| 469 |
Guañabens N, Gifre L, Peris P. The role of Wnt signaling and sclerostin in the pathogenesis of glucocorticoid-induced osteoporosis. Curr Osteoporos Rep 2014;12:90-7. [PMID: 24488619 DOI: 10.1007/s11914-014-0197-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 50] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 470 |
Petranova T, Sheytanov I, Monov S, Nestorova R, Rashkov R. Denosumab improves bone mineral density and microarchitecture and reduces bone pain in women with osteoporosis with and without glucocorticoid treatment. Biotechnol Biotechnol Equip 2014;28:1127-37. [PMID: 26019600 DOI: 10.1080/13102818.2014.967827] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 471 |
Markula-Patjas KP, Ivaska KK, Pekkinen M, Andersson S, Moilanen E, Viljakainen HT, Mäkitie O. High adiposity and serum leptin accompanied by altered bone turnover markers in severe juvenile idiopathic arthritis. J Rheumatol 2014;41:2474-81. [PMID: 25320222 DOI: 10.3899/jrheum.131107] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 472 |
Ďúranová H, Martiniaková M, Boboňová I, Omelka R, Stawarz R, Toman R. Acute and subchronic co-administrations to cadmium, diazinon and selenium induce apparent osteoporotic symptoms in adult male rats. Biologia 2014;69:1431-1438. [DOI: 10.2478/s11756-014-0436-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 473 |
Briot K, Cortet B, Roux C, Fardet L, Abitbol V, Bacchetta J, Buchon D, Debiais F, Guggenbuhl P, Laroche M, Legrand É, Lespessailles É, Marcelli C, Weryha G, Thomas T. Actualisation 2014 des recommandations sur la prévention et le traitement de l’ostéoporose cortico-induite. Revue du Rhumatisme 2014;81:385-94. [DOI: 10.1016/j.rhum.2014.07.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 474 |
Abrahamsen B, Brask-Lindemann D, Rubin KH, Schwarz P. A review of lifestyle, smoking and other modifiable risk factors for osteoporotic fractures. Bonekey Rep 2014;3:574. [PMID: 25228987 DOI: 10.1038/bonekey.2014.69] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 475 |
Koromila T, Baniwal SK, Song YS, Martin A, Xiong J, Frenkel B. Glucocorticoids antagonize RUNX2 during osteoblast differentiation in cultures of ST2 pluripotent mesenchymal cells. J Cell Biochem 2014;115:27-33. [PMID: 23943595 DOI: 10.1002/jcb.24646] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 476 |
Porcelli T, Gotti D, Cristiano A, Maffezzoni F, Mazziotti G, Focà E, Castelli F, Giustina A, Quiros-Roldan E. Role of bone mineral density in predicting morphometric vertebral fractures in patients with HIV infection. Osteoporos Int 2014;25:2263-9. [PMID: 25056799 DOI: 10.1007/s00198-014-2760-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 477 |
Johnston JC, Haile A, Wang D, Ronnett G, Jones LC. Dexamethasone treatment alters function of adipocytes from a mesenchymal stromal cell line. Biochemical and Biophysical Research Communications 2014;451:473-9. [DOI: 10.1016/j.bbrc.2014.07.063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 478 |
Jiang P, Xue Y, Li HD, Liu YP, Cai HL, Tang MM, Zhang LH. Dysregulation of vitamin D metabolism in the brain and myocardium of rats following prolonged exposure to dexamethasone. Psychopharmacology (Berl) 2014;231:3445-51. [PMID: 24448902 DOI: 10.1007/s00213-014-3440-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 479 |
Szadek LL, Scharer K. Identification, prevention, and treatment of children with decreased bone mineral density. J Pediatr Nurs 2014;29:e3-14. [PMID: 24333239 DOI: 10.1016/j.pedn.2013.11.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 480 |
Jernigan SM. Hematuria in the newborn. Clin Perinatol 2014;41:591-603. [PMID: 25155729 DOI: 10.1016/j.clp.2014.05.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 481 |
Prickett TC, Wellby M, Barrell GK, Richards AM, Espiner EA. Differential response of C-type natriuretic peptide to estrogen and dexamethasone in adult bone. Steroids 2014;87:1-5. [DOI: 10.1016/j.steroids.2014.05.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 482 |
Bauman WA, Cirnigliaro CM, La Fountaine MF, Martinez L, Kirshblum SC, Spungen AM. Zoledronic acid administration failed to prevent bone loss at the knee in persons with acute spinal cord injury: an observational cohort study. J Bone Miner Metab 2015;33:410-21. [PMID: 25158630 DOI: 10.1007/s00774-014-0602-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 483 |
Hattiholi J, Gaude GS. Prevalence and correlates of osteoporosis in chronic obstructive pulmonary disease patients in India. Lung India 2014;31:221-7. [PMID: 25125807 DOI: 10.4103/0970-2113.135759] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 484 |
Modi A, Sajjan S, Gandhi S. Challenges in implementing and maintaining osteoporosis therapy. Int J Womens Health 2014;6:759-69. [PMID: 25152632 DOI: 10.2147/IJWH.S53489] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 485 |
Böcker W, El Khassawna T, Bauer N, Brodsky K, Weisweiler D, Govindarajan P, Schlewitz G, Kampschulte M, Dürselen L, Thormann U, Szalay G, Schnettler R, Langheinrich AC, Heiss C. Short-term glucocorticoid treatment causes spinal osteoporosis in ovariectomized rats. Eur Spine J 2014;23:2437-48. [DOI: 10.1007/s00586-014-3463-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 486 |
Dhainaut A, Daibes K, Odinsson A, Hoff M, Syversen U, Haugeberg G. Exploring the relationship between bone density and severity of distal radius fragility fracture in women. J Orthop Surg Res 2014;9:57. [PMID: 25030810 DOI: 10.1186/s13018-014-0057-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 487 |
Zhou DA, Zheng HX, Wang CW, Shi D, Li JJ. Influence of glucocorticoids on the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. BMC Musculoskelet Disord 2014;15:239. [PMID: 25027542 DOI: 10.1186/1471-2474-15-239] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 488 |
von Scheven E, Corbin KJ, Stefano S, Cimaz R. Glucocorticoid-Associated Osteoporosis in Chronic Inflammatory Diseases: Epidemiology, Mechanisms, Diagnosis, and Treatment. Curr Osteoporos Rep 2014;12:289-99. [DOI: 10.1007/s11914-014-0228-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 489 |
Tsampalieros A, Berkenstock MK, Zemel BS, Griffin L, Shults J, Burnham JM, Baldassano RN, Leonard MB. Changes in trabecular bone density in incident pediatric Crohn's disease: a comparison of imaging methods. Osteoporos Int 2014;25:1875-83. [PMID: 24760243 DOI: 10.1007/s00198-014-2701-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 490 |
Brance ML, Brun LR, Lioi S, Sánchez A, Abdala M, Oliveri B. Vitamin D levels and bone mass in rheumatoid arthritis. Rheumatol Int 2015;35:499-505. [DOI: 10.1007/s00296-014-3071-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 491 |
Patt H, Bandgar T, Lila A, Shah N. Management issues with exogenous steroid therapy. Indian J Endocrinol Metab 2013;17:S612-7. [PMID: 24910822 DOI: 10.4103/2230-8210.123548] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 492 |
Gómez de Tejada Romero M, Sosa Henríquez M. Osteoporosis: definición, tendencia epidemiológica, avances en la fisiopatología y clínica. Medicine - Programa de Formación Médica Continuada Acreditado 2014;11:3527-3534. [DOI: 10.1016/s0304-5412(14)70811-x] [Reference Citation Analysis]
|
| 493 |
Tabatabaei N, Rodd CJ, Kremer R, Weiler HA. Osteocalcin, but not deoxypyridinoline, increases in response to isoflurane-induced anaesthesia in young female guinea pigs. J Bone Miner Metab 2015;33:253-60. [DOI: 10.1007/s00774-014-0593-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 494 |
Fumoto T, Ishii K, Ito M, Berger S, Schütz G, Ikeda K. Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia. Biochemical and Biophysical Research Communications 2014;447:407-12. [DOI: 10.1016/j.bbrc.2014.03.149] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 495 |
Triadafilopoulos G. Glucocorticoid therapy for gastrointestinal diseases. Expert Opinion on Drug Safety 2014;13:563-72. [DOI: 10.1517/14740338.2014.904852] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 496 |
Korpi-Steiner N, Milhorn D, Hammett-Stabler C. Osteoporosis in men. Clin Biochem 2014;47:950-9. [PMID: 24726494 DOI: 10.1016/j.clinbiochem.2014.03.026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 497 |
Luther J, David J. Interaktion zwischen Knochen, Fett und Insulin. Z Rheumatol 2014;73:265-268. [DOI: 10.1007/s00393-013-1246-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 498 |
Haffner D, Schüler U. Metabolic bone disease after renal transplantation. Curr Opin Pediatr 2014;26:198-206. [PMID: 24535492 DOI: 10.1097/MOP.0000000000000058] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 499 |
Park JS, Bae SJ, Choi SW, Son YH, Park SB, Rhee SD, Kim HY, Jung WH, Kang SK, Ahn JH, Kim SH, Kim KY. A novel 11β-HSD1 inhibitor improves diabesity and osteoblast differentiation. J Mol Endocrinol 2014;52:191-202. [PMID: 24444497 DOI: 10.1530/JME-13-0177] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 500 |
Ragnar Agnarsson H, Johannsson G, Ragnarsson O. The impact of glucocorticoid replacement on bone mineral density in patients with hypopituitarism before and after 2 years of growth hormone replacement therapy. J Clin Endocrinol Metab 2014;99:1479-85. [PMID: 24423362 DOI: 10.1210/jc.2013-3851] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 501 |
Oei L, Campos-Obando N, Dehghan A, Oei EH, Stolk L, van Meurs JB, Hofman A, Uitterlinden AG, Franco OH, Zillikens MC, Rivadeneira F. Dissecting the relationship between high-sensitivity serum C-reactive protein and increased fracture risk: the Rotterdam Study. Osteoporos Int 2014;25:1247-54. [PMID: 24337661 DOI: 10.1007/s00198-013-2578-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 502 |
Henneicke H, Gasparini SJ, Brennan-Speranza TC, Zhou H, Seibel MJ. Glucocorticoids and bone: local effects and systemic implications. Trends Endocrinol Metab 2014;25:197-211. [PMID: 24418120 DOI: 10.1016/j.tem.2013.12.006] [Cited by in Crossref: 110] [Cited by in F6Publishing: 115] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 503 |
Ding CZ, Yao Y, Feng XB, Fang Y, Zhao C, Wang Y. Clinical analysis of chinese patients with rheumatoid arthritis treated with leflunomide and methotrexate combined with different dosages of glucocorticoid. Curr Ther Res Clin Exp 2012;73:123-33. [PMID: 24653514 DOI: 10.1016/j.curtheres.2012.06.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 504 |
Bentley L, Esapa CT, Nesbit MA, Head RA, Evans H, Lath D, Scudamore CL, Hough TA, Podrini C, Hannan FM, Fraser WD, Croucher PI, Brown MA, Brown SD, Cox RD, Thakker RV. An N-ethyl-N-nitrosourea induced corticotropin-releasing hormone promoter mutation provides a mouse model for endogenous glucocorticoid excess. Endocrinology 2014;155:908-22. [PMID: 24302625 DOI: 10.1210/en.2013-1247] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 505 |
Cook DA, Fellgett SW, Pownall ME, O'shea PJ, Genever PG. Wnt-dependent osteogenic commitment of bone marrow stromal cells using a novel GSK3β inhibitor. Stem Cell Research 2014;12:415-27. [DOI: 10.1016/j.scr.2013.10.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 506 |
Siggelkow H, Etmanski M, Bozkurt S, Groβ P, Koepp R, Brockmöller J, Tzvetkov MV. Genetic polymorphisms in 11β-hydroxysteroid dehydrogenase type 1 correlate with the postdexamethasone cortisol levels and bone mineral density in patients evaluated for osteoporosis. J Clin Endocrinol Metab 2014;99:E293-302. [PMID: 24285685 DOI: 10.1210/jc.2013-1418] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 507 |
Phan V, Blydt-Hansen T, Feber J, Alos N, Arora S, Atkinson S, Bell L, Clarson C, Couch R, Cummings EA, Filler G, Grant RM, Grimmer J, Hebert D, Lentle B, Ma J, Matzinger M, Midgley J, Pinsk M, Rodd C, Shenouda N, Stein R, Stephure D, Taback S, Williams K, Rauch F, Siminoski K, Ward LM; Canadian STOPP Consortium. Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome. Osteoporos Int 2014;25:627-37. [PMID: 23948876 DOI: 10.1007/s00198-013-2466-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 508 |
de Vrieze E, van Kessel MA, Peters HM, Spanings FA, Flik G, Metz JR. Prednisolone induces osteoporosis-like phenotype in regenerating zebrafish scales. Osteoporos Int 2014;25:567-78. [PMID: 23903952 DOI: 10.1007/s00198-013-2441-3] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 509 |
Hattiholi J, Gaude GS. Bone mineral density among elderly patients with chronic obstructive pulmonary disease patients in India. Niger Med J 2013;54:295-301. [PMID: 24403704 DOI: 10.4103/0300-1652.122329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 510 |
Ballesteros Pomar MD, Vidal Casariego A, Cano Rodríguez I. El hueso en otras situaciones con alteración nutricional: enfermedades digestivas. El hueso en las enfermedades endocrinas y nutricionales 2014. [DOI: 10.1016/b978-84-9022-503-5.00022-8] [Reference Citation Analysis]
|
| 511 |
Lee S. Proper time to initiate antiosteoporotic treatment in rheumatoid arthritis with or without glucocorticoid use. Korean J Intern Med 2014;29:434. [DOI: 10.3904/kjim.2014.29.4.434] [Reference Citation Analysis]
|
| 512 |
Krajewski CM, Burke AE. Contraception for Women with a History of Solid Organ Transplantation. Contraception for the Medically Challenging Patient 2014. [DOI: 10.1007/978-1-4939-2341-0_9] [Reference Citation Analysis]
|
| 513 |
García Martín A, Reyes García R. El hueso en el hipercortisolismo endógeno y exógeno. El hueso en las enfermedades endocrinas y nutricionales 2014. [DOI: 10.1016/b978-84-9022-503-5.00008-3] [Reference Citation Analysis]
|
| 514 |
Chee C, Sellahewa L, Pappachan JM. Inhaled corticosteroids and bone health. Open Respir Med J 2014;8:85-92. [PMID: 25674178 DOI: 10.2174/1874306401408010085] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 515 |
Krajewski CM, Burke AE. Contraception for Women with a History of Solid Organ Transplantation. Contraception for the Medically Challenging Patient 2014. [DOI: 10.1007/978-1-4939-1233-9_9] [Reference Citation Analysis]
|
| 516 |
Martineau C, Martin-Falstrault L, Brissette L, Moreau R. The atherogenic Scarb1 null mouse model shows a high bone mass phenotype. Am J Physiol Endocrinol Metab 2014;306:E48-57. [PMID: 24253048 DOI: 10.1152/ajpendo.00421.2013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 517 |
Pańczyk-tomaszewska M, Adamczuk D, Kisiel A, Skrzypczyk P, Przedlacki J, Górska E, Stelmaszczyk-emmel A, Demkow U, Roszkowska-blaim M. Markers of Bone Metabolism in Children with Nephrotic Syndrome Treated with Corticosteroids. Body Metabolism and Exercise 2014. [DOI: 10.1007/5584_2014_87] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 518 |
Ikeda T, Maruyama K, Kaji H, Akagi M. Effects of alendronate or alfacalcidol on bone metabolic indices and bone mineral density in patients with ophthalmologic disease treated with glucocorticoid. Mod Rheumatol 2014;24:671-6. [PMID: 24313921 DOI: 10.3109/14397595.2013.860886] [Reference Citation Analysis]
|
| 519 |
Lebdai S, Branchereau J, Robert G, De La Taille A, Bouchaert P. [Corticotherapy in castration-resistant prostate cancer]. Prog Urol 2013;23 Suppl 1:S23-33. [PMID: 24314736 DOI: 10.1016/S1166-7087(13)70043-5] [Reference Citation Analysis]
|
| 520 |
Farahmand P, Marin F, Hawkins F, Möricke R, Ringe JD, Glüer CC, Papaioannou N, Minisola S, Martínez G, Nolla JM, Niedhart C, Guañabens N, Nuti R, Martín-Mola E, Thomasius F, Peña J, Graeff C, Kapetanos G, Petto H, Gentzel A, Reisinger A, Zysset PK. Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis. Osteoporos Int 2013;24:2971-81. [PMID: 23740422 DOI: 10.1007/s00198-013-2379-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 521 |
Baschant U, Culemann S, Tuckermann J. Molecular determinants of glucocorticoid actions in inflammatory joint diseases. Mol Cell Endocrinol 2013;380:108-18. [PMID: 23769823 DOI: 10.1016/j.mce.2013.06.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 522 |
Khan M, Mishra J, Sharan K, Yadav M, Singh A, Srivastava A, Kumar S, Bhaduaria S, Maurya R, Sanyal S, Chattopadhyay N. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: A comparative study with human parathyroid hormone. Phytomedicine 2013;20:1256-66. [DOI: 10.1016/j.phymed.2013.07.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 523 |
Canalis E. Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches. Nat Rev Endocrinol 2013;9:575-83. [PMID: 23938284 DOI: 10.1038/nrendo.2013.154] [Cited by in Crossref: 206] [Cited by in F6Publishing: 212] [Article Influence: 20.6] [Reference Citation Analysis]
|
| 524 |
Rauner M, Thiele S, Sinningen K, Winzer M, Salbach-Hirsch J, Gloe I, Peschke K, Haegeman G, Tuckermann JP, Hofbauer LC. Effects of the selective glucocorticoid receptor modulator compound A on bone metabolism and inflammation in male mice with collagen-induced arthritis. Endocrinology 2013;154:3719-28. [PMID: 23885015 DOI: 10.1210/en.2012-2221] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 525 |
Dahir K, Perry B, Jagasia S. Post-Transplantation Bone Disease: Prevalence, Monitoring, Prevention, and Management Guidelines. Blood and Marrow Transplantation Long-Term Management 2013. [DOI: 10.1002/9781118473306.ch15] [Reference Citation Analysis]
|
| 526 |
Sofía Oviedo G. Osteoporosis secundaria. tratamiento actualizado. Revista Médica Clínica Las Condes 2013;24:805-811. [DOI: 10.1016/s0716-8640(13)70227-x] [Reference Citation Analysis]
|
| 527 |
Naito M, Mikami Y, Takagi M, Takahashi T. Up-regulation of Axin2 by dexamethasone promotes adipocyte differentiation in ROB-C26 mesenchymal progenitor cells. Cell Tissue Res 2013;354:761-70. [PMID: 23996200 DOI: 10.1007/s00441-013-1696-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 528 |
Gensler LS. Glucocorticoids: complications to anticipate and prevent. Neurohospitalist 2013;3:92-7. [PMID: 23983891 DOI: 10.1177/1941874412458678] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 529 |
Gifre L, Ruiz-Gaspà S, Monegal A, Nomdedeu B, Filella X, Guañabens N, Peris P. Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover. Bone 2013;57:272-6. [PMID: 23981659 DOI: 10.1016/j.bone.2013.08.016] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 530 |
Santoro FA, Stoopler ET, Werth VP. Pemphigus. Dent Clin North Am 2013;57:597-610. [PMID: 24034068 DOI: 10.1016/j.cden.2013.06.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 531 |
Kocijan R, Finzel S, Englbrecht M, Engelke K, Rech J, Schett G. Differences in bone structure between rheumatoid arthritis and psoriatic arthritis patients relative to autoantibody positivity. Ann Rheum Dis 2014;73:2022-8. [PMID: 23926056 DOI: 10.1136/annrheumdis-2013-203791] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 532 |
Wu K, Lin TH, Liou HC, Lu DH, Chen YR, Fu WM, Yang RS. Dextromethorphan inhibits osteoclast differentiation by suppressing RANKL-induced nuclear factor-κB activation. Osteoporos Int 2013;24:2201-14. [PMID: 23400250 DOI: 10.1007/s00198-013-2279-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 533 |
Tsampalieros A, Lam CK, Spencer JC, Thayu M, Shults J, Zemel BS, Herskovitz RM, Baldassano RN, Leonard MB. Long-term inflammation and glucocorticoid therapy impair skeletal modeling during growth in childhood Crohn disease. J Clin Endocrinol Metab 2013;98:3438-45. [PMID: 23690309 DOI: 10.1210/jc.2013-1631] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 534 |
Belaya ZE, Rozhinskaya LY, Melnichenko GA, Solodovnikov AG, Dragunova NV, Iljin AV, Dzeranova LK, Dedov II. Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome. Osteoporos Int 2013;24:2191-9. [PMID: 23358608 DOI: 10.1007/s00198-013-2268-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 535 |
Oh SM, Kim HC, Kim KM, Ahn SV, Choi DP, Suh I. Association between depressive symptoms and bone stiffness index in young adults: the Kangwha study. PLoS One 2013;8:e69929. [PMID: 23894562 DOI: 10.1371/journal.pone.0069929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 536 |
Weinstein RS. Glucocorticoid-Induced Bone Disease. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 2013. [DOI: 10.1002/9781118453926.ch58] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 537 |
Riesco Diaz M, Manzano Gómez F. Osteoporosis en la artritis psoriásica. Seminarios de la Fundación Española de Reumatología 2013;14:72-79. [DOI: 10.1016/j.semreu.2013.04.002] [Reference Citation Analysis]
|
| 538 |
Tóth M, Grossman A. Glucocorticoid-induced osteoporosis: lessons from Cushing's syndrome. Clin Endocrinol (Oxf) 2013;79:1-11. [PMID: 23452135 DOI: 10.1111/cen.12189] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 539 |
Sadie-Van Gijsen H, Hough FS, Ferris WF. Determinants of bone marrow adiposity: the modulation of peroxisome proliferator-activated receptor-γ2 activity as a central mechanism. Bone 2013;56:255-65. [PMID: 23800517 DOI: 10.1016/j.bone.2013.06.016] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 540 |
Cheng ML, Gupta V. Premenopausal osteoporosis. Indian J Endocrinol Metab 2013;17:240-4. [PMID: 23776895 DOI: 10.4103/2230-8210.109681] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 541 |
Glüer CC, Marin F, Ringe JD, Hawkins F, Möricke R, Papaioannu N, Farahmand P, Minisola S, Martínez G, Nolla JM, Niedhart C, Guañabens N, Nuti R, Martín-Mola E, Thomasius F, Kapetanos G, Peña J, Graeff C, Petto H, Sanz B, Reisinger A, Zysset PK. Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial. J Bone Miner Res 2013;28:1355-68. [PMID: 23322362 DOI: 10.1002/jbmr.1870] [Cited by in Crossref: 118] [Cited by in F6Publishing: 121] [Article Influence: 11.8] [Reference Citation Analysis]
|
| 542 |
Cohen A, Dempster DW, Recker RR, Lappe JM, Zhou H, Zwahlen A, Müller R, Zhao B, Guo X, Lang T, Saeed I, Liu XS, Guo XE, Cremers S, Rosen CJ, Stein EM, Nickolas TL, McMahon DJ, Young P, Shane E. Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study. J Clin Endocrinol Metab 2013;98:2562-72. [PMID: 23515452 DOI: 10.1210/jc.2013-1047] [Cited by in Crossref: 144] [Cited by in F6Publishing: 144] [Article Influence: 14.4] [Reference Citation Analysis]
|
| 543 |
Dore RK. Long-term safety, efficacy, and patient acceptability of teriparatide in the management of glucocorticoid-induced osteoporosis. Patient Prefer Adherence 2013;7:435-46. [PMID: 23717037 DOI: 10.2147/PPA.S31067] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 544 |
Briot K, Roux C. Ostéoporose cortico-induite. La Revue de Médecine Interne 2013;34:315-23. [DOI: 10.1016/j.revmed.2012.11.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 545 |
Derakhshanian H, Djalali M, Djazayery A, Nourijelyani K, Ghadbeigi S, Pishva H, Saedisomeolia A, Bahremand A, Dehpour AR. Quercetin prevents experimental glucocorticoid-induced osteoporosis: a comparative study with alendronate. Can J Physiol Pharmacol 2013;91:380-5. [DOI: 10.1139/cjpp-2012-0190] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 546 |
Smith M, Williams F, Ward BB. Hard Tissue Reconstruction. Management of Complications in Oral and Maxillofacial Surgery 2013. [DOI: 10.1002/9781118704493.ch13] [Reference Citation Analysis]
|
| 547 |
Brabnikova Maresova K, Pavelka K, Stepan JJ. Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes. Calcif Tissue Int 2013;92:354-61. [PMID: 23247536 DOI: 10.1007/s00223-012-9684-4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 548 |
Ren Z, Yang L, Xue F, Meng Q, Wang K, Wu X, Ji C, Jiang T, Liu D, Zhou L, Zhang J, Fu Q. Yeast-Incorporated Gallium Attenuates Glucocorticoid-Induced Bone Loss in Rats by Inhibition of Bone Resorption. Biol Trace Elem Res 2013;152:396-402. [DOI: 10.1007/s12011-013-9634-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 549 |
Esposito K, Capuano A, Sportiello L, Giustina A, Giugliano D. Should we abandon statins in the prevention of bone fractures? Endocrine 2013;44:326-33. [DOI: 10.1007/s12020-013-9924-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 550 |
Vanderoost J, Søe K, Merrild DM, Delaissé JM, van Lenthe GH. Glucocorticoid-induced changes in the geometry of osteoclast resorption cavities affect trabecular bone stiffness. Calcif Tissue Int 2013;92:240-50. [PMID: 23187898 DOI: 10.1007/s00223-012-9674-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 551 |
Tsampalieros A, Gupta P, Denburg MR, Shults J, Zemel BS, Mostoufi-Moab S, Wetzsteon RJ, Herskovitz RM, Whitehead KM, Leonard MB. Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome. J Bone Miner Res 2013;28:480-8. [PMID: 23044926 DOI: 10.1002/jbmr.1785] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 552 |
Brunetti G, Faienza MF, Piacente L, Ventura A, Oranger A, Carbone C, Benedetto AD, Colaianni G, Gigante M, Mori G, Gesualdo L, Colucci S, Cavallo L, Grano M. High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment. Am J Physiol Endocrinol Metab 2013;304:E546-54. [PMID: 23299503 DOI: 10.1152/ajpendo.00535.2012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 553 |
Seguro LP, Rosario C, Shoenfeld Y. Long-term complications of past glucocorticoid use. Autoimmunity Reviews 2013;12:629-32. [DOI: 10.1016/j.autrev.2012.12.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 554 |
Hsiao MC, Liu CY, Wang CJ. Factors associated with low bone density among women with major depressive disorder. Int J Psychiatry Med 2012;44:77-90. [PMID: 23356095 DOI: 10.2190/PM.44.1.f] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 555 |
Cianferotti L, Brandi ML. Pathogenesis of osteoporosis. Osteoporosis 2013. [DOI: 10.2217/ebo.12.159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 556 |
Bultink IE, Baden M, Lems WF. Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions. Expert Opin Pharmacother 2013;14:185-97. [PMID: 23317448 DOI: 10.1517/14656566.2013.761975] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 557 |
Ventura A, Brunetti G, Colucci S, Oranger A, Ladisa F, Cavallo L, Grano M, Faienza MF. Glucocorticoid-induced osteoporosis in children with 21-hydroxylase deficiency. Biomed Res Int. 2013;2013:250462. [PMID: 23484098 DOI: 10.1155/2013/250462] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 558 |
Navarra SV, Torralba TP. The Musculoskeletal System and Bone Metabolism. Dubois' Lupus Erythematosus and Related Syndromes 2013. [DOI: 10.1016/b978-1-4377-1893-5.00025-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 559 |
Griffith JF, Genant HK. Imaging of Osteoporosis. Osteoporosis 2013. [DOI: 10.1016/b978-0-12-415853-5.00064-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 560 |
Rabenda V, Nicolet D, Beaudart C, Bruyère O, Reginster JY. Relationship between use of antidepressants and risk of fractures: a meta-analysis. Osteoporos Int 2013;24:121-37. [PMID: 22638709 DOI: 10.1007/s00198-012-2015-9] [Cited by in Crossref: 92] [Cited by in F6Publishing: 73] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 561 |
Ramli ES, Suhaimi F, Asri SF, Ahmad F, Soelaiman IN. Glycyrrhizic acid (GCA) as 11β-hydroxysteroid dehydrogenase inhibitor exerts protective effect against glucocorticoid-induced osteoporosis. J Bone Miner Metab 2013;31:262-73. [PMID: 23274351 DOI: 10.1007/s00774-012-0413-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 562 |
Tanner SB, Moore CF Jr. A review of the use of dual-energy X-ray absorptiometry (DXA) in rheumatology. Open Access Rheumatol 2012;4:99-107. [PMID: 27790018 DOI: 10.2147/OARRR.S29000] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 563 |
Di Somma C, Rubino M, Faggiano A, Vuolo L, Contaldi P, Tafuto N, Andretti M, Savastano S, Colao A. Spinal deformity index in patients with type 2 diabetes. Endocrine 2013;43:651-8. [DOI: 10.1007/s12020-012-9848-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 564 |
Rangel ÉB, Sá JR, Gomes SA, Carvalho AB, Melaragno CS, Gonzalez AM, Linhares MM, Medina-Pestana JO. Charcot neuroarthropathy after simultaneous pancreas-kidney transplant. Transplantation 2012;94:642-5. [PMID: 22929593 DOI: 10.1097/TP.0b013e31825cadbb] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 565 |
Sadie-Van Gijsen H, Crowther NJ, Hough FS, Ferris WF. The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity. Cell Mol Life Sci 2013;70:2331-49. [PMID: 23178849 DOI: 10.1007/s00018-012-1211-2] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 566 |
Graeff C, Marin F, Petto H, Kayser O, Reisinger A, Peña J, Zysset P, Glüer CC. High resolution quantitative computed tomography-based assessment of trabecular microstructure and strength estimates by finite-element analysis of the spine, but not DXA, reflects vertebral fracture status in men with glucocorticoid-induced osteoporosis. Bone 2013;52:568-77. [PMID: 23149277 DOI: 10.1016/j.bone.2012.10.036] [Cited by in Crossref: 89] [Cited by in F6Publishing: 89] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 567 |
Thiele S, Ziegler N, Tsourdi E, De Bosscher K, Tuckermann JP, Hofbauer LC, Rauner M. Selective glucocorticoid receptor modulation maintains bone mineral density in mice. J Bone Miner Res 2012;27:2242-50. [PMID: 22714558 DOI: 10.1002/jbmr.1688] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 568 |
Chauhan V, Ranganna KM, Chauhan N, Vaid M, Kelepouris E. Bone disease in organ transplant patients: pathogenesis and management. Postgrad Med 2012;124:80-90. [PMID: 22691902 DOI: 10.3810/pgm.2012.05.2551] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 569 |
Kim BY, Yoon HY, Yun SI, Woo ER, Song NK, Kim HG, Jeong SY, Chung YS. In vitro and in vivo inhibition of glucocorticoid-induced osteoporosis by the hexane extract of Poncirus trifoliata. Phytother Res 2011;25:1000-10. [PMID: 21225901 DOI: 10.1002/ptr.3373] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 570 |
Baschant U, Lane NE, Tuckermann J. The multiple facets of glucocorticoid action in rheumatoid arthritis. Nat Rev Rheumatol 2012;8:645-55. [PMID: 23045254 DOI: 10.1038/nrrheum.2012.166] [Cited by in Crossref: 102] [Cited by in F6Publishing: 103] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 571 |
van Lierop AH, van der Eerden AW, Hamdy NA, Hermus AR, den Heijer M, Papapoulos SE. Circulating sclerostin levels are decreased in patients with endogenous hypercortisolism and increase after treatment. J Clin Endocrinol Metab 2012;97:E1953-7. [PMID: 22844062 DOI: 10.1210/jc.2012-2218] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 572 |
Ke HZ, Richards WG, Li X, Ominsky MS. Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases. Endocr Rev 2012;33:747-83. [PMID: 22723594 DOI: 10.1210/er.2011-1060] [Cited by in Crossref: 300] [Cited by in F6Publishing: 304] [Article Influence: 27.3] [Reference Citation Analysis]
|
| 573 |
Rizzoli R, Adachi JD, Cooper C, Dere W, Devogelaer JP, Diez-Perez A, Kanis JA, Laslop A, Mitlak B, Papapoulos S, Ralston S, Reiter S, Werhya G, Reginster JY. Management of glucocorticoid-induced osteoporosis. Calcif Tissue Int 2012;91:225-43. [PMID: 22878667 DOI: 10.1007/s00223-012-9630-5] [Cited by in Crossref: 69] [Cited by in F6Publishing: 54] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 574 |
Sewerynek E, Stuss M. Steroid-induced osteoporosis. Aging Health 2012;8:471-477. [DOI: 10.2217/ahe.12.52] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 575 |
Rangel EB. The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation. Expert Opinion on Drug Metabolism & Toxicology 2012;8:1531-48. [DOI: 10.1517/17425255.2012.724058] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 576 |
Burnham JM. Inflammatory diseases and bone health in children. Current Opinion in Rheumatology 2012;24:548-53. [DOI: 10.1097/bor.0b013e328356b0c2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 577 |
Lekamwasam S, Adachi JD, Agnusdei D, Bilezikian J, Boonen S, Borgström F, Cooper C, Diez Perez A, Eastell R, Hofbauer LC, Kanis JA, Langdahl BL, Lesnyak O, Lorenc R, McCloskey E, Messina OD, Napoli N, Obermayer-Pietsch B, Ralston SH, Sambrook PN, Silverman S, Sosa M, Stepan J, Suppan G, Wahl DA, Compston JE; Joint IOF-ECTS GIO Guidelines Working Group. A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int 2012;23:2257-76. [PMID: 22434203 DOI: 10.1007/s00198-012-1958-1] [Cited by in Crossref: 244] [Cited by in F6Publishing: 193] [Article Influence: 22.2] [Reference Citation Analysis]
|
| 578 |
Demontiero O, Vidal C, Duque G. Aging and bone loss: new insights for the clinician. Ther Adv Musculoskelet Dis 2012;4:61-76. [PMID: 22870496 DOI: 10.1177/1759720X11430858] [Cited by in Crossref: 248] [Cited by in F6Publishing: 261] [Article Influence: 22.5] [Reference Citation Analysis]
|
| 579 |
Fraser LA, Adachi JD. Glucocorticoid-induced osteoporosis: treatment update and review. Ther Adv Musculoskelet Dis 2009;1:71-85. [PMID: 22870429 DOI: 10.1177/1759720X09343729] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 580 |
Mazziotti G, Giustina A, Canalis E, Bilezikian JP. Treatment of glucocorticoid-induced osteoporsis. Ther Adv Musculoskelet Dis 2009;1:27-34. [PMID: 22870425 DOI: 10.1177/1759720X09343222] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 581 |
Naito M, Omoteyama K, Mikami Y, Takahashi T, Takagi M. Inhibition of Wnt/β-catenin signaling by dexamethasone promotes adipocyte differentiation in mesenchymal progenitor cells, ROB-C26. Histochem Cell Biol 2012;138:833-45. [DOI: 10.1007/s00418-012-1007-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 582 |
Cohen A, Dempster DW, Stein EM, Nickolas TL, Zhou H, McMahon DJ, Müller R, Kohler T, Zwahlen A, Lappe JM, Young P, Recker RR, Shane E. Increased marrow adiposity in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 2012;97:2782-91. [PMID: 22701013 DOI: 10.1210/jc.2012-1477] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 583 |
Laakso S, Valta H, Verkasalo M, Toiviainen-Salo S, Viljakainen H, Mäkitie O. Impaired bone health in inflammatory bowel disease: a case-control study in 80 pediatric patients. Calcif Tissue Int 2012;91:121-30. [PMID: 22729560 DOI: 10.1007/s00223-012-9617-2] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 584 |
Casella C, Seguro L, Takayama L, Medeiros D, Bonfa E, Pereira R. Juvenile onset systemic lupus erythematosus: a possible role for vitamin D in disease status and bone health. Lupus 2012;21:1335-42. [DOI: 10.1177/0961203312454929] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 585 |
Rayar MS, Nayiager T, Webber CE, Barr RD, Athale UH. Predictors of bony morbidity in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2012;59:77-82. [PMID: 22190454 DOI: 10.1002/pbc.24040] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 586 |
Sergio Jacobelli G, Claudia Campusano M. Osteoporosis en enfermedades reumáticas. Revista Médica Clínica Las Condes 2012;23:425-431. [DOI: 10.1016/s0716-8640(12)70333-4] [Reference Citation Analysis]
|
| 587 |
Watkins MP, Norris JY, Grimston SK, Zhang X, Phipps RJ, Ebetino FH, Civitelli R. Bisphosphonates improve trabecular bone mass and normalize cortical thickness in ovariectomized, osteoblast connexin43 deficient mice. Bone 2012;51:787-94. [PMID: 22750450 DOI: 10.1016/j.bone.2012.06.018] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 588 |
Costa AG, Bilezikian JP. Sclerostin: therapeutic horizons based upon its actions. Curr Osteoporos Rep 2012;10:64-72. [PMID: 22234741 DOI: 10.1007/s11914-011-0089-5] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 589 |
Tantawy AA, El Bostany EA, Matter RM, El Ghoroury EA, Ragab S, El Sherif NH. Bone mass and biochemical markers of bone turnover in children and adolescents with chronic immune thrombocytopenia: relation to corticosteroid therapy and vitamin D receptor gene polymorphisms. Platelets 2013;24:282-7. [PMID: 22671537 DOI: 10.3109/09537104.2012.690544] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 590 |
Tse SM, Kelly HW, Litonjua AA, Van Natta ML, Weiss ST, Tantisira KG; Childhood Asthma Management Program Research Group. Corticosteroid use and bone mineral accretion in children with asthma: effect modification by vitamin D. J Allergy Clin Immunol 2012;130:53-60.e4. [PMID: 22608570 DOI: 10.1016/j.jaci.2012.04.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 591 |
Moutsatsou P, Kassi E, Papavassiliou AG. Glucocorticoid receptor signaling in bone cells. Trends Mol Med 2012;18:348-59. [PMID: 22578718 DOI: 10.1016/j.molmed.2012.04.005] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 592 |
Godbole TR, Dabadghao P. Glucocorticoid use in children: The problems and solutions. Indian Journal of Rheumatology 2012;7:112-116. [DOI: 10.1016/s0973-3698(12)60037-5] [Reference Citation Analysis]
|
| 593 |
Jensen PR, Andersen TL, Søe K, Hauge EM, Bollerslev J, Amling M, Barvencik F, Delaissé JM. Premature loss of bone remodeling compartment canopies is associated with deficient bone formation: a study of healthy individuals and patients with Cushing's syndrome. J Bone Miner Res 2012;27:770-80. [PMID: 22162180 DOI: 10.1002/jbmr.1490] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 594 |
Knoss R, Halsey LG, Reeves S. Ethnic Dress, Vitamin D Intake, and Calcaneal Bone Health in Young Women in the United Kingdom. Journal of Clinical Densitometry 2012;15:250-4. [DOI: 10.1016/j.jocd.2011.09.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 595 |
Perrot S, Le Jeunne C. Ostéoporose cortisonique. La Presse Médicale 2012;41:406-13. [DOI: 10.1016/j.lpm.2012.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 596 |
Shandala T, Shen Ng Y, Hopwood B, Yip Y, Foster BK, Xian CJ. The role of osteocyte apoptosis in cancer chemotherapy-induced bone loss. J Cell Physiol 2012;227:2889-97. [DOI: 10.1002/jcp.23034] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 597 |
Kauh E, Mixson L, Malice M, Mesens S, Ramael S, Burke J, Reynders T, Van Dyck K, Beals C, Rosenberg E, Ruddy M. Prednisone affects inflammation, glucose tolerance, and bone turnover within hours of treatment in healthy individuals. European Journal of Endocrinology 2012;166:459-67. [DOI: 10.1530/eje-11-0751] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 598 |
Diez-perez A, Sole E. Teriparatide for Glucocorticoid-induced Osteoporosis. J Rheumatol 2012;39:461-462. [DOI: 10.3899/jrheum.111629] [Reference Citation Analysis]
|
| 599 |
Davidson ZE, Walker KZ, Truby H. Clinical review: Do glucocorticosteroids alter vitamin D status? A systematic review with meta-analyses of observational studies. J Clin Endocrinol Metab 2012;97:738-44. [PMID: 22188740 DOI: 10.1210/jc.2011-2757] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 600 |
Folwarczna J, Pytlik M, Sliwiński L, Cegieła U, Nowińska B, Rajda M. Effects of propranolol on the development of glucocorticoid-induced osteoporosis in male rats. Pharmacol Rep 2011;63:1040-9. [PMID: 22001992 DOI: 10.1016/s1734-1140(11)70620-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 601 |
Souto MI, Coelho A, Guo C, Mendonça LM, Pinheiro MF, Papi JA, Farias ML. The prevalence of low bone mineral density in Brazilian patients with systemic lupus erythematosus and its relationship with the disease damage index and other associated factors. J Clin Densitom 2012;15:320-7. [PMID: 22321657 DOI: 10.1016/j.jocd.2011.12.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 602 |
Nixon M, Upreti R, Andrew R. 5α-Reduced glucocorticoids: a story of natural selection. Journal of Endocrinology 2012;212:111-27. [DOI: 10.1530/joe-11-0318] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 603 |
Katz S, Weinerman S. The elderly inflammatory bowel disease patient and osteoporosis. Aging Health 2012;8:31-42. [DOI: 10.2217/ahe.11.86] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 604 |
Feber J, Gaboury I, Ni A, Alos N, Arora S, Bell L, Blydt-Hansen T, Clarson C, Filler G, Hay J, Hebert D, Lentle B, Matzinger M, Midgley J, Moher D, Pinsk M, Rauch F, Rodd C, Shenouda N, Siminoski K, Ward LM; Canadian STOPP Consortium. Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome. Osteoporos Int 2012;23:751-60. [PMID: 21494860 DOI: 10.1007/s00198-011-1621-2] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 605 |
Ragnarsson O, Nyström HF, Johannsson G. Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism. Clin Endocrinol (Oxf) 2012;76:246-52. [PMID: 21767286 DOI: 10.1111/j.1365-2265.2011.04174.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 606 |
Pinto AS, Radominski S, Zerbini CAF. Osteoporose secundária a drogas. Rev Paul Reumatol 2012. [DOI: 10.46833/reumatologiasp.2011.10.s1.55-63] [Reference Citation Analysis]
|
| 607 |
Lopes JB, Pereira RMR. Classificação e fisiopatologia da osteoporose. Rev Paul Reumatol 2012. [DOI: 10.46833/reumatologiasp.2011.10.s1.21-29] [Reference Citation Analysis]
|
| 608 |
Terpstra AM, Kalkwarf HJ, Shults J, Zemel BS, Wetzsteon RJ, Foster BJ, Strife CF, Foerster DL, Leonard MB. Bone density and cortical structure after pediatric renal transplantation. J Am Soc Nephrol 2012;23:715-26. [PMID: 22282589 DOI: 10.1681/ASN.2011050480] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 609 |
Karras D, Stoykov I, Lems WF, Langdahl BL, Ljunggren Ö, Barrett A, Walsh JB, Fahrleitner-Pammer A, Rajzbaum G, Jakob F, Marin F. Effectiveness of teriparatide in postmenopausal women with osteoporosis and glucocorticoid use: 3-year results from the EFOS study. J Rheumatol 2012;39:600-9. [PMID: 22247365 DOI: 10.3899/jrheum.110947] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 610 |
Rizk A, Honegger J, Milian M, Psaras T. Treatment Options in Cushing's Disease. Clin Med Insights Oncol 2012;6:75-84. [PMID: 22346367 DOI: 10.4137/CMO.S6198] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 611 |
Falhammar H, Thorén M. Clinical outcomes in the management of congenital adrenal hyperplasia. Endocrine 2012;41:355-73. [PMID: 22228497 DOI: 10.1007/s12020-011-9591-x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 70] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 612 |
Diez-morales LF, Cunanan V. Osteoporosis. Chronic Obstructive Pulmonary Disease 2012. [DOI: 10.1007/978-1-60761-673-3_5] [Reference Citation Analysis]
|
| 613 |
Sambrook PN, Roux C, Devogelaer J, Saag K, Lau C, Reginster J, Bucci-rechtweg C, Su G, Reid DM. Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate. Bone 2012;50:289-95. [DOI: 10.1016/j.bone.2011.10.024] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 614 |
Bianchi ML, Glorieux FH. The Spectrum of Pediatric Osteoporosis. Pediatric Bone 2012. [DOI: 10.1016/b978-0-12-382040-2.10018-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 615 |
Ng KW, Martin TJ. Glucocorticoids, Inflammation, and Bone. Bone-Metabolic Functions and Modulators 2012. [DOI: 10.1007/978-1-4471-2745-1_7] [Reference Citation Analysis]
|
| 616 |
Riahi S, Noble B. Techniques for the study of apoptosis in bone. Methods Mol Biol 2012;816:335-49. [PMID: 22130939 DOI: 10.1007/978-1-61779-415-5_22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 617 |
Miller PD. Diseases of Mineral Metabolism and Bone: Emerging Therapeutics for Postmenopausal Osteoporosiss. Bone-Metabolic Functions and Modulators 2012. [DOI: 10.1007/978-1-4471-2745-1_9] [Reference Citation Analysis]
|
| 618 |
Maes C, Kronenberg HM. Postnatal Bone Growth: Growth Plate Biology, Bone Formation, and Remodeling. Pediatric Bone. Elsevier; 2012. pp. 55-82. [DOI: 10.1016/b978-0-12-382040-2.10004-8] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 619 |
Markula-Patjas KP, Valta HL, Kerttula LI, Soini IH, Honkanen VE, Toiviainen-Salo SM, Mäkitie OM. Prevalence of vertebral compression fractures and associated factors in children and adolescents with severe juvenile idiopathic arthritis. J Rheumatol 2012;39:365-73. [PMID: 22133619 DOI: 10.3899/jrheum.110305] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 620 |
Edo LP, Ruiz AA, Vilaseca DR, Vadillo AG, Gay NG, Peris P, Eslava AT, Audera CB, Aresté JF, Rodríguez LA, Gil JG, Abelló JC, Nolla JM, Pérez SH, Heredia ES, Tabernero JZ, Montes JDP, Rubió JBI, Freire MC, Pérez MR, Castañeda S, Cerdá D, Vaquero CG, Catalá JC, Ciria M, Loza E. 2011 Up-Date of the Consensus Statement of the Spanish Society of Rheumatology on Osteoporosis. Reumatología Clínica (English Edition) 2011;7:357-79. [DOI: 10.1016/j.reumae.2011.05.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 621 |
Marenzana M, Greenslade K, Eddleston A, Okoye R, Marshall D, Moore A, Robinson MK. Sclerostin antibody treatment enhances bone strength but does not prevent growth retardation in young mice treated with dexamethasone. Arthritis Rheum 2011;63:2385-95. [PMID: 21484764 DOI: 10.1002/art.30385] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 622 |
Lehmann G. 13 Systemische Osteopathien. Pathologie des Bewegungsapparates 2011. [DOI: 10.1515/9783110221909.253] [Reference Citation Analysis]
|
| 623 |
Tatsuno I, Suzuki S, Yoshida T, Nagano H, Hashimoto N, Mayama T, Tanaka T, Sugiyama T. Disease-related risk of vertebral fracture during glucocorticoid treatment of collagen vascular diseases. J Rheumatol 2011;38:2270-2. [PMID: 21965698 DOI: 10.3899/jrheum.110412] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 624 |
Naves MA, Pereira RM, Comodo AN, de Alvarenga ÉL, Caparbo VF, Teixeira VP. Effect of dexamethasone on human osteoblasts in culture: involvement of β1 integrin and integrin-linked kinase. Cell Biol Int 2011;35:1147-51. [DOI: 10.1042/cbi20100731] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 625 |
Mokuda S, Okuda Y, Onishi M, Sawada N, Matoba K, Yamada A, Jouyama K, Takasugi K. Post-menopausal women with rheumatoid arthritis who are treated with raloxifene or alendronate or glucocorticoids have lower serum undercarboxylated osteocalcin levels. J Endocrinol Invest 2012;35:661-4. [PMID: 21970822 DOI: 10.3275/7971] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
|
| 626 |
Pérez Edo L, Alonso Ruiz A, Roig Vilaseca D, García Vadillo A, Guañabens Gay N, Peris P, Torrijos Eslava A, Beltrán Audera C, Fiter Aresté J, Arboleya Rodríguez L, Graña Gil J, Carbonell Abelló J, Nolla JM, Holgado Pérez S, Salas Heredia E, Zubieta Tabernero J, Del Pino Montes J, Blanch i Rubió J, Caamaño Freire M, Rodríguez Pérez M, Castañeda S, Cerdá D, Gómez Vaquero C, Calvo Catalá J, Ciria M, Loza E; Spanish Society of Rheumatology. [2011 Up-date of the consensus statement of the Spanish Society of Rheumatology on osteoporosis]. Reumatol Clin 2011;7:357-79. [PMID: 22078694 DOI: 10.1016/j.reuma.2011.05.013] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 627 |
Conradie MM, Cato AC, Ferris WF, de Wet H, Horsch K, Hough S. MKP-1 knockout does not prevent glucocorticoid-induced bone disease in mice. Calcif Tissue Int 2011;89:221-7. [PMID: 21698455 DOI: 10.1007/s00223-011-9509-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 628 |
Wetzsteon RJ, Kalkwarf HJ, Shults J, Zemel BS, Foster BJ, Griffin L, Strife CF, Foerster DL, Jean-Pierre DK, Leonard MB. Volumetric bone mineral density and bone structure in childhood chronic kidney disease. J Bone Miner Res 2011;26:2235-44. [PMID: 21590737 DOI: 10.1002/jbmr.427] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 629 |
den Uyl D, Bultink IE, Lems WF. Advances in glucocorticoid-induced osteoporosis. Curr Rheumatol Rep 2011;13:233-40. [PMID: 21365209 DOI: 10.1007/s11926-011-0173-y] [Cited by in Crossref: 109] [Cited by in F6Publishing: 116] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 630 |
Weivoda MM, Hohl RJ. The effects of direct inhibition of geranylgeranyl pyrophosphate synthase on osteoblast differentiation. J Cell Biochem 2011;112:1506-13. [PMID: 21503955 DOI: 10.1002/jcb.23087] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 631 |
Madsen SH, Andreassen KV, Christensen ST, Karsdal MA, Sverdrup FM, Bay-Jensen AC, Henriksen K. Glucocorticoids exert context-dependent effects on cells of the joint in vitro. Steroids 2011;76:1474-82. [PMID: 21855558 DOI: 10.1016/j.steroids.2011.07.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 632 |
Dionyssiotis Y. Bone loss and fractures in multiple sclerosis: focus on epidemiologic and physiopathological features. Int J Gen Med 2011;4:505-9. [PMID: 21845056 DOI: 10.2147/IJGM.S22255] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 633 |
Tatsuno I, Sugiyama T. Glucocorticoid-induced diabetes mellitus is a risk for vertebral fracture during glucocorticoid treatment. Diabetes Research and Clinical Practice 2011;93:e18-20. [DOI: 10.1016/j.diabres.2011.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 634 |
Conaway HH, Pirhayati A, Persson E, Pettersson U, Svensson O, Lindholm C, Henning P, Tuckermann J, Lerner UH. Retinoids stimulate periosteal bone resorption by enhancing the protein RANKL, a response inhibited by monomeric glucocorticoid receptor. J Biol Chem 2011;286:31425-36. [PMID: 21715325 DOI: 10.1074/jbc.M111.247734] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 635 |
Pagonis T, Givissis P, Pagonis A, Petsatodis G, Christodoulou A. Osteoporosis onset differences between rural and metropolitan populations: correlation to fracture type, severity, and treatment efficacy. J Bone Miner Metab 2012;30:85-92. [PMID: 21667356 DOI: 10.1007/s00774-011-0286-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 636 |
Adler RA, Hochberg MC. Glucocorticoid-induced osteoporosis in men. J Endocrinol Invest 2011;34:481-4. [PMID: 21623147 DOI: 10.1007/BF03346716] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 637 |
Le Meignen M, Auquier P, Barlogis V, Sirvent N, Contet A, Simeoni MC, Galambrun C, Poirée M, Chastagner P, Play B, Villes V, Berbis J, Chambost H, Bordigoni P, Michel G. Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalities. Blood 2011;118:1481-9. [PMID: 21596857 DOI: 10.1182/blood-2011-01-332866] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 638 |
Feng X, McDonald JM. Disorders of bone remodeling. Annu Rev Pathol 2011;6:121-45. [PMID: 20936937 DOI: 10.1146/annurev-pathol-011110-130203] [Cited by in Crossref: 690] [Cited by in F6Publishing: 719] [Article Influence: 57.5] [Reference Citation Analysis]
|
| 639 |
Ohlsson C, Mellström D, Carlzon D, Orwoll E, Ljunggren O, Karlsson MK, Vandenput L. Older men with low serum IGF-1 have an increased risk of incident fractures: the MrOS Sweden study. J Bone Miner Res 2011;26:865-72. [PMID: 21433071 DOI: 10.1002/jbmr.281] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 640 |
Li B, Ling Chau JF, Wang X, Leong WF. Bisphosphonates, specific inhibitors of osteoclast function and a class of drugs for osteoporosis therapy. J Cell Biochem 2011;112:1229-42. [DOI: 10.1002/jcb.23049] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 641 |
Davidge Pitts CJ, Kearns AE. Update on medications with adverse skeletal effects. Mayo Clin Proc 2011;86:338-43; quiz 343. [PMID: 21389249 DOI: 10.4065/mcp.2010.0636] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 642 |
Rousière M. Os et transplantation. Revue du Rhumatisme Monographies 2011;78:107-13. [DOI: 10.1016/j.monrhu.2011.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 643 |
Lehouck A, Boonen S, Decramer M, Janssens W. COPD, Bone Metabolism, and Osteoporosis. Chest 2011;139:648-57. [DOI: 10.1378/chest.10-1427] [Cited by in Crossref: 114] [Cited by in F6Publishing: 138] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 644 |
Henriksen K, Bollerslev J, Everts V, Karsdal MA. Osteoclast activity and subtypes as a function of physiology and pathology--implications for future treatments of osteoporosis. Endocr Rev 2011;32:31-63. [PMID: 20851921 DOI: 10.1210/er.2010-0006] [Cited by in Crossref: 168] [Cited by in F6Publishing: 168] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 645 |
Gabet Y, Noh T, Lee C, Frenkel B. Developmentally regulated inhibition of cell cycle progression by glucocorticoids through repression of cyclin a transcription in primary osteoblast cultures. J Cell Physiol 2011;226:991-8. [DOI: 10.1002/jcp.22412] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 646 |
Rauch A, Gossye V, Bracke D, Gevaert E, Jacques P, Van Beneden K, Vandooren B, Rauner M, Hofbauer LC, Haegeman G, Elewaut D, Tuckermann JP, De Bosscher K. An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. FASEB J 2011;25:1323-32. [PMID: 21233489 DOI: 10.1096/fj.10-173393] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 647 |
Sugiyama T, Suzuki S, Yoshida T, Suyama K, Tanaka T, Sueishi M, Tatsuno I. Incidence of symptomatic vertebral fractures in women of childbearing age newly treated with high-dose glucocorticoid. Gend Med 2010;7:218-29. [PMID: 20638627 DOI: 10.1016/j.genm.2010.06.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 648 |
Lorenzo JA, Canalis E, Raisz LG. Metabolic Bone Disease. Williams Textbook of Endocrinology 2011. [DOI: 10.1016/b978-1-4377-0324-5.00029-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 649 |
Pignolo RJ. Evaluation of Bone Fragility and Fracture Prevention. Fractures in the Elderly 2011. [DOI: 10.1007/978-1-60327-467-8_16] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 650 |
Marcelli C. Osteoporosis inducida por corticoides. EMC - Aparato Locomotor 2011;44:1-11. [DOI: 10.1016/s1286-935x(11)71143-1] [Reference Citation Analysis]
|
| 651 |
Marcelli C. Ostéoporose cortisonique. EMC - Appareil locomoteur 2011;6:1-10. [DOI: 10.1016/s0246-0521(11)51769-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 652 |
Weinstein BM, Epstein S. Drug and Hormone Effects on Vitamin D Metabolism. Vitamin D 2011. [DOI: 10.1016/b978-0-12-381978-9.10067-8] [Reference Citation Analysis]
|
| 653 |
Sambrook P. Glucocorticoids and Vitamin D. Vitamin D 2011. [DOI: 10.1016/b978-0-12-381978-9.10066-6] [Reference Citation Analysis]
|
| 654 |
Rauner M, Goettsch C, Stein N, Thiele S, Bornhaeuser M, De Bosscher K, Haegeman G, Tuckermann J, Hofbauer LC. Dissociation of osteogenic and immunological effects by the selective glucocorticoid receptor agonist, compound A, in human bone marrow stromal cells. Endocrinology 2011;152:103-12. [PMID: 21084452 DOI: 10.1210/en.2010-0456] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 655 |
Sugiyama T, Suzuki S, Yoshida T, Mayama T, Hashimoto N, Suyama K, Tanaka T, Sueishi M, Tatsuno I. Age, Initial Dose and Dose Increase are Independent Risk Factors for Symptomatic Vertebral Fractures in Glucocorticoid-Treated Male Patients. Intern Med 2011;50:817-824. [DOI: 10.2169/internalmedicine.50.4443] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 656 |
Sambrook PN. Glucocorticoid-induced osteoporosis. Rheumatology 2011. [DOI: 10.1016/b978-0-323-06551-1.00198-6] [Reference Citation Analysis]
|
| 657 |
Roth P, Wick W, Weller M. Steroids in neurooncology: actions, indications, side-effects: . Current Opinion in Neurology 2010;23:597-602. [DOI: 10.1097/wco.0b013e32833e5a5d] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 658 |
van Lierop AH, Hamdy NA, Papapoulos SE. Glucocorticoids are not always deleterious for bone. J Bone Miner Res 2010;25:2796-800. [PMID: 20549703 DOI: 10.1002/jbmr.151] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 659 |
Lehouck A, van Remoortel H, Troosters T, Decramer M, Janssens W. BPCO et métabolisme osseux: une mise à jour clinique. Revue des Maladies Respiratoires 2010;27:1231-42. [DOI: 10.1016/j.rmr.2010.10.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 660 |
Arlt W, Willis DS, Wild SH, Krone N, Doherty EJ, Hahner S, Han TS, Carroll PV, Conway GS, Rees DA, Stimson RH, Walker BR, Connell JM, Ross RJ; United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE). Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J Clin Endocrinol Metab 2010;95:5110-21. [PMID: 20719839 DOI: 10.1210/jc.2010-0917] [Cited by in Crossref: 305] [Cited by in F6Publishing: 319] [Article Influence: 23.5] [Reference Citation Analysis]
|
| 661 |
Russell LA. Osteoporosis and Osteomalacia. Rheumatic Disease Clinics of North America 2010;36:665-80. [DOI: 10.1016/j.rdc.2010.09.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 662 |
Mancini T, Porcelli T, Giustina A. Treatment of Cushing disease: overview and recent findings. Ther Clin Risk Manag 2010;6:505-16. [PMID: 21063461 DOI: 10.2147/TCRM.S12952] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 663 |
Bon JM, Zhang Y, Duncan SR, Pilewski JM, Zaldonis D, Zeevi A, McCurry KR, Greenspan SL, Sciurba FC. Plasma inflammatory mediators associated with bone metabolism in COPD. COPD 2010;7:186-91. [PMID: 20486817 DOI: 10.3109/15412555.2010.482114] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 664 |
Mazziotti G, Canalis E, Giustina A. Drug-induced osteoporosis: mechanisms and clinical implications. Am J Med 2010;123:877-84. [PMID: 20920685 DOI: 10.1016/j.amjmed.2010.02.028] [Cited by in Crossref: 181] [Cited by in F6Publishing: 186] [Article Influence: 13.9] [Reference Citation Analysis]
|
| 665 |
Søe K, Delaissé JM. Glucocorticoids maintain human osteoclasts in the active mode of their resorption cycle. J Bone Miner Res 2010;25:2184-92. [PMID: 20499345 DOI: 10.1002/jbmr.113] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 666 |
Kaji H, Kuroki Y, Murakawa Y, Funakawa I, Funasaka Y, Kanda F, Sugimoto T. Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: a prospective study. Osteoporos Int 2010;21:1565-71. [PMID: 19921083 DOI: 10.1007/s00198-009-1110-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 667 |
Bellido T. Antagonistic interplay between mechanical forces and glucocorticoids in bone: a tale of kinases. J Cell Biochem 2010;111:1-6. [PMID: 20506204 DOI: 10.1002/jcb.22660] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 668 |
Cauley JA, Blackwell T, Zmuda JM, Fullman RL, Ensrud KE, Stone KL, Barrett-Connor E, Orwoll ES; Osteoporotic Fractures in Men Study. Correlates of trabecular and cortical volumetric bone mineral density at the femoral neck and lumbar spine: the osteoporotic fractures in men study (MrOS). J Bone Miner Res 2010;25:1958-71. [PMID: 20572023 DOI: 10.1002/jbmr.86] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 669 |
Silva SRB, Tempone AJ, Silva TP, Costa MRS, Pereira GM, Lara FA, Pessolani MCV, Esquenazi D. Mycobacterium leprae downregulates the expression of PHEX in Schwann cells and osteoblasts. Mem Inst Oswaldo Cruz 2010;105:627-32. [DOI: 10.1590/s0074-02762010000500005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 670 |
Mazziotti G, Porcelli T, Bianchi A, Cimino V, Patelli I, Mejia C, Fusco A, Giampietro A, De Marinis L, Giustina A. Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency. European Journal of Endocrinology 2010;163:15-20. [DOI: 10.1530/eje-10-0125] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 671 |
Desai SP, Solomon DH. The use of glucocorticoids in rheumatoid arthritis--no 'rational' approach yet. Arthritis Res Ther 2010;12:127. [PMID: 20602811 DOI: 10.1186/ar3035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 672 |
Yang M, Trettel LB, Adams DJ, Harrison JR, Canalis E, Kream BE. Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation. Bone 2010;47:573-82. [PMID: 20541046 DOI: 10.1016/j.bone.2010.06.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 673 |
Rauch A, Seitz S, Baschant U, Schilling AF, Illing A, Stride B, Kirilov M, Mandic V, Takacz A, Schmidt-Ullrich R, Ostermay S, Schinke T, Spanbroek R, Zaiss MM, Angel PE, Lerner UH, David JP, Reichardt HM, Amling M, Schütz G, Tuckermann JP. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab 2010;11:517-31. [PMID: 20519123 DOI: 10.1016/j.cmet.2010.05.005] [Cited by in Crossref: 298] [Cited by in F6Publishing: 304] [Article Influence: 22.9] [Reference Citation Analysis]
|
| 674 |
Kao CL, Tai LK, Chiou SH, Chen YJ, Lee KH, Chou SJ, Chang YL, Chang CM, Chen SJ, Ku HH. Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells. Stem Cells Dev. 2010;19:247-258. [PMID: 19656070 DOI: 10.1089/scd.2009.0186] [Cited by in Crossref: 90] [Cited by in F6Publishing: 91] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 675 |
Bhalla AK. Management of osteoporosis in a pre-menopausal woman. Best Practice & Research Clinical Rheumatology 2010;24:313-27. [DOI: 10.1016/j.berh.2010.01.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 676 |
Ringe JD. Strontium ranelate: an effective solution for diverse fracture risks. Osteoporos Int 2010;21 Suppl 2:S431-6. [PMID: 20464377 DOI: 10.1007/s00198-010-1241-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 677 |
Payer J, Brazdilova K, Jackuliak P. Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options. Drug Healthc Patient Saf 2010;2:49-59. [PMID: 21701617 DOI: 10.2147/dhps.s7197] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 678 |
Breathnach SM, Smith CH, Chalmers RJG, Hay RJ. Systemic Therapy. Rook's Textbook of Dermatology 2010. [DOI: 10.1002/9781444317633.ch74] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 679 |
Zaidi M, Sun L, Robinson LJ, Tourkova IL, Liu L, Wang Y, Zhu LL, Liu X, Li J, Peng Y, Yang G, Shi X, Levine A, Iqbal J, Yaroslavskiy BB, Isales C, Blair HC. ACTH protects against glucocorticoid-induced osteonecrosis of bone. Proc Natl Acad Sci U S A 2010;107:8782-7. [PMID: 20421485 DOI: 10.1073/pnas.0912176107] [Cited by in Crossref: 104] [Cited by in F6Publishing: 110] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 680 |
Fedotova AS, Molitvoslovova NN, Alekseeva LI, Rozhinskaya LY, Fedotova AS, Molitvoslovova NN, Alexeeva LI, Rozhinskaya LY. CONDITION OF THE MUSCULOSKELETAL SYSTEM IN PATIENTSWITH ACROMEGALY. Osteopor Bone Dis 2010;13:19-27. [DOI: 10.14341/osteo2010119-27] [Reference Citation Analysis]
|
| 681 |
Chia FL, Thong BY, Lau TC, Feng PH. Recurrent fractures in an elderly patient with systemic lupus erythematosus. Int J Rheum Dis 2009;12:256-63. [PMID: 20374356 DOI: 10.1111/j.1756-185X.2009.01422.x] [Reference Citation Analysis]
|
| 682 |
Canalis E. Update in new anabolic therapies for osteoporosis. J Clin Endocrinol Metab 2010;95:1496-504. [PMID: 20375217 DOI: 10.1210/jc.2009-2677] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 683 |
Ibañez M, Ortiz AM, Castrejón I, García-Vadillo JA, Carvajal I, Castañeda S, González-Alvaro I. A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass. Arthritis Res Ther 2010;12:R50. [PMID: 20331862 DOI: 10.1186/ar2961] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 684 |
Hofbauer LC, Hamann C, Ebeling PR. Approach to the patient with secondary osteoporosis. Eur J Endocrinol 2010;162:1009-20. [PMID: 20231368 DOI: 10.1530/EJE-10-0015] [Cited by in Crossref: 62] [Cited by in F6Publishing: 68] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 685 |
Järveläinen H, Sainio A, Koulu M, Wight TN, Penttinen R. Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev 2009;61:198-223. [PMID: 19549927 DOI: 10.1124/pr.109.001289] [Cited by in Crossref: 331] [Cited by in F6Publishing: 353] [Article Influence: 25.5] [Reference Citation Analysis]
|
| 686 |
Alomran AS. Osteoporosis-related simultaneous four joints fractures and dislocation after a seizure: a case report. J Osteoporos 2010;2010:808341. [PMID: 20981335 DOI: 10.4061/2010/808341] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 687 |
Mazziotti G, Porcelli T, Patelli I, Vescovi PP, Giustina A. Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density. Bone 2010;46:747-51. [DOI: 10.1016/j.bone.2009.10.031] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 688 |
Zaidi M, Turner CH, Canalis E, Pacifici R, Sun L, Iqbal J, Guo XE, Silverman S, Epstein S, Rosen CJ. Bone loss or lost bone: rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss. Curr Osteoporos Rep 2009;7:118-26. [PMID: 19968915 DOI: 10.1007/s11914-009-0021-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 689 |
Canalis E. Growth factor control of bone mass. J Cell Biochem 2009;108:769-77. [PMID: 19718659 DOI: 10.1002/jcb.22322] [Cited by in Crossref: 81] [Cited by in F6Publishing: 85] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 690 |
Gennari L. Pharmacogenomics of Osteoporosis. Clinic Rev Bone Miner Metab 2010;8:77-94. [DOI: 10.1007/s12018-010-9071-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 691 |
Weber AJ, Li G, Kalak R, Street J, Buttgereit F, Dunstan CR, Seibel MJ, Zhou H. Osteoblast-targeted disruption of glucocorticoid signalling does not delay intramembranous bone healing. Steroids 2010;75:282-6. [PMID: 20096296 DOI: 10.1016/j.steroids.2010.01.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 692 |
Eastell R, Chen P, Saag KG, Burshell AL, Wong M, Warner MR, Krege JH. Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate. Bone 2010;46:929-34. [PMID: 20060078 DOI: 10.1016/j.bone.2009.12.021] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 693 |
Pereira RM, Carvalho JF, Canalis E. Glucocorticoid-induced osteoporosis in rheumatic diseases. Clinics (Sao Paulo) 2010;65:1197-205. [PMID: 21243296 DOI: 10.1590/s1807-59322010001100024] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 694 |
Eriksen EF, Halse J. The Use of Bone Biopsies in the Diagnosis of Male Osteoporosis. Osteoporosis in Men 2010. [DOI: 10.1016/b978-0-12-374602-3.00047-x] [Reference Citation Analysis]
|
| 695 |
Mazziotti G, Giustina A. Glucocorticoid-induced Osteoporosis. Osteoporosis in Men 2010. [DOI: 10.1016/b978-0-12-374602-3.00034-1] [Reference Citation Analysis]
|
| 696 |
Loechner KJ, Patel S, Fordham L, McLaughlin JT. Decreased bone mineral density and vertebral compression fractures in a young adult male with 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH): is CAH an unrecognized population at risk for glucocorticoid-induced osteoporosis? J Pediatr Endocrinol Metab 2010;23:179-87. [PMID: 20432821 DOI: 10.1515/jpem.2010.23.1-2.179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 697 |
Ferrari S, Ringe JD. Pathophysiology of postmenopausal osteoporosis. Atlas of Postmenopausal Osteoporosis 2010. [DOI: 10.1007/978-1-907673-28-3_1] [Reference Citation Analysis]
|
| 698 |
Clarke B. Effects of Teriparatide Versus Alendronate for Treating Glucocorticoid-Induced Osteoporosis: Thirty-Six–Month Results of a Randomized, Double-Blind, Controlled Trial. Yearbook of Endocrinology 2010;2010:223-226. [DOI: 10.1016/s0084-3741(10)79517-2] [Reference Citation Analysis]
|
| 699 |
Hwang J, Lee SH, Kim GS, Koh J, Go MJ, Kim Y, Kim H, Kim T, Hong JM, Park EK, Lee J, Kim S. HSD11B1 polymorphisms predicted bone mineral density and fracture risk in postmenopausal women without a clinically apparent hypercortisolemia. Bone 2009;45:1098-103. [DOI: 10.1016/j.bone.2009.07.080] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 700 |
Langdahl BL, Marin F, Shane E, Dobnig H, Zanchetta JR, Maricic M, Krohn K, See K, Warner MR. Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status. Osteoporos Int 2009;20:2095-104. [PMID: 19350340 DOI: 10.1007/s00198-009-0917-y] [Cited by in Crossref: 85] [Cited by in F6Publishing: 67] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 701 |
Postnov A, De Schutter T, Sijbers J, Karperien M, De Clerck N. Glucocorticoid-induced osteoporosis in growing mice is not prevented by simultaneous intermittent PTH treatment. Calcif Tissue Int 2009;85:530-7. [PMID: 19844646 DOI: 10.1007/s00223-009-9301-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 702 |
Kok C, Sambrook P. Secondary osteoporosis in patients with an osteoporotic fracture. Best Practice & Research Clinical Rheumatology 2009;23:769-79. [DOI: 10.1016/j.berh.2009.09.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 703 |
Malluche HH, Monier-Faugere MC, Herberth J. Bone disease after renal transplantation. Nat Rev Nephrol. 2010;6:32-40. [PMID: 19918255 DOI: 10.1038/nrneph.2009.192] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 704 |
Devogelaer JP, Adler RA, Recknor C, See K, Warner MR, Wong M, Krohn K. Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis. J Rheumatol 2010;37:141-8. [PMID: 19918047 DOI: 10.3899/jrheum.090411] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 705 |
Szappanos A, Patócs A, Tõke J, Boyle B, Sereg M, Majnik J, Borgulya G, Varga I, Likó I, Rácz K, Tóth M. BclI polymorphism of the glucocorticoid receptor gene is associated with decreased bone mineral density in patients with endogenous hypercortisolism. Clin Endocrinol (Oxf) 2009;71:636-43. [PMID: 19207316 DOI: 10.1111/j.1365-2265.2009.03528.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 706 |
Saag KG, Zanchetta JR, Devogelaer J, Adler RA, Eastell R, See K, Krege JH, Krohn K, Warner MR. Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial: Teriparatide Versus Alendronate in Glucocorticoid-Induced OP. Arthritis & Rheumatism 2009;60:3346-55. [DOI: 10.1002/art.24879] [Cited by in Crossref: 331] [Cited by in F6Publishing: 342] [Article Influence: 23.6] [Reference Citation Analysis]
|
| 707 |
Langhammer A, Forsmo S, Syversen U. Long-term therapy in COPD: any evidence of adverse effect on bone? Int J Chron Obstruct Pulmon Dis 2009;4:365-80. [PMID: 19888355 DOI: 10.2147/copd.s4797] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 708 |
Zimmermann A, Sido PG, Schulze E, Al Khzouz C, Lazea C, Coldea C, Weber MM. Bone mineral density and bone turnover in Romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy. Clin Endocrinol (Oxf) 2009;71:477-84. [PMID: 19170706 DOI: 10.1111/j.1365-2265.2008.03518.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 709 |
van Brussel MS, Bultink IE, Lems WF. Prevention of glucocorticoid-induced osteoporosis. Expert Opin Pharmacother. 2009;10:997-1005. [PMID: 19351276 DOI: 10.1517/14656560902868225] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 710 |
Mak A, Cheung MW, Ho RC, Cheak AA, Lau CS. Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies. BMC Musculoskelet Disord 2009;10:113. [PMID: 19772579 DOI: 10.1186/1471-2474-10-113] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 711 |
Chaiban J, Muwakkit S, Arabi A, Jomaa L, Daouk LO, El-Rassi R, Abboud M, El-Hajj Fuleihan G. Modeling pathways for low bone mass in children with malignancies. J Clin Densitom 2009;12:441-9. [PMID: 19766031 DOI: 10.1016/j.jocd.2009.06.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 712 |
Dvorak G, Reich K, Tangl S, Lill C, Gottschalk-baron M, Watzek G, Gruber R, Haas R. Periodontal histomorphometry and status of aged sheep subjected to ovariectomy, malnutrition and glucocorticoid application. Archives of Oral Biology 2009;54:857-63. [DOI: 10.1016/j.archoralbio.2009.05.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 713 |
Haney EM, Warden SJ, Bliziotes MM. Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management? Bone 2010;46:13-7. [PMID: 19664737 DOI: 10.1016/j.bone.2009.07.083] [Cited by in Crossref: 76] [Cited by in F6Publishing: 83] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 714 |
Helas S, Goettsch C, Schoppet M, Zeitz U, Hempel U, Morawietz H, Kostenuik PJ, Erben RG, Hofbauer LC. Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice. Am J Pathol 2009;175:473-8. [PMID: 19590040 DOI: 10.2353/ajpath.2009.080957] [Cited by in Crossref: 111] [Cited by in F6Publishing: 117] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 715 |
Weinstein RS. Glucocorticoids, osteocytes, and skeletal fragility: the role of bone vascularity. Bone 2010;46:564-70. [PMID: 19591965 DOI: 10.1016/j.bone.2009.06.030] [Cited by in Crossref: 92] [Cited by in F6Publishing: 84] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 716 |
Bouamar R, Koper JW, van Rossum EF, Weimar W, van Gelder T. Polymorphisms of the glucocorticoid receptor and avascular necrosis of the femoral heads after treatment with corticosteroids. NDT Plus 2009;2:384-6. [PMID: 25949351 DOI: 10.1093/ndtplus/sfp082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 717 |
Faienza MF, Brunetti G, Colucci S, Piacente L, Ciccarelli M, Giordani L, Del Vecchio GC, D'Amore M, Albanese L, Cavallo L, Grano M. Osteoclastogenesis in children with 21-hydroxylase deficiency on long-term glucocorticoid therapy: the role of receptor activator of nuclear factor-kappaB ligand/osteoprotegerin imbalance. J Clin Endocrinol Metab 2009;94:2269-76. [PMID: 19401376 DOI: 10.1210/jc.2008-2446] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 718 |
Hofbauer LC, Zeitz U, Schoppet M, Skalicky M, Schüler C, Stolina M, Kostenuik PJ, Erben RG. Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL. Arthritis Rheum 2009;60:1427-37. [PMID: 19404943 DOI: 10.1002/art.24445] [Cited by in Crossref: 98] [Cited by in F6Publishing: 103] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 719 |
Järveläinen H, Sainio A, Koulu M, Wight TN, Penttinen R. Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy. Pharmacol Rev 2009;61:198-223. [DOI: 10.1124/pr.109.001289] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 720 |
Bouvard B, Legrand E, Audran M, Chappard D. Glucocorticoid-Induced Osteoporosis: A Review. Clinic Rev Bone Miner Metab 2010;8:15-26. [DOI: 10.1007/s12018-009-9051-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 721 |
Lirani-Galvão AP, Chavassieux P, Portero-Muzy N, Bergamaschi CT, Silva OL, Carvalho AB, Lazaretti-Castro M, Delmas PD. Low-intensity electrical stimulation counteracts the effects of ovariectomy on bone tissue of rats: effects on bone microarchitecture, viability of osteocytes, and nitric oxide expression. Calcif Tissue Int 2009;84:502-9. [PMID: 19458889 DOI: 10.1007/s00223-009-9227-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 722 |
Bouvard B, Audran M, Legrand E, Chappard D. Ultrastructural characteristics of glucocorticoid-induced osteoporosis. Osteoporos Int 2009;20:1089-92. [PMID: 19340501 DOI: 10.1007/s00198-009-0864-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 723 |
Hofbauer LC, Rauner M. Minireview: live and let die: molecular effects of glucocorticoids on bone cells. Mol Endocrinol 2009;23:1525-31. [PMID: 19477950 DOI: 10.1210/me.2009-0069] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 724 |
Caplan L, Saag KG. Glucocorticoids and the risk of osteoporosis. Expert Opin Drug Saf 2009;8:33-47. [PMID: 19236216 DOI: 10.1517/14740330802648194] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 725 |
Cauley JA, Lui LY, Genant HK, Salamone L, Browner W, Fink HA, Cohen P, Hillier T, Bauer DC, Cummings SR; Study of Osteoporotic Fractures Research and Group. Risk factors for severity and type of the hip fracture. J Bone Miner Res 2009;24:943-55. [PMID: 19113930 DOI: 10.1359/jbmr.081246] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 726 |
Tatsuno I, Sugiyama T, Suzuki S, Yoshida T, Tanaka T, Sueishi M, Saito Y. Age dependence of early symptomatic vertebral fracture with high-dose glucocorticoid treatment for collagen vascular diseases. J Clin Endocrinol Metab 2009;94:1671-7. [PMID: 19258412 DOI: 10.1210/jc.2008-1578] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 727 |
Sadat-Ali M, Alelq AH, Alshafei BA, Al-Turki HA, Abujubara MA. Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy. Ann Saudi Med 2009;29:215-8. [PMID: 19448373 DOI: 10.5144/0256-4947.2009.215] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 728 |
Gennari L, Bilezikian JP. Glucocorticoid-induced osteoporosis: hope on the HORIZON. Lancet 2009;373:1225-6. [PMID: 19362657 DOI: 10.1016/S0140-6736(09)60704-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 729 |
Reid DM, Devogelaer JP, Saag K, Roux C, Lau CS, Reginster JY, Papanastasiou P, Ferreira A, Hartl F, Fashola T, Mesenbrink P, Sambrook PN; HORIZON investigators. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet 2009;373:1253-63. [PMID: 19362675 DOI: 10.1016/S0140-6736(09)60250-6] [Cited by in Crossref: 361] [Cited by in F6Publishing: 268] [Article Influence: 25.8] [Reference Citation Analysis]
|
| 730 |
Islam S, Liu Q, Chines A, Helzner E. Trend in incidence of osteoporosis-related fractures among 40- to 69-year-old women: analysis of a large insurance claims database, 2000-2005. Menopause 2009;16:77-83. [PMID: 18703983 DOI: 10.1097/gme.0b013e31817b816e] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 731 |
Teplyuk NM, Zhang Y, Lou Y, Hawse JR, Hassan MQ, Teplyuk VI, Pratap J, Galindo M, Stein JL, Stein GS, Lian JB, van Wijnen AJ. The osteogenic transcription factor runx2 controls genes involved in sterol/steroid metabolism, including CYP11A1 in osteoblasts. Mol Endocrinol 2009;23:849-61. [PMID: 19342447 DOI: 10.1210/me.2008-0270] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 732 |
Olkku A, Mahonen A. Calreticulin mediated glucocorticoid receptor export is involved in β-catenin translocation and Wnt signalling inhibition in human osteoblastic cells. Bone 2009;44:555-65. [DOI: 10.1016/j.bone.2008.11.013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 733 |
Bitto A, Burnett BP, Polito F, Levy RM, Marini H, Di Stefano V, Irrera N, Armbruster MA, Minutoli L, Altavilla D, Squadrito F. Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate. Br J Pharmacol 2009;156:1287-95. [PMID: 19302595 DOI: 10.1111/j.1476-5381.2008.00100.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 734 |
Løvås K, Gjesdal CG, Christensen M, Wolff AB, Almås B, Svartberg J, Fougner KJ, Syversen U, Bollerslev J, Falch JA, Hunt PJ, Chatterjee VK, Husebye ES. Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. Eur J Endocrinol 2009;160:993-1002. [PMID: 19282465 DOI: 10.1530/EJE-08-0880] [Cited by in Crossref: 108] [Cited by in F6Publishing: 114] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 735 |
Cui L, Liu YY, Wu T, Ai CM, Chen HQ. Osteogenic effects of D+beta-3,4-dihydroxyphenyl lactic acid (salvianic acid A, SAA) on osteoblasts and bone marrow stromal cells of intact and prednisone-treated rats. Acta Pharmacol Sin 2009;30:321-32. [PMID: 19262556 DOI: 10.1038/aps.2009.9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 736 |
Wetzsteon RJ, Shults J, Zemel BS, Gupta PU, Burnham JM, Herskovitz RM, Howard KM, Leonard MB. Divergent effects of glucocorticoids on cortical and trabecular compartment BMD in childhood nephrotic syndrome. J Bone Miner Res 2009;24:503-13. [PMID: 19016583 DOI: 10.1359/jbmr.081101] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 737 |
Bachrach LK, Ward LM. Clinical review 1: Bisphosphonate use in childhood osteoporosis. J Clin Endocrinol Metab 2009;94:400-9. [PMID: 19033370 DOI: 10.1210/jc.2008-1531] [Cited by in Crossref: 167] [Cited by in F6Publishing: 175] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 738 |
Yao W, Cheng Z, Pham A, Busse C, Zimmermann EA, Ritchie RO, Lane NE. Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization. Arthritis Rheum 2008;58:3485-97. [PMID: 18975341 DOI: 10.1002/art.23954] [Cited by in Crossref: 96] [Cited by in F6Publishing: 102] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 739 |
Dubner SE, Shults J, Baldassano RN, Zemel BS, Thayu M, Burnham JM, Herskovitz RM, Howard KM, Leonard MB. Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease. Gastroenterology 2009;136:123-30. [PMID: 19026647 DOI: 10.1053/j.gastro.2008.09.072] [Cited by in Crossref: 135] [Cited by in F6Publishing: 141] [Article Influence: 9.6] [Reference Citation Analysis]
|
| 740 |
Sambrook PN. Glucocorticoid-induced osteoporosis. International Journal of Rheumatic Diseases 2008;11:381-5. [DOI: 10.1111/j.1756-185x.2008.00391.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 741 |
Aulakh R, Singh S. Strategies for minimizing corticosteroid toxicity: a review. Indian J Pediatr 2008;75:1067-73. [PMID: 19023531 DOI: 10.1007/s12098-008-0211-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 742 |
Kaufman JM, Goemaere S. Osteoporosis in men. Best Pract Res Clin Endocrinol Metab 2008;22:787-812. [PMID: 19028357 DOI: 10.1016/j.beem.2008.09.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 743 |
Dvorak G, Gruber R, Huber C, Goldhahn J, Zanoni G, Salaberger D, Watzek G, Haas R. Trabecular Bone Structures in the Edentulous Diastema of Osteoporotic Sheep. J Dent Res 2008;87:866-70. [DOI: 10.1177/154405910808700918] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 744 |
Arabi A, Fuleihan Gel-H. How effective is risedronate in preventing bone loss in patients on high-dose steroids? Nat Clin Pract Endocrinol Metab 2008;4:540-1. [PMID: 18711408 DOI: 10.1038/ncpendmet0923] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 745 |
Därr R, Ziller V, Hadji P, Hofbauer LC. [Clinical presentation and diagnosis of osteoporosis and osteomalacia]. Internist (Berl) 2008;49:1170, 1172-7. [PMID: 18704352 DOI: 10.1007/s00108-008-2114-z] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 746 |
Giustina A, Mazziotti G, Canalis E. Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 2008;29:535-59. [PMID: 18436706 DOI: 10.1210/er.2007-0036] [Cited by in Crossref: 568] [Cited by in F6Publishing: 579] [Article Influence: 37.9] [Reference Citation Analysis]
|
| 747 |
McMaster A, Ray DW. Drug insight: selective agonists and antagonists of the glucocorticoid receptor. Nat Clin Pract Endocrinol Metab 2008;4:91-101. [PMID: 18212811 DOI: 10.1038/ncpendmet0745] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 748 |
Khosla S, Amin S, Orwoll E. Osteoporosis in men. Endocr Rev 2008;29:441-64. [PMID: 18451258 DOI: 10.1210/er.2008-0002] [Cited by in Crossref: 265] [Cited by in F6Publishing: 277] [Article Influence: 17.7] [Reference Citation Analysis]
|
| 749 |
Prabhakaran R, Misra M. Impaired bone health in anorexia nervosa. Future Rheumatology 2008;3:281-296. [DOI: 10.2217/17460816.3.3.281] [Reference Citation Analysis]
|
| 750 |
John Wiley & Sons, Ltd.. Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidem Drug Safe 2008;17:i-xvi. [DOI: 10.1002/pds.1485] [Reference Citation Analysis]
|
| 751 |
Trikudanathan S, Mcmahon GT. Optimum management of glucocorticoid-treated patients. Nat Rev Endocrinol 2008;4:262-71. [DOI: 10.1038/ncpendmet0791] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 752 |
Kream BE, Graves L, Lukert BP. Clinical and Basic Aspects of Glucocorticoid Action in Bone. Principles of Bone Biology 2008. [DOI: 10.1016/b978-0-12-373884-4.00061-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 753 |
Mazziotti G, Giustina A, Canalis E, Bilezikian JP. Glucocorticoid-Induced osteoporosis: clinical and therapeutic aspects. Arq Bras Endocrinol Metab 2007;51:1404-12. [DOI: 10.1590/s0004-27302007000800028] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 754 |
Ferrari S, Seeman E, Strewler GJ. Clinical and basic research papers–September 2007 selections. IBMS BoneKEy 2007;4:257-261. [DOI: 10.1138/20070273] [Reference Citation Analysis]
|
